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1. Introduction 
Early embryonic development, implantation and maintenance of pregnancy are 
critically dependent on an intact embryo-maternal communication. In cattle, up to 
40% of total embryonic losses occur between days 8 and 17 of pregnancy, indicating 
that early embryonic mortality is the major cause of reproductive failure and has 
enormous economic implications (Humblot, 2001). Failures in the embryo-maternal 
cross-talk are in particular assumed to be responsible for the high failure rate to 
maintain early pregnancy. In ruminants conceptus-derived IFNτ is well characterized 
as an important pregnancy recognition signal. It is secreted by trophectoderm cells of 
blastocysts between days 14 to 26 with maximum secretion occurring around day 17 
(Bazer et al., 1997), which coincides with the time of “maternal recognition of 
pregnancy”. IFNτ acts in a paracrine manner on the endometrium to prevent pulsatile 
release of PGF2α and thereby rescues the corpus luteum from regression. The 
abrogation of the luteolytic mechanism by IFNτ ensures ongoing secretion of luteal 
progesterone. Progesterone is among other hormones mainly responsible for uterine 
remodeling and uterine gland morphogenesis, which is a prerequisite for production 
of histotrophs necessary to nourish the conceptus during the pre-implantation period. 
Further, IFNτ is known to stimulate the transcription of several genes, which are 
hypothesized to play roles in endometrial differentiation and conceptus implantation. 
Although, the general mechanisms of hormonal regulation in the endometrium during 
establishment of a pregnancy in ruminants are known, the detailed molecular 
mechanisms are not completely understood. Therefore, a combination of subtracted 
cDNA libraries and microarray technology was applied to identify genes upregulated 
in the bovine endometrium due to the presence of a conceptus in the pre-
implantation period. The knowledge of the mechanisms underlying successful 
establishment of pregnancy could help to reduce embryonic losses, e.g. by 
supplementation of embryotrophic factors or components of embryo-maternal 
signaling in optimized formulations such as bioartificial matrices. As a long-term goal, 
signaling mechanisms identified in the bovine species could also be functionally 
evaluated in other species. 
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2. Review of the literature 
2.1. Implantation 
After fertilization in the oviduct, the fertilized ovum moves towards the uterus while 
undergoing several cell divisions. At the 8-cell-stage, about 72 hours after ovulation, 
the bovine conceptus reaches the uterus. The morula stage is reached by day 5 to 6 
post ovulationem and on day 8 the first differentiation, formation of the blastocyst, 
occurs. The blastocyst, which contains a blastocoel, consists of two distinct cell 
types: the trophectoderm, the outer layer of rapidly dividing cells, and the inner cell 
mass (ICM), which comprises undifferentiated cuboidal cells. The ICM gives rise to 
the embryo plus extra-embryonic membranes such as allantois and amnion, while 
the trophectoderm contributes to the trophoblast layers of the placenta. On day 9 
post conceptionem (p.c.) the blastocyst hatches from the zona pellucida and on day 
13 p.c. rapid elongation starts. After elongation the ruminant conceptus occupies 
almost the entire surface of the uterine luminal epithelium. During this pre-attachment 
period the blastocyst is free floating in the uterus until about day 18 to 19 of gestation 
when implantation starts (Rüsse and Sinowatz, 1998). Implantation is the process 
through which a developing conceptus attaches to the endometrium. It is a 
temporally and spatially restricted process that involves a precise cross-talk between 
the embryo and the receptive maternal endometrium. A variety of cytokines and 
growth factors have become increasingly implicated in embryonic implantation. 
2.1.1. Cytokines and implantation 
Leukemia inhibitory factor 
Many cytokines are expressed in the uterus, but only few have been shown to be 
required for embryonic implantation. The clearest example is the requirement, at 
least in the murine and human species, of maternally produced leukemia inhibitory 
factor (LIF), a pleiotropic cytokine. In mice, the sites of most abundant LIF expression 
are the uterine endometrial glands, specifically on day 4 of pregnancy, which 
coincides with the time of implantation. Analysis of LIF expression in pseudopregnant 
mice and in those undergoing implantation showed that it is under maternal control 
and coincides with blastocyst formation and always precedes implantation (Bhatt et 
al., 1991). Blastocysts of female mice lacking a functional LIF gene fail to implant and 
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do not develop. The blastocysts, however are viable and, when transferred to wild-
type pseudopregnant recipients, they can implant and develop to term (Stewart et al., 
1992). Hence, blastocyst implantation in mice depends on maternal expression of 
LIF. Chen et al. (2000) showed that in LIF-deficient mice up to the onset of 
implantation changes in uterine cell proliferation, hormone levels, blastocyst 
localization, as well as expression of lactoferrin and Mucin-1, do not differ from wild-
types. However, the uterus fails to respond to the presence of embryos or artificial 
stimuli by the process of decidualization. They further showed that uterine expression 
of LIF is upregulated by estrogen and that LIF can replace nidatory estrogen at 
inducing both implantation and decidualization in ovariectomized mice. Implantation 
of LIF-deficient embryos in LIF-deficient females with normal development to term is 
rescued by i.p. injection of LIF. Leukemia inhibitory factor is therefore neither 
required by the embryo for development nor for the maintenance of pregnancy, but it 
is absolutely necessary for implantation in mice. In human, LIF expression is also 
coincident with the onset of implantation (Aghajanova, 2004) as well as in the mink 
(Song et al., 1998) and rabbit uterus (Yang et al., 1994). In the bovine species the 
gene expression of LIF was investigated using quantitative RT-PCR in bovine 
endometrial tissues during early and mid-pregnancy (Oshima et al., 2003). The LIF 
gene was expressed in all samples examined. The highest expression was observed 
in the intercaruncular endometrium at days 48-49 and 74-140 of pregnancy and the 
expression was greater than at days 13-14 of the estrous cycle and at other days of 
pregnancy. In the ovine endometrium a decrease in mRNA encoding LIF is observed 
during early pregnancy (on days 12-14) followed by an increase to reach high 
expression levels of LIF mRNA on days 16-20 of pregnancy (Vogiagis et al., 1997a). 
Immunoreactive LIF was mainly localized in the caruncular and intercaruncular 
luminal epithelium, and moderate staining was observed in the glandular epithelium 
and intercaruncular stroma. Passive immunization of ewes against human 
recombinant LIF resulted in a reduced pregnancy rate in comparison to control 
animals (Vogiagis et al., 1997b). In ruminants LIF may not be obligatory for 
implantation but it does appear to have a role during the establishment of pregnancy. 
Interleukin-1 
Interleukin-1 (IL-1) is another cytokine that is assumed to play an important role in 
implantation of the early embryo since blockade of the IL-1 receptor prevents 
implantation in the mouse by interfering with embryonic attachment (Simon et al., 
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1994). In mice, IL-1 bioactivity increases from a low concentration on day 3 of 
pregnancy to a peak between days 4 and 5, the time of blastocyst implantation and 
decreases thereafter to low concentrations on days 7 and 8 (De et al., 1993). 
Besides IL-1, the interleukin-1 type I receptor is found in the mouse uterus around 
the time of implantation (Simon et al., 1994). In human endometrial tissue, IL-1 type I 
receptor mRNA is expressed throughout the entire menstrual cycle. However, IL-1 
type I receptor mRNA levels were found to be significantly higher during both early 
and late luteal phase than in follicular and midluteal phase (Simon et al., 1993). 
Interleukin-1 was also detected in human endometrium during the implantation 
process (Kauma et al., 1990). However, the precise role of IL-1 in the context of 
implantation is not clearly defined, as mice lacking a functional type 1 IL-1 receptor 
do not exhibit any profound alterations in their reproduction, apart from a slight 
reduction in mean litter size (Abbondanzo et al., 1996). 
Macrophage-colony stimulating factor 
Macrophage-colony stimulating factor (M-CSF or CSF-1) is a glycoprotein growth 
factor required for the proliferation and differentiation of mononuclear phagocytotic 
cells (Flanagan and Lader, 1998). Detection of high concentrations of M-CSF in the 
mouse uterus during pregnancy led to the assumption that this cytokine also plays a 
role outside the haematopoietic system (Bartocci et al., 1986). Results from M-CSF 
null mutant mice suggest that M-CSF is required for pregnancy as homozygous 
mutant crosses are consistently infertile. However, maternally derived M-CSF is not 
an absolute requirement for embryonic survival and development, since null mutant 
females are fertile when mated to heterozygous males (Pollard et al., 1991). Pollard 
and coworkers (1987) showed that uterine M-CSF concentration is regulated by the 
synergistic action of the female sex steroids estradiol-17 beta and progesterone. 
These findings indicate that M-CSF, under hormonal influence, plays a role in 
implantation. In the bovine endometrium no significant changes occur in M-CSF gene 
expression in the caruncular area during early to mid-pregnancy. In the 
intercaruncular endometrium M-CSF gene expression is highest at days 74-140 
compared to earlier pregnancy states (Oshima et al., 2003). 
HOXA10 
Hox genes are well known transcriptional regulators that play an essential role in 
embryonic development. The expression of Hoxa10 increases dramatically during the 
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midsecretory phase of the human menstrual cycle, overlapping with the time of 
implantation (Taylor et al., 1998). In mice Hoxa10 gene expression in the uterus is 
strongly activated by progesterone and this activation is blocked by the progesterone 
receptor antagonist RU486 (Ma et al., 1998). Female mice that are homozygous for a 
targeted disruption of the Hoxa10 gene exhibit infertility. Female null mutant mice 
ovulate normally, but about 80% are sterile because of embryonic death between 
days 2.5 and 3.5 post coitum (Satokata et al., 1995). While expression of LIF and 
heparin-binding epidermal growth factor (HB-EGF) appears unaffected in the mutant 
uteri, a decrease is observed in the intensity and number of blue dye reactions, an 
indicator of increased vascular permeability in response to implantation. In addition 
mutant uteri exhibit decreased decidualization in response to artificial stimuli (Benson 
et al., 1996). One mechanism through which HOXA10 might influence the process of 
implantation is by direct regulation of the beta3-integrin subunit expression in the 
endometrium. Seven consensus HOXA10 binding sites were identified 5´ of the 
beta 3-integrin gene and direct binding of HOXA10 protein to four sites has been 
demonstrated (Daftary et al., 2002). 
2.1.2. Growth factors and implantation 
Growth hormone 
Pituitary growth hormone (GH) is known to control postnatal growth and 
differentiation. For a long time embryonic growth and development has been 
assumed to be independent of GH because hypophysectomized mouse, rat and 
rabbit fetuses display almost normal intrauterine growth (Gluckman et al., 1981). 
However, litter sizes in growth hormone receptor (GHR) knockout mice are reduced 
(Danilovich et al., 1999) and several experiments have shown that GH is able to 
influence embryonic development, differentiation, and metabolism. For example, 
culture of murine pre-implantation embryos in the presence of GH supports their 
development in vitro (Drakakis et al., 1995). Growth hormone is able to modulate 
apoptosis during early bovine in vitro embryogenesis and consequently increases 
thereby the cell number in the inner cell mass and the trophectoderm (Kolle et al., 
2002). Further, Kolle et al. (2004) showed that treatment with GH induced the 
elimination of glycogen storage in the inner cell mass and stimulated the exocytosis 
of lipid vesicles in the inner cell mass and the trophectoderm. Overall, treatment with 
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GH results in an improvement of the ultrastructural features of embryos produced in 
vitro. In human endometrium intense staining for GH was observed in the mid and 
late luteal phase of the menstrual cycle, while no staining was observed during the 
proliferative or early luteal phase which implies a role of GH in blastocyst 
implantation (Sbracia et al., 2004). In the sheep, both endometrium and conceptus 
express GH and GHR during early pregnancy (Lacroix et al., 1999). The bovine 
conceptus has been shown to express GH and GHR (Kolle et al., 1998; Kolle et al., 
2001) and the bovine endometrium produces low levels of GHR mRNA during the 
first trimester of gestation which gradually increase to peak at the end of gestation 
(Kolle et al., 1997). 
Epidermal growth factor 
Accumulated evidence suggests that growth factors of the epidermal growth factor 
(EGF) family, including epidermal growth factor (EGF), amphiregulin (AR), heparin-
binding epidermal growth factor (HB-EGF), and transforming growth factor alpha 
(TGF-alpha) play an important role in the implantation process in a variety of species. 
The EGF members signal through a family of receptor tyrosine kinases (Ullrich and 
Schlessinger, 1990), which lead to a signal transduction cascade that regulates 
diverse cellular functions including cell proliferation, survival, adhesion, migration and 
differentiation (Yarden, 2001). In the human endometrium HB-EGF mRNA and 
protein expression is low during the proliferative stage of the menstrual cycle and 
increases in the secretory phase, with highest expression immediately prior to the 
window of implantation (Yoo et al., 1997; Stavreus-Evers et al., 2002; Lessey et al., 
2002). In the mouse, HB-EGF is expressed in the luminal epithelium solely at the 
presumptive sites of blastocyst attachment (Das et al., 1994). Highest levels of EGF, 
TGF-alpha, HB-EGF, AR, and EGF receptor (EGF-R) were detected on days 9 and 
11 of pregnancy in the rhesus monkey uterus, with primarily localization in glandular 
and luminal epithelium, which suggests that they play a role in monkey implantation 
(Yue et al., 2000). Transforming growth factor alpha and EGF were found to be 
present in the caprine endometrium during the peri-implantation period (Flores et al., 
1998). In the ovine and rat species, TGF-alpha and EGF-R have been detected 
around the time of implantation in the endometrium and conceptuses (Gharib-
Hamrouche et al., 1995; Tamada et al., 1997; Tamada et al., 2002). The elongating 
bovine blastocyst expresses EGF-R, EGF, TGF-alpha, and HB-EGF. Further, at day 
13 of gestation, the expression of EGF-R, EGF, and TGF-alpha could be detected in 
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the bovine endometrium (Kliem et al., 1998). It has been shown that EGF and TGF-
alpha stimulate the proliferation of mouse uterine epithelial cells in vitro (Komatsu et 
al., 2003) and, additionally, directly promote trophoblast development (Machida et al., 
1995). Intraluminal injection of EGF is sufficient to initiate implantation and 
decidualization in ovariectomized progesterone-treated delayed implanting rats 
(Tamada et al., 1994), whereas intraluminal injection of anti-TGF-alpha antibodies 
into uterine horns prior to implantation decreases the number of rats showing 
implantation (Tamada et al., 1997). However, regardless of the conserved expression 
pattern of members of the EGF family, their precise role is not clear yet. Gene 
targeting experiments have demonstrated that mice null for EGF, AR (Luetteke et al., 
1999), or TGF-alpha (Mann et al., 1993) are fertile. In addition, compound knockouts 
for all three alleles are still fertile (Troyer et al., 2001). 
Vascular endothelial growth factor 
Angiogenesis is a crucial event during the process of implantation and the uterine 
expression of vascular endothelial growth factor (VEGF) has been characterized in a 
number of species. The vascular endothelial growth factor is related with the platelet-
derived growth factor, PDGF, and exhibits potent angiogenetic activity (Alberts et al., 
2004). The temporal and spatial expression pattern of VEGF in the uterus of rhesus 
monkeys and marmosets implies that this factor may play a critical role in evolving 
pregnancy in these species (Ghosh et al., 2000; Rowe et al., 2003; Wang et al., 
2003). A significant upregulation of the mRNAs of VEGF and its receptors was 
observed in the endometrium during the peri-implantation period when compared 
with the pre-implantation period in pigs (Welter et al., 2003). In human endometrium 
intense immunostaining of VEGF was observed in both glandular epithelial and 
stromal cells during the mid-secretory phase of the menstrual cycle. Further, strong 
staining for VEGF was observed in decidual cells of early pregnant uteri (Sugino et 
al., 2002). 
Insulin-like growth factor system 
Insulin-like growth factors (IGFs) are growth promoting peptides that share significant 
structural homology with insulin. The IGF-system comprises an increasingly complex 
network of ligands (IGF-I and IGF-II), receptors (type I and type II IGF receptor, IGF-
IR and IGF-IIR), and high-affinity binding proteins (IGFBP-1 to -6), which modulate 
bioavailability and effects of the IGFs (Rajaram et al., 1997). The IGF-system has 
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been implicated to play a role in early embryonic development and decreased 
expression of certain members of the IGF-system may be one of the major causes of 
unexplained infertility in women (Wu and Zhou, 2004). Numerous studies have been 
conducted to describe temporal and spatial expression patterns of components of the 
IGF-system during early pregnancy in the uterus of humans (Zhou and Bondy, 1992; 
Strowitzki et al., 1996), baboons (Fazleabas et al., 1989; Tarantino et al., 1992; Hild-
Petito et al., 1994), rats (Sadek et al., 1994; Cerro and Pintar, 1997; Korgun et al., 
2003; Tamura et al., 2004), cats (Boomsma et al., 1994), mice (Hofig et al., 1991; 
Markoff et al., 1995; Liu et al., 1995), pigs (Hofig et al., 1991), and rhesus monkeys 
(Dhara et al., 2001). In the ewe, temporal variations in endometrial expression of 
mRNAs encoding IGF-I and IGF-II, and IGFBP-1 and -2 were investigated between 
estrus and day 20 of pregnancy. The IGF-II transcript level was unaffected by day of 
pregnancy. Insulin-like growth factor I expression was increased at estrus and at day 
8 of pregnancy, relative to expression on day 15, whereas IGFBP-2 expression 
decreased. The insulin-like growth factor binding protein 1 was expressed only on 
day 15. The temporal variation of the expression of mRNAs encoding IGF-I and 
IGFBP-2 suggests a role for these factors in the uterine environment during early 
pregnancy in ewes (Cann et al., 1997). In the bovine species it has been 
demonstrated that endometrial expression of IGF-II mRNA is greater in pregnant 
than cycling endometrium on days 15 and 18. Levels of endometrial IGFBP-2 mRNA 
increased between days 10 and 18 of the estrous cycle and early pregnancy. These 
results suggest that the presence of the bovine conceptus has a stimulatory effect on 
endometrial expression levels of IGF-II, whereas progesterone appears to be 
involved with enhancement of IGFBP-2 (Geisert et al., 1991). In order to determine 
the role that IGFBPs may have in regulating initial stages of conceptus elongation in 
cattle, Keller et al. (1998) evaluated the type and relative abundance of IGFBPs in 
serum, uterine tissues, and uterine fluid from pregnant and non-inseminated cows on 
days 13 and 15 postestrus and in day 15 conceptuses. Insulin-like growth factor 
binding proteins in conceptuses and conceptus-conditioned culture media were only 
faintly detectable, whereas tissue specificity and changes in abundance of IGFBPs 
indicate the potential importance of endometrial IGFBPs in regulating uterine IGFs 
during the time period of conceptus elongation in the bovine species. 
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2.1.3. Blastocyst implantation and the adhesion cascade 
In domestic ruminants endometrial invasion, as it takes place in humans or rodents, 
does not occur; thus, definitive implantation is achieved by tight adhesion of 
mononuclear trophoblast cells to the endometrial luminal epithelium. Conceptus 
attachment in the ewe has been studied using scanning and transmission electron 
microscopy. Three stages could be determined: i) from day 14 on precontact was 
established and the conceptus appeared to be immobilized in the uterine lumen, ii) 
on day 15 apposition occurred and iii) between days 16 and 18 adhesion began 
(Guillomot et al., 1981). Several adhesion molecules have been implicated in the 
process of embryonic implantation, such as Muc-1, integrins, and selectins. 
Mucin-1 
Mucin-1 (Muc-1) is a major epithelial apical surface glycoprotein molecule in the 
endometrium of various species. It has a large, extended and highly glycosylated 
ectodomain that contains keratin sulphate chains and has been shown 
experimentally to inhibit cell-cell interactions by steric hindrance of binding 
interactions mediated by receptors, including integrins and cadherins (Aplin, 1999). 
Thus, Muc-1 contributes to a functionally non-receptive uterine environment and high 
expression levels during the time of blastocyst implantation are unexpected. Indeed, 
this glycoprotein coat is drastically reduced in the uterus of many species during the 
time of embryo implantation (Carson et al., 1998). In the murine uterus Muc-1 
expression is high in the proestrus and estrus stages and decreases during diestrus. 
Both Muc-1 mRNA and protein decline to barely detectable levels by day 4 of 
pregnancy, i.e. before the time of blastocyst attachment (Surveyor et al., 1995). 
Similar to the observations made in the murine uterus, a decreasing expression of 
Muc-1 towards the time of implantation was observed in the rat (Isaacs and Murphy, 
2003) and porcine uterus (Bowen et al., 1996). In the ovine uterus immunoreactive 
Muc-1 is highly expressed at the apical surfaces of uterine luminal and glandular 
epithelium in both cycling and pregnant ewes but decreases dramatically by day 9 
and is nearly undetectable by day 17 of pregnancy when intimate contact between 
the luminal epithelium and trophectoderm begins (Johnson et al., 2001). It has been 
shown that the expression of Muc-1 is modulated by steroid hormones and that 
down-regulation of Muc-1 towards the time of blastocyst implantation is a 
progesterone dominated event (Braga and Gendler, 1993; Surveyor et al., 1995). In 
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the human and rabbit uterus the situation differs substantially from that described 
above. In these species Muc-1 expression is stimulated by progesterone so that high 
expression levels of Muc-1 are present during the time of implantation (Hey et al., 
1994; Hoffman et al., 1998; Acosta et al., 2000). However, Muc-1 is locally reduced 
at implantation sites which is presumably accomplished via signals apparently 
produced by the blastocyst (Hoffman et al., 1998). Furthermore, Muc-1 has been 
considered to play a role in unexplained infertility because these women exhibit a 
smaller Muc-1 allele size than fertile women (Horne et al., 2001). 
Integrins 
Integrins are transmembrane glycoproteins composed of α and β subunits that exist 
in close association with the cytoskeleton and signaling proteins (Hillis and MacLeod, 
1996; Lukashev and Werb, 1998; Porter and Hogg, 1998). Until now 22 integrin 
receptors have been identified, and these comprise at least 16 types of α subunits 
and 8 types of β subunits (Juliano and Haskill, 1993). Integrin receptors interact with 
a variety of ligands including ECM proteins and cell surface molecules and many of 
them recognize the tripeptide sequence arginine-glycine-aspartic acid (RGD), which 
commonly appears in ECM components (Ruoslahti and Pierschbacher, 1987). 
Altered expression of integrins is associated with several causes of infertility in 
women (Chen et al., 1998; Skrzypczak et al., 2001) and the temporal and spatial 
expression pattern of several integrins has been investigated in different species to 
elucidate their role in reproductive processes. In the human endometrium certain 
integrins are expressed constitutively throughout the menstrual cycle whereas others, 
like alpha(4)beta(1) and alpha(v)beta(3) are only expressed during the luteal phase. 
The cycle dependent expression, which frames the putative window of implantation, 
suggests a role for these integrins in the establishment of uterine receptivity (Lessey 
et al., 1994; Nardo et al., 2002). In the rhesus monkey there is evidence that 
correlated expression of integrins and their ECM ligands might be involved in the 
regulation of cell proliferation and differentiation and the counterbalanced invasion-
accelerating and invasion-restraining processes in trophoblast cells during early 
stages of pregnancy (Qin et al., 2003). In the rabbit uterus higher levels of mRNA for 
beta(3) subunit were observed at the implantation site, with reduced expression in 
nonimplantation sites and in non-pregnant adult and immature endometrium (Illera et 
al., 2003). During the peri-implantation period, alpha(v)beta(3) integrin and alpha(4) 
and alpha(5) subunits, as well as the ECM components vitronectin and fibronectin 
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are expressed in the caprine endometrium and may play a role in the cascade of 
embryonic implantation (Garcia et al., 2004). In swine, the alpha(4), alpha(5), 
alpha(v), beta(1), and beta(3) integrin subunits, along with the ECM components 
fibronectin and vitronectin were detected at sites of attachment between uterine 
epithelial cells and trophectoderm during early pregnancy (Bowen et al., 1996). The 
ewe does not appear to limit receptivity to implantation by modifying temporal and 
spatial patterns of integrin expression as the integrin subunits alpha(v), alpha(4), 
alpha(5), beta(1), beta(3), and beta(5) are constitutively expressed on conceptus 
trophectoderm and at the apical surface of uterine luminal epithelium and glandular 
epithelium in both cyclic and pregnant ewes. The constitutive expression of these 
subunits could contribute to the apical assembly of several osteopontin receptors. 
Therefore the authors conclude that osteopontin might act as a bridge between 
integrins heterodimers expressed by trophectoderm and uterine luminal epithelium 
and thereby being responsible for initial conceptus attachment (Johnson et al., 2001). 
Throughout the bovine estrous cycle the luminal epithelium was found to express 
integrin subunits beta(1), alpha(3), alpha(6), and integrin alpha(v)beta(3). Of these 
integrins, alpha(6) and alpha(v)beta(3) exhibited estrous cycle dependent 
expression. Alpha(v)beta(3) showed a reduced subepithelial stromal staining during 
diestrus which differs from the situation in women, where alpha(v)beta(3) is 
considered to be a marker of uterine receptivity (Kimmins and MacLaren, 1999). 
Furthermore, the mRNA of integrin beta(4) was shown to be upregulated at diestrus 
as compared to estrus (Bauersachs et al., 2005). Implantation associated changes in 
bovine uterine expression of integrins were investigated by McIntyre and coworkers 
(2002). The uterine epithelium constitutively expressed the alpha(1), alpha(3), and 
alpha(6) integrin subunits during early pregnancy, but the alpha(1) subunit was 
down-regulated as the luminal epithelium was modified by trophoblast cell migration. 
The cycle dependent expression of integrins led to the assumption that their 
expression is modulated by steroid hormones and, indeed, in the murine uterus the 
alpha(4)beta(1) integrin is induced by estradiol and down-regulated by progesterone 
during implantation (Basak et al., 2002). Further evidence for the involvement of 
integrins in the implantation process was drawn from functional blockage 
experiments. Functional blocking of the alpha(v)beta(3) integrin leads to a reduced 
number of implantation sites in mice and in rabbits (Illera et al., 2000; Illera et al., 
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2003). In addition, intrauterine blockade of alpha(4) subunit by a specific antibody 
resulted in implantation failure in mice (Basak et al., 2002). 
Selectins 
Selectins are carbohydrate-binding proteins that recognize specific oligosaccharide 
structures. In the vasculature they mediate interactions between leukocytes and 
endothelium to permit cell adhesion under flow (Alberts et al., 2004). To determine 
whether selectin ligands are present at appropriate times and locations to function in 
blastocyst adhesion to the uterus, Genbavec and coworkers (2003) studied their 
expression at the maternal-fetal interface in women using specific antibodies. During 
the luteal phase of the menstrual cycle staining was much stronger, particularly on 
the luminal epithelium, than throughout the follicular phase. Immunoblot analysis 
confirmed upregulation of selectin ligands as the window of human receptivity opens. 
They further examined whether the embryo expresses L-selectin. After hatching of 
the embryo from the zona pellucida, strong immunoreactivity was observed in 
association with the trophectoderm over the entire embryo surface. The authors next 
investigated the physiological importance of the interactions between L-selectin and 
its oligosaccharide ligands. They coated polystyrene latex beads with an 
oligosaccharide that binds to L-selectin and observed that the beads bound avidly to 
trophoblast cells under conditions that mimic those in the uterus. Additionally, 
isolated trophoblasts bound preferentially to uterine epithelial cells from endometrial 
tissue harvested during the receptive, but not the nonreceptive, period. 
Glycosylation-dependent cell adhesion molecule 1 
In the ovine uterus the expression of Glycosylation-dependent cell adhesion 
molecule 1 (GlyCAM-1) was detected (Spencer et al., 1999). GlyCAM-1 is a sulfated 
glycoprotein that functions as carbohydrate ligand for L-selectin in the vasculature. It 
is secreted by the endothelium and mediates leukocyte-endothelial cell adhesion 
(Lasky et al., 1992; Rosen, 1993). In pregnant ewes, GlyCAM-1 in the luminal 
epithelium and stratum compactum glandular epithelium was low on days 11 and 13, 
increased on day 15, and was abundant on days 17 and 19. Immunoreactive 
GlyCAM-1 was also detected in the conceptus trophectoderm on days 13-19. The 
presence and pattern of expression of GlyCAM-1 in pregnant sheep endometria and 
conceptuses suggest a role in conceptus-maternal interaction during the peri-
implantation period, presumably by acting as a selectin ligand. 
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2.1.4. The role of uterine secretions during the pre-implantation period 
In contrast to rodents and primates, where the embryo attaches almost immediately 
to the uterine epithelium upon entering the uterus, domestic animals have a 
prolonged pre-implantation period upon arrival of the embryo in the uterus. During 
this period of time, the embryo is free floating in the uterine lumen and its survival, 
development and nourishment is dependent upon the secretion of the so called 
histotrophs from the uterine glands. The histotrophs are a complete mixture of 
enzymes, growth factors, cytokines, hormones, transport proteins and other 
substances (Bazer and Roberts, 1983) and evidence that endometrial gland 
secretions are required for conceptus development were obtained from observations 
of the ovine uterine gland knockout (UGKO) model. Ovine endometrial gland 
development is a postnatal event that can be inhibited by chronic exposure of ewe 
lambs to a synthetic progestin from birth to puberty. As adults these neonatally 
progestin-treated ewes lack endometrial glands and display an uterine gland 
knockout phenotype (Allison et al., 2000). When mature UGKO ewes were 
repeatedly bred to fertile rams, no pregnancies were observed by ultrasound on day 
25. Transfer of day 7 blastocysts form normal superovulated ewes resulted in the 
establishment of a pregnancy in control ewes but not in UGKO ewes. When UGKO 
ewes were bred with fertile rams and the uteri were flushed on day 14, either no 
conceptus or severely growth retarded concepti were obtained. Histological analyses 
revealed that endometrial gland density was directly related to conceptus survival 
and developmental stage. Collectively, these results demonstrate that endometrial 
glands and, by interference, their secretions are required for peri-implantation 
conceptus survival and development (Gray et al., 2001). Furthermore, it has been 
shown that the expression of mucin 1, integrin alpha(v), alpha(5), beta(3), and 
beta(5) is not altered in UGKO ewes, whereas osteopontin and glycosylation-
dependent cell adhesion molecule one (Gly-CAM1) are absent in uterine flushings 
from pregnant UGKO ewes. This further supports the hypothesis that UGKO are 
infertile due to the absence of uterine gland secretions rather than due the to altered 
expression of adhesion molecules (Gray et al., 2002). 
There are hints that progesterone is the primary hormone regulating accumulation of 
fluid, protein, calcium, and specific endometrial proteins in the uterine lumen during 
gestation (Moffatt et al., 1987). The two best characterized glandular epithelium 
secretory products are the uterine milk protein and osteopontin.  
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Uterine milk protein 
As shown by Moffatt and coworkers (1987), the uterine milk protein (UTMP) is the 
major component of uterine secretions obtained from pregnant ewes. On day 5 of 
gestation they ligated the uterine horn contralateral to the ovary bearing the corpus 
luteum to create a nongravid, ligated uterine horn and to confine the conceptus to the 
remaining nonligated uterine body and horn. Uterine fluids were obtained by 
aspirating the ligated uterine horn during later stages of pregnancy and UTMP was 
shown to be the predominant protein. Several authors have the expression of UTMP 
suggested to be regulated by progesterone: Amounts of UTMP in uterine flushings of 
ovariectomized ewes were greatly enhanced by subcutaneous administration of 
progesterone for 10 respectively 30 days when compared with the control group and 
immunhistochemical analysis indicated that the major site of UTMP localization was 
the glandular epithelium. In ovariectomized cows enhanced amounts of UTMP were 
not observed until after 30 days of progesterone treatment (Leslie and Hansen, 
1991). Similar observations were made by Ing and coworkers (1989): progesterone 
treatment of ovariectomized ewes resulted in low levels of UTMP in uterine flushings, 
whereas increasing levels were observed after 14 and 30 days of progesterone 
administration. Production of a protein similar to UTMP was also noted in the uterus 
of a pregnant cow. Treatment of ovariectomized ewes with estrogens does not lead 
to enhanced presence of UTMP in uterine secretion (Moffatt et al., 1987). The 
findings of Bauersachs and coworkers (2005), however, contradict the common view 
that the expression of UTMP is directly stimulated by progesterone. In a global gene 
expression analysis, comparing bovine intercaruncular endometrium at two stages of 
the estrous cycle, end of the day of standing heat and day 12 of the estrous cycle, 
UTMP was found to be upregulated 150-fold at estrus. 
Not only progesterone, respectively estrogen seems to influence the expression of 
UTMP, also administration of placental lactogen and growth hormone increases 
UTMP mRNA levels in the endometrium of ovariectomized ewes (Spencer et al., 
1996). There is further evidence that lactogenic hormones play a role in the 
regulation of UTMP, as UTMP mRNA expression is correlated with placental 
lactogen production by the trophectoderm and state of superficial gland differentiation 
during pregnancy, which is driven by lactogenic hormones as well (Stewart et al., 
2000). 
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Osteopontin 
Osteopontin (OPN) is an acidic member of the small integrin-binding ligand N-linked 
glycoprotein (SIBLING) family of extracellular matrix proteins that undergoes 
extensive posttranslational modification (Johnson et al., 2003a). Osteopontin 
contains a Gly-Arg-Gly-Asp-Ser (GRGDS) sequence that binds to cell surface 
integrins to promote cell-cell attachment and it has been demonstrated that 
alpha(v)beta(5), alpha(v)beta(3), and alpha(v)beta(5) serve as receptors for 
osteopontin (Liaw et al., 1995; Hu et al., 1995; Bayless et al., 1998). Osteopontin is 
present in uterine flushings from pregnant ewes during the peri-implantation period 
(Johnson et al., 1999c) and immunoreactive osteopontin was shown to be localized 
to luminal and glandular epithelia, and to trophectoderm of day 19 conceptuses. 
Further, the alpha(v) and beta(3) integrins were detected on day 19 endometrium 
and conceptuses in the same study. This accumulation of osteopontin protein on 
endometrial luminal epithelium and conceptus trophectoderm led to the postulation 
that osteopontin induces adhesion between luminal epithelium and trophectoderm 
essential for implantation and placentation (Johnson et al., 1999b). In the rabbit 
uterus a dramamtic increase in osteopontin expression could be observed on days 4-
7 of pregnancy, corresponding to the rise in circulating progesterone and the time of 
initial embryo attachment in this species and the mRNA was most prominently 
expressed on the endometrial epithelium. Induction of endometrial osteopontin 
expression was observed in unmated rabbits treated with progesterone and was 
prevented by cotreatment with an antiprogestin. Estradiol-17beta had no effect on 
osteopontin expression by itself (Apparao et al., 2003).  
2.1.5. Remodeling of the ECM at implantation 
The extracellular matrix (ECM) is a complex structural entity surrounding and 
supporting cells that are found within mammalian tissues. The ECM is often referred 
to as the connective tissue and is composed of 3 major classes of biomolecules: 
structural proteins, such as collagen and elastin, spezialized proteins, e.g. fibrillin, 
fibronectin, and laminin, and proteoglycans (Alberts et al., 2004). Remodeling of the 
endometrial extracellular matrix, mediated by an altered balance of matrix 
metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs), is 
indispensable for successful implantation and placentation, and has been well 
described in humans and rodents (Farrar and Carson, 1992; Clark et al., 1993; Das 
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et al., 1997; Hurst and Palmay, 1999). Defects in the distribution of certain ECM 
glycoproteins have been implicated in implantation failure in women suffering from 
unexplained infertility (Bilalis et al., 1996) and functional studies using MMP inhibitors 
showed, that administration of these inhibitors retards decidual remodeling and 
growth during murine implantation (Alexander et al., 1996). 
Although the bovine placenta is defined as epitheliochorial placenta, and trophoblast 
invasiveness is limited to fusion of migrating binucleate cells with uterine epithelial 
cells, extracellular matrix remodeling is a crucial event during the process of 
embryonic implantation. A change in the distribution pattern of ECM components, 
namely types I and IV collagen, laminin and fibronectin is evident by day 14 of 
gestation, as their immunoreactivity remarkably declines. Interestingly, 
immunoreactivity is reconstituted by day 30 of gestation, as implantation is completed 
(Yamada et al., 2002). In the caprine endometrium similar observations were made: 
as implantation proceeded, immunolabeling of the ECM proteins type I and IV 
collagen and laminin became undetectable in the endometrium adherent to the 
trophoblast. In the uterine compartments not in contact with the trophoblast, 
immunostaining remained unaltered, which suggests a local control of protease 
activity within the endometrium (Guillomot, 1999). The expression of MMPs and 
TIMPs has been studied at the trophoblast-uterine interface in the ewe. Messenger 
RNA for TIMP-1 and TIMP-2 is expressed in the endometrium throughout the estrous 
cycle and early pregnancy. Both TIMP-1 and TIMP-2 mRNA expression increases at 
day 12 to day 20. Uterine flushings from both non-pregnant and pregnant ewes on 
day 16 after estrus contain proMMP-2 and proMMP-9, but concentrations are higher 
in pregnancy. The production of MMPs and TIMPs in the endometrium and the 
changes associated with implantation suggest that they contribute to the marked 
endometrial remodeling associated with early placentation (Salamonsen et al., 1995). 
 
2.2. Maternal recognition of pregnancy and the pivotal role of IFNτ 
The bovine species exhibits an aseasonal polyestric sexual cycle with an average 
length of 21 days and the day of standing heat is designated as day 0 of the estrous 
cycle (Rüsse and Sinowatz, 1998). During the time course of each sexual cycle a 
dominant follicle is raised, and after ovulation the corpus luteum cyclicum is formed, 
which produces progesterone during the luteal phase of the estrous cycle. In the 
absence of a fertilized oocyte, an uterine-dependent luteolytic mechanism comes into 
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effect, resulting in the regression of the corpus luteum cyclicum approximately on day 
16 of the sexual cycle (Döcke, 1994). The luteolytic factor produced by the 
endometrium is PGF2α, and binding of luteal oxytocin to its endometrial receptor is 
assumed to initiate pulsatile release of PGF2α (Flint and Sheldrick, 1983). Hence, for 
successful establishment of a pregnancy, the embryo has to signal its presence to 
the uterine environment in order to abrogate the luteolytic mechanism described 
above. The maintenance of the corpus luteum ensures ongoing secretion of 
progesterone, which is a prerequisite for early embryonic development, implantation, 
placentation, and overall the successful outcome of gestation. Roger Short referred 
to this embryo-maternal cross-talk in 1969 as the process of “maternal recognition of 
pregnancy”.  
The factors produced by the embryo to signal its presence vary considerably within 
different species, and in ruminants IFNτ, which has been shown to closely resemble 
the interferon-alpha family of antiviral proteins (Imakawa et al., 1987; Stewart et al., 
1987; Stewart et al., 1989), especially the interferon alphas of class II (Charpigny et 
al., 1988; Charlier et al., 1989), is assumed to play a pivotal role in the context of 
maternal recognition of pregnancy. The trophoblast interferons were discovered in 
1987 through the purification of ovine blastocyst secreted proteins with antiluteolytic 
properties. Their biological function was assessed, among other assays, by 
administration into the uterus of cyclic sheep and cows, which resulted in the 
prolongation of the estrous cycle (Knickerbocker et al., 1986; Stewart et al., 1987; 
Vallet et al., 1988; Meyer et al., 1995). Despite its clear role as reproductive 
hormone, IFNτ has the typical antiviral, antiproliferative, and immunmodulatory 
activities of other type I IFNs, but unlike, it is not virally inducible (Roberts, 1996). 
Interferon-tau is synthesized and secreted by mononuclear cells of the bovine 
conceptus trophectoderm between days 15 to 26 postconception, with maximal 
secretion occurring around day 18 (Bazer et al., 1997). It acts in a paracrine manner 
on the endometrium to establish and maintain pregnancy by suppressing the normal 
pattern of pulsatile release of uterine PFG2α leading to luteolysis at the end of the 
estrous cycle. Several studies in the ewe have shown that IFNτ suppresses cyclic 
increases of the estrogen receptor gene transcription and thereby prevents estrogen 
induced increases in oxytocin receptor gene expression, which normally occurs in 
cyclic ewes undergoing luteolysis (Knickerbocker et al., 1986; Spencer et al., 1995). 
The situation in the cow differs a little, since the expression of the oxytocin receptor 
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gene, but not the estrogen receptor gene, is altered due to the presence of a 
conceptus, implicating that the bovine conceptus exerts a direct effect on endometrial 
oxytocin receptor gene expression (Robinson et al., 1999). Even though one may 
assume, IFNτ does not act to stabilize or prevent autologous downregulation of the 
progesterone receptor mRNA and protein expression in the endometrium, which 
normally occurs towards the end of the estrous cycle (Spencer et al., 1995). 
Furthermore, IFNτ acts on the endometrial luminal epithelium, the glandular 
epithelium and the stroma to regulate the expression of a number of IFN-stimulated 
genes (ISGs) which are hypothesized to play roles in endometrial differentiation and 
conceptus implantation (Thatcher et al., 1995). One of the most intensely 
investigated gene product induced by IFNτ, is the interferon stimulated gene 15 
(ISG15) also called ISG17 or ubiquitin cross reactive protein (UCRP), due to its 
crossreactivity with antibodies against ubiquitin (Austin et al., 1996). Johnson et al. 
(1999a) showed by Northern Blotting that ISG15 mRNA is present in endometrial 
tissue samples of day 18 pregnant cows, but is absent in the endometrium from non-
pregnant control animals. In situ hybridization localized the mRNA to the stromal and 
glandular epithelial cells of pregnant cows. Several experiments have shown that 
IFNτ treatment of endometrial explants is able to induce the expression of both 
ISG15 mRNA and protein after a certain period of time (Staggs et al., 1998; Johnson 
et al., 1999a). Further, Western blot analysis revealed elevated levels of ISG15 
protein (ISG15 conjugates) on day 17 of pregnancy when compared with the estrous 
cycle. ISG15 protein remained elevated from days 18 to 23 and levels declined 
sharply from days 23 to 45 and on day 50 of pregnancy no difference could be 
observed between pregnant and non-pregnant cows (Austin et al., 2004). The 
ubiquitin crossreactive protein conjugates to endometrial cytosolic proteins and 
thereby may regulate uterine proteins important for maintenance of early pregnancy 
(Johnson et al., 1998). Since the ISG15 gene contains an interferon response 
element (ISRE) (Perry et al., 1999), one can assume that it is only upregulated in 
ruminants, where conceptus derived IFNτ is believed to be responsible for 
establishment of pregnancy. But nevertheless, upregulation of the ubiquitin homolog 
seems to be a universal response to the embryo, as it is upregulated in many 
different species, including humans, baboons, cows, sheep, swine, and mice 
(Chwetzoff and d'Andrea, 1997; Bebington et al., 1999; Austin et al., 2003). 
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Granulocyte-macrophage colony-stimulating factor (GM-CSF), known to promote 
survival and growth of embryos, is expressed by the ruminant endometrium during 
early pregnancy and in response to intrauterine infusions of IFNτ (Teixeira et al., 
1997; Emond et al., 2004). Separate culture of endometrial epithelial and stromal 
cells showed that high basal production of GM-CSF by epithelial cells is not regulated 
by recombinant ovine IFNτ. In contrast GM-CSF gene expression was readily 
stimulated in stromal cells (Emond et al., 2000). Granulocyte chemotatic protein-2, a 
member of the alpha-chemokine family is also released by cultured endometrial cells 
in response to IFNτ (Teixeira et al., 1997; Staggs et al., 1998). Transcripts of the 1-8 
family (1-8 and LeuU 13/9-27) of interferon inducible genes are elevated in 
endometrial tissue samples from pregnant cows when compared with non-pregnant 
animals. The mRNA is mainly localized to the glandular epithelium and to a lesser 
degree to the luminal epithelium, stroma and myometrium. In endometrial cells, 
treatment with recombinant IFNτ upregulated the gene expression of 1-8 family 
members (Pru et al., 2001). Pru and coworkers hypothesize that these proteins act 
as novel E2-like enzymes and therefore facilitate ligation of ISG15 to cytosolic 
proteins. Mx, a functional GTPase, is an IFN-induced antiviral protein. Its expression 
is directly induced in response to viral infections (Muller-Doblies et al., 2002) as well 
as during early pregnancy in both endometrium and myometrium (Ott et al., 1998; 
Hicks et al., 2003), where steady-state levels of Mx mRNA increase 10-fold above 
levels observed in cyclic cows by day 15 to 18.  
On days 15 and 18 of bovine gestation, the 2´-5´-oligoadenylate synthase activity 
was greater in endometrial surface epithelium, glandular epithelium, and stromal 
cells, when compared with the corresponding day of the estrous cycle. Additionally, 
in cultured bovine uterine cells a dose dependent stimulation of 2´-5´-oligoadenylate 
synthase by IFNτ could be observed (Schmitt et al., 1993). 
The results of a study conducted by Spencer et al. (1998) suggest that IFNτ acts 
directly on the luminal and superficial glandular epithelium to during ovine pregnancy 
to sequentially induce IRF-1 and then IRF-2 gene expression. The induction of these 
genes is correlated temporally with the absence of the estrogen receptor as well as 
the oyxtocin receptor. The ovine estrogen receptor gene may contain an IFNτ 
responsive element that binds negative-acting, IFNτ inducible transcription factors, 
such as IRF-2, which silences transcription of the estrogen receptor gene in the 
endometrial epithelium during maternal recognition of pregnancy, thereby preventing 
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the luteolysis of the corpus luteum. Additionally, IRF-2 is made responsible for the 
phenomen that in the pregnant uterus interferon stimulated genes are induced or 
upregulated in the endometrial stroma and glandular epithelium, but expression of 
these genes is not detectable in the endometrial luminal epithelium or superficial 
glandular epithelium because expression of IRF-2 in the pregnant uterus is only 
detectable in the luminal epithelium and superficial glandular epithelium (Choi et al., 
2001). Thus, IFNτ supports the maintenance of a pregnancy via multiple mechanisms 
 
2.3. Mechanism of action of interferon tau on endometrial cells 
All type I interferons, including IFNτ, exert their action through binding to classical 
type I IFN receptors which consist of two transmembrane subunits, IFNAR1 and 
IFNAR2 (Li and Roberts, 1994). Immunhistochemistry revealed that both polypeptide 
subunits are expressed in the ovine endometrium and that the major site of 
expression is the luminal and superficial glandular epithelium. The caruncular stromal 
cells also express IFNAR1 and IFNAR2 subunits, whereas the glandular epithelial 
cells near the myometrium are negative for both polypeptides. To localize the binding 
sites of IFNτ, immunhistochemistry with an antiserum against IFNτ was performed on 
uterine sections from day 14 non-pregnant ewes whose uteri had previously been 
infused with IFNτ. Staining was concentrated on the LE and superficial GE cells, and 
was absent from the deeper regions of the glands and from the stromal tissues, 
indicating that the LE and the superficial GE are the main targets for IFNτ (Rosenfeld 
et al., 2002). 
The intracellular domains of both receptor subunits are associated with cytoplasmatic 
tyrosine kinases (Janus kinases, JAKs); IFNAR1 is associated with Tyk2 and 
IFNAR2 is associated with Jak1. Binding of IFNτ to its receptor leads to activation of 
the JAKs, which in turn phosphorylate each other leading to subsequent 
phosphorylation of receptor tyrosine residues. Once the receptor subunits are 
phosphorylated, signal transducers and activators of transcription (STAT) proteins 
are bound to the phosphotyrosine residues via their SH2 domain. After docking of the 
STAT proteins to the receptor subunits they become tyrosine phosphorylated by the 
JAKs with subsequent dissociation of the phosphorylated STATs. The 
phosphorylated STATs are now able to form homo- and heterodimers which are 
shuttled into the nucleus where they influence the expression of certain genes 
(Alberts et al., 2004) (see Fig. 1). Of particular interest is the STAT1-2 homodimer 
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because it associates with the interferon regulatory factor (IRF) protein 9, also known 
as p48 or ISGF3G, to form the interferon-stimulated gene factor 3 (ISGF3) 
transcription factor complex (Fu et al., 1990; Schindler et al., 1992; Veals et al., 
1992). The ISGF3 complex is translocated into the nucleus, where the IRF9 
component acts as a sequence specific DNA-binding protein and confers recognition 
upon the activated STAT1-2 homodimer (Levy et al., 1989; Veals et al., 1993; 
Horvath et al., 1996; Martinez-Moczygemba et al., 1997). The contribution of IRF9 as 
an adapter for the STAT1-2 heterodimer represents a unique feature of the ISGF3 
complex, as other STAT-signaling pathways involve STAT homodimers that bind 
directly to DNA. The ISGF3 complex binds to interferon-stimulated response 
elements (ISREs), resulting in the expression of interferon stimulated genes (ISGs) 
(Fu et al., 1990) such as ISG15 (Kessler et al., 1988; Zhao et al., 2004) and OAS 
(Floyd-Smith et al., 1999; Zhao et al., 2004). STAT1 homodimers (γ –activated factor, 
GAF) increase the expression of genes through gamma activated sequences (GAS) 
elements in the promotor region of genes, such as the interferon regulatory factor 1 
(IRF-1) gene (Pine et al., 1994). The interferon regulatory factor 1 in turn activates 
IRF-2, a transcriptional repressor which is proposed to block directly or indirectly the 
expression of the oxytocin receptor, thereby preventing the uterine-dependent 
luteolytic mechanism and ensuring the establishment of pregnancy (Bazer et al., 
1997). 
The signal transduction cascade has been studied more detailed using an ovine 
endometrial cell line (Stewart et al., 2001). Within 30 min of IFNτ stimulation, STAT1, 
-2, -3, 5a/b, and 6 become tyrosine phosphorylated and translocated to the nucleus. 
However, in response to stimulation with IFNτ for longer than 30 min, STAT1 and -2 
remain tyrosine phosphorylated, whereas STAT3, -5a/b, and -6 are rapidly 
dephosphorylated. Because STAT1 and STAT2 are persistently tyrosine 
phsophorylated it is likely that only these two STAT proteins mediate the long-term 
effects of IFNτ on target gene expression relevant for establishing of pregnancy. 
Whether STAT3, -5a/b, and -6 form dimers in response to IFNτ and regulate gene 
expression is not known yet. 
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Fig. 1: Signal transduction cascade of IFNτ 
 For further explanation see text. 
 
2.4. Holistic approaches for the analysis of the transcriptome 
Nearly each cell contains a complete genome, but there is a distinct pattern of gene 
activity for every single cell type and also for different physiological stages of a cell or 
tissue. Biological processes, such as the embryo-maternal cross-talk, are associated 
with differential gene expression patterns resulting in characteristic cell and stage 
specific protein repertoires in the corresponding tissues. Thus, a powerful approach 
to analyze the regulation and the nature of a biological process at the molecular level 
is to characterize genes that vary in expression levels of their mRNAs during this 
process. 
Besides targeting specific genes, the global description of transcriptional activity is of 
particular interest. Techniques for the analysis of small sets of candidate genes 
include for example quantitative RT-PCR, in situ hybridization and Northern blotting. 
For the systematic identification of differentially expressed genes techniques like 
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differential display PCR (DD-PCR) (Liang and Pardee, 1992), serial analysis of gene 
expression (SAGE) (Velculescu et al., 1995), hybridization to gene arrays of various 
formats (Chee et al., 1996) or suppression subtractive hybridization (SSH) 
(Diatchenko et al., 1996) can be udsed. Suppression subtractive hybridization (SSH), 
a highly efficient method for the generation of subtracted cDNA libraries and the 
screening of such libraries by cDNA array hybridization is now described in detail. 
SSH combines subtractive hybridization and the so-called suppressor PCR. 
Subtraction of common sequences within two populations of cDNAs is achieved by 
subtractive hybridization, which involves hybridization of cDNAs from one population 
to cDNAs of the second population and subsequent separation of the unhybridized 
fraction from hybridized, common sequences. First both mRNA populations are 
converted into cDNA. The cDNA population that contains specific, differentially 
expressed transcripts of interest is referred to as “tester” and the reference cDNA is 
reffered to as “driver”. Both cDNA populations are digested with a restriction enzyme 
that yields blunt ends. The tester cDNA is then subdivided into two portions, and 
each portion is ligated with a different adapter composed of a long and a short 
oligonucleotide. The 5´-ends of the adapters do not have a phosphate group, so that 
only the long oligonucleotide of the adapter is ligated to the 5´-end of each cDNA. 
The driver cDNA sample is left without adapters. Subsequently two rounds of 
hybridization are performed. In the first round, an excess of driver cDNA is added to 
each sample of the tester cDNA resulting in the formation of the molecules ‘a’, ‘b’, ‘c’, 
and ‘d’ in each sample (see Fig. 2). The type ‘a’ molecules represent differentially 
expressed sequences that are only present in the tester cDNA population. The 
concentration of high- and low abundance sequences is equalized among the single 
strand type ‘a’ molecules because reannealing forming the type ‘b’ molecules is 
faster for the more abundant molecules due to the second order kinetics of 
hybridization (a process referred to as normalization). Those cDNAs that are not 
differentially expressed within the two populations form the type ‘c’ molecules. The 
type ‘d’ molecules represent sequences that are only present in the driver cDNA 
population. For the second round of hybridization the two hybridization samples are 
mixed together. Now, only the remaining equalized and subtracted single stranded 
tester cDNAs (type ‘a’ molecules) can hybridize and form new type ‘e’ molecules. 
These new hybrids are double stranded tester molecules with different ends, which 
correspond to the sequences of the two different adapters. The entire population is 
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then subjected to PCR. The type ‘a’ and ‘d’ molecules are missing primer annealing 
sites and thus cannot be amplified. Most type ‘b’ molecules form a panhandle-like 
structure because they possess the same adapter on each end. This panhandle-like 
structure prevents their exponential amplification, a phenomen referred to as 
suppressor PCR effect. Type ‘c’ molecules only have one primer annealing site and 
can only be amplified linearly. Only type ‘e’ molecules, which possess two different 
adapters, can be amplified exponentially. These are the equalized, differentially 
expressed sequences. The PCR products can then be utilized to establish a 
subtracted cDNA library. 
The major disadvantage of subtracted cDNA libraries is the presence of background 
clones representing non-differentially expressed cDNA species in the subtracted 
library. Therefore, a further step is necessary to identify the differentially expressed 
cDNA fragments within a subtracted library. This can be accomplished by transferring 
a certain number of individual cDNA clones from the subtracted library onto a nylon 
membrane and subsequent array hybridization with labeled cDNA probes derived 
from both cDNA populations. Those cDNA clones that show a difference in signal 
intensity are differentially expressed and hence subjected to further analyses, e.g. 
DNA sequencing, and bioinformatic analyses. 
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Fig. 2: Scheme of the SSH method according to Diatchenko et al. (1996).  
Solid lines represent the RsaI digested driver or tester cDNA. The boxes represent 
the outer and inner parts of adapter 1 and adapter 2, respectively. 
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2.5. Global gene expression analyses of female reproductive tissues 
As already mentioned above (2.4), global gene expression profiling is a powerful 
method to gain deeper insight into the molecular basics of biological processes and a 
number of studies of this kind dealing with female reproductive tissues have been 
performed so far in several species. 
In humans several studies using commercially available microarrays were done 
investigating gene expression changes occurring in the endometrium during the 
menstrual cycle. In two studies, the proliferative phase of the menstrual cycle was 
compared with the phase coincident with the “window of implantation” (Kao et al., 
2002; Carson et al., 2002) and in another three studies gene expression differences 
between the early secretory phase (2-4 days after the LH-surge) and mid-luteal 
phase (days 7-9 after the LH-surge) were analyzed (Martin et al., 2002; Riesewijk et 
al., 2003; Borthwick et al., 2003). Endometrial gene expression of the proliferative 
phase versus the secretory phase of the sexual cycle was also compared in the 
rhesus monkey (Ace and Okulicz, 2004) and in the mouse (Tan et al., 2003). 
Tanaka et al. (2000) applied a mouse developmental cDNA microarray to elucidate 
divergence of embryo-derived mid-gestation placenta and embryonic gene 
expression profiles. 
In order to identify progesterone-regulated pathways in the uterus during 
implantation, mice were treated at day 3 of pregnancy with either RU486 (a 
progesterone receptor antagonist) or a vehicle (Cheon et al., 2002). Tissues were 
collected on day 4 of pregnancy and conducted to microarray analysis to determine 
the difference in gene expression. To gain knowledge about genes whose expression 
is regulated by estrogens, Andrade and others (2002) compared endometrial mRNA 
profiles of ovariectomized virgin rats either treated with conjugated equine estrogens 
or a placebo. 
Bauersachs and coworkers (2003) used a combination of subtracted cDNA libraries 
and array hybridization to compare gene expression profiles of bovine epithelial cells 
from the ipsilateral oviduct versus the contralateral oviduct at day 3.5 of the estrous 
cycle. In an additional study they evaluated the differerence in gene expression 
profiles of epithelial cells from the ipsilateral oviduct at estrus and diestrus 
(Bauersachs et al., 2004). They furthermore performed a holistic screen of 
transcriptome changes in bovine intercaruncular endometrium at the day of standing 
heat and day 12 of the estrous cycle (Bauersachs et al., 2005). 
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Reese et al. (2001) compared mRNA profiles of implantation and interimplantation 
sites in mice at day 4 of pregnancy. They further compared the uterine gene 
expression profile of ovariectomized progesterone-treated, delayed implanting mice 
to that of mice in which delayed implantation was terminated by estrogen activation. 
Recently, suppression subtractive hybridization and an array of oligonucleotides, 
respectively was applied to determine genes involved in the early process of 
embryonic implantation in the rhesus monkey (Sun et al., 2004) and in mice 
(Yoshioka et al., 2000). Until now, only one approach was undertaken in the bovine 
species to characterize gene expression profiles in the bovine endometrium during 
pregnancy. Ishiwata et al. (2003) collected endometrial (caruncular and 
intercaruncular) and placental (cotyledonary and intercotyledonary) tissue samples 
on days 0 and 10 of the estrus cycle and days 30, 60, 100, and 245 of gestation to 
establish a normalized cDNA library. For microarray analysis endometrial and 
placental tissue were obtained on day 13 of the estrous cycle and days 56, 59, and 
64 of gestation. 
So far, no study was conducted to investigate endometrial gene expression changes 
occurring in the endometrium during the pre-implantation period due to the presence 
of a conceptus in the bovine species. 
 
2.6. The usage of monozygotic twin pairs as experimental animals 
When performing gene expression studies which utilize tissue samples obtained from 
different individuals, it has to be considered that monitored differences in gene 
expression levels are partly due to a different genetic background of individuals, 
rather than due to the influence of a certain condition investigated (e.g. the presence 
of a conceptus in the uterine lumen). Hence, an experimental strategy which 
eliminates the influence of a different genetic background of individuals on the results 
of gene expression studies would be of great benefit. Such an experimental design is 
the exploitation of monozygotic twin uniformity, which arises from the fact that 
monozygotic twin pairs are genetically identical. Only few global gene expression 
studies, exploring the potential usefulness of this approach have been performed so 
far (Evans et al., 1999; Mak et al., 2004). 
Embryo splitting has been described to be a viable method for producing 
monozygotic twins (Niemann and Meinecke, 1993). Clones produced by embryo 
splitting are completely genetically identical with respect to nuclear as well as 
Review of the literature 
32 
 
mitochondrial DNA, whereas clones produced by nuclear transfer exhibit a various 
degree of mitochondrial heterogeneity (Evans et al. 1999). Consequently, the usage 
of monozygotic twin pairs as experimental model is a unique possibility to eliminate 
the influence of a different gentic background of individuals on the results of gene 
expression analyses.  
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3. Materials and Methods 
3.1. Materials 
3.1.1. Chemicals 
Agarose (15510-027)  Invitrogen, Karlsruhe 
Agarose (Typ VII Low Gelling)  Sigma, Deisenhofen 
Agarose Seakem LE  Biozym, Hess. Oldendorf 
ammonium acetat  Merck, Darmstadt 
ampicillin  Boehringer, Mannheim 
bromphenolblue  Serva, Heidelberg 
chloroform  Riedel-de Hâen, Deisenhofen 
DTT (100 mM)  Invitrogen, Karlsruhe 
EDTA  Merck, Darmstadt 
ethanol  Roth, Karlsruhe 
ethidium bromide (10mg/ml)  Roth, Karlsruhe 
glycerol  Fluka, Buchs, Switzerland 
isopropanol  Roth, Karlsruhe 
magnesium chloride (MgCl2)  Merck, Darmstadt 
mineral oil (Nujol)  Perkin Elmer, Köln 
SDS ultrapure  ICN, Irvine, CA, USA 
sodium acetate  Merck, Darmstadt 
sodiumchloride  Merck, Darmstadt 
sodium hydroxide  Merck, Darmstadt 
Tris-(hydroxymethyl)-amino-methan (Tris) Roth, Karlsruhe 
Tris-HCl (pH 8.4)  Roth, Karlsruhe 
3.1.2. Enzymes and other reagents 
α-[33P]-dCTP (2500 Ci/mmol)  Amersham Bioscience, Freiburg 
Advantage2 cDNA Polymerase Mix  BD Clontech, Heidelberg 
AscI (10 U/µl)  New England Biolabs, Beverly, USA 
Better Buffer  Web Scientific, Cheshire, UK 
BigDye® Terminator v1.1/v3.1   Applied Biosystems, Langen 
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Sequencing Buffer (5X)  
BSA (10 mg/ml)  New England Biolabs, Beverly, USA 
BssHII (4U/µl)  New England Biolabs, Beverly, USA 
buffer L  Roche Diagnostics, Mannheim 
dephosphorylization buffer (10x)  Roche Diagnostics, Mannheim 
DNA ligase (E. coli) (10 U/µl)  Invitrogen, Karlsruhe 
DNA polymerase I (E. coli) (10 U/µl)  Invitrogen, Karlsruhe 
dNTP  Roche Diagnostics, Mannheim 
DYEnamic ET Terminator   Amersham Bioscience, Freiburg 
Cylce Sequencing Kit  
E. coli SURE©  Stratagene, Heidelberg 
Estrumate®  Essex Tierarznei, München 
FIREPol  AGT biosynthesis, Merzhausen 
first-strand buffer (5x)  Invitrogen, Karlsruhe 
High Prime DNA Labeling Kit  Roche Diagnostics, Mannheim 
Human C0T-1 DNA (1 mg/ml)  Invitrogen, Karlsruhe 
ligasebuffer (10x) for T4-ligase  New England Biolabs, Beverly, USA 
Low Gelling Type VII Agarose  Sigma, Deisenhofen 
NEBuffer3  New England Biolabs, Beverly, USA 
NEBuffer4  New England Biolabs, Beverly, USA 
pBSIISKֿMO (208 ng/µl)  Stratagene, Heidelberg 
PCR buffer (10x)  BD, Clontech, Heidelberg 
phenol-chloroform-isoamylalcohol  Merck, Darmstadt 
(25:24:1, TE saturated, pH 7.5)   
QIA prep Spin Miniprep Kit  Quiagen, Hilden 
RNase, DNase-free (0.5 mg/ml)  Roche Diagnostics, Mannheim 
RNaseH (E. coli) (2 U/µl)  Invitrogen, Karlsruhe 
RNase-Inhbitor (40 U/µl)  Invitrogen, Karlsruhe 
RNAlater™  Ambion, Huntigton, UK 
RsaI (10 U/µl)  Roche Diagnostics, Mannheim 
second-strand buffer (5x)  Invitrogen, Karlsruhe 
Shrimps-AP (1 U/µl)  Roche Diagnostics, Mannheim 
Superscript III (200 U/µl)  Invitrogen, Karlsruhe 
T4-DNA Polymerase (1 U/µl)  Roche Diagnostics, Mannheim 
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T4-DNA-Ligase (2000 U/µl)  New England Biolabs, Beverly, USA 
Trizol®Reagent  Invitrogen, Karlsruhe  
3.1.3. Apparatuses 
3100-Avant Genetic Analyzer  Applied Biosystems, Langen 
agarose gel electrophoresis chamber  Harnischmacher, Fröndenberg 
electronic dispensing system EDOS 5222 Eppendorf, Hamburg 
E. coli-Pulser  BioRad, Hercules, Ca, USA 
Eagle Eye® II  Stratagene, Heidelberg 
DU® 640 Spectrophotometer  Beckman, München 
heater with magnetic stirrer  IKA Labortechnik, Staufen 
HERAhybrid 12, hybridiaztion oven  Kendro Laboratory Products, 
  Langenselbold 
Horizon® 58   Invitrogen, Karlsruhe 
incubator WTB  Binder, Tuttlingen 
incubator shaker KF-4  Infors, Bottmingen 
microwave Electronic M 708  Miele, Gütersloh 
multi channel pipette  Eppendorf, Hamburg 
Omnigrid Accent Microarrayer  Gene Machines, San Carlos, USA 
oven  Heraeus, München 
Pioetus®  Hirschmann Laborgeräte, 
Pipetman®  Gilson, Bad Camberg 
precise balance  Sartorius, Göttingen 
shaker IKA-Vibrax®  IKA Labortechnik, Staufen 
Solid pins (SSP015) für Omnigrid Acc.  Telechem International, Suunyvale, 
   USA 
Storm 860  Amersham Bioscience, Freiburg 
tissue homogenizer (DIAX 900)  ART Labortechnik, Mühlheim 
Vortex-Genie 2  Scientifics Industries, Bohemia, USA 
water bath  Memmert, Schwabach 
XL-1500 UV-Crosslinker  Spectronics Corp., New York, USA 
Thermocyclers 
PerkinElmer Cetus, 480  Perkin Elmer, Köln 
T1 Thermocycler T3  Biometra, Göttingen 
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Centrifuges 
Centrifuge (5417R)  Eppendorf, Hamburg 
GS-15R  Beckman, München 
Sorvall® RC 5C  Kendro Laboratory Products, 
  Langenselbold 
3.1.4. Other Materials 
384-Well Storage Plate  Abgene, Hamburg 
adhesive PCR Foils Seal  ABgene, Hamburg 
AIDA Image Analyzer, Version 4.00  Raytest, Straubenhardt 
Bibliosphere software,Version 5.02   GenomatiX, Munich 
centrifuge tubes (15ml)  Josef Peske oHG, Aindling 
cryotube  Nunc, Wiesbaden 
electroporation cuvette  BioRad, Hercules, CA, USA 
gel blotting paper (GB002, GB005)  Schleicher & Schuell, Dassel 
glass hybridization bottles  VWR, Darmstadt 
imaging plate BAS-IP SR 2025  Fujifilm, Kanagawa, Japan 
MF-Millipore Membrane Filter (0.25 µm)  Millipore, Billerica, Mass., USA 
MicroSpin™ G-25 Columns  Amersham Bioscience, Freiburg 
MicroSpin™ S200-HR  Amersham Bioscience, Freiburg 
Miltex® GP (0.22µm)  Milipore, Carrigtwohill, Ireland 
Nytran® SuperCharge  Schleicher & Schuell, Dassel 
PCR reaction tubes (0.2, 0.5 ml)  Perkin Elmer, Köln 
ProbeQuant™ G-50 Micro Columns  Amersham Bioscience, Freiburg 
QIAquick Gel Extraction Kit  Quiagen, Hilden 
reaction tubes „safe lock“ (2, 1,5, 0,5, 0,2 ml) Eppendorf, Hamburg 
Thermo-Fast®, 96, Low Profile  AbGene, Hamburg 
tube with cap, 84x30 mm  Sarstedt, Nümbrecht 
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3.1.5. Media and Solutions 
better buffer special 
1 µl Better Buffer 
1 µl BigDye® Terminator v1.1/v3.1 Sequencing Buffer (5X) 
1 µl deionized water 
 
PBS (10x) 
Solution A: 
250 mM Na2HPO4 
1.25 mM NaCl 
Solution B: 
250 mM Na2HPO4 
1.25 mM NaCl 
Solution B is added to solution A until pH = 7.5 is reached. 
 
TE buffer 
10 mM  Tris-HCl, (pH 8,0) 
1 mM   EDTA 
 
TBE electrophoresis buffer (10x) 
108 g  Tris-Base 
55 g  boric acid 
40 ml  0,5 M EDTA, (pH 8,0) 
fill up with deionized water at 1000 ml 
 
SOB-medium 
2 %   trypton 
0.5 %   yeast extract 
0.05 %  NaCl 
10 mM  MgCl2 
10 mM  MgSO4 
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SOC-medium 
2 %   trypton 
0.5 %   yeast extract 
0.05 %  NaCl 
10 mM  MgCl2 
10 mM  MgSO4 
0.4 %   Glucose 
 
loading buffer for agarose gel elctrophoresis (2.5x) 
4 M  urea 
5 g  saccharose 
0.5 M  EDTA (pH 8,0) 
0.1 %   bromphenolblue  
 
dilution buffer for SSH 
20 mM HEPES (pH 8,3) 
50 mM NaCl 
0.2 mM EDTA 
 
LB (luria broth)-medium (low salt) 
1 %  Trypton 
0,5 %  yeast extract 
0.5 %  NaCl 
Adjust pH at 7 - 7.5 with 0.1 % 2 M NaOH. 
 
LB-agar plates 
1,2 %  agar 
1 %  trypton 
0,5 %  yeast extract 
0.5 %  NaCl 
Adjust pH at 7 – 7.5 with 0.1 % 2 M NaOH; ad ampicillin to a final concentration of 
100 µg/ml. 
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hybridization buffer for SSH (4x) 
200 mM HEPES (pH 8,3) 
2 M  NaCl 
40 %  PEG 8000 
0,08 mM EDTA 
 
 
reaction buffer (10x) for FIREPol® 
200 mM Tris-HCl (pH (8.55) 
160 mM (NH4)2SO4 
20 mM MgCl2 
3.1.6. Oligonucleotides 
cDNA primer 1: 3'-AACTGCGGCCGCGTACAGCT20VN (V=A, C or G)-5' 
cDNA primer 2: 3'-GAGAT20VN-5'  
adapter 1:  5'-GTAATACGACTCACTATAGGGCTGGAGCGCGCCGC 
AGGGCAGTG-3' 
adapter 1 reverse: 3'-GGGCGTCCCGTCAC-5´ 
adapter 2:  5'-GTAATACGACTCACTATAGGGCAGGGCGTGGTGC 
GCGCTGCTGG-3' 
adapter 2 reverse: 5'-CCAGCAGCGCGCAG-3' 
PCR primer 1: 5'-GTAATACGACTCACTATAGGGC-3' 
nested primer 1:  5'-TCGAGCGCGCCGCAGGGCAGTG-3' 
nested primer 2:  5'-AGGGCGTGGTGCGCGCTGCTGG-3' 
NLT7:   3'-GCGTAATACGACTCACTATAGG 
LT3:   3'-CTCACTAAAGGGAACAAAAGCTG 
T7ex:   3'-GTAATACGACTCACTATAGGGC   
PM0:   3'-CCAAATATCTCTCCCACCAGC 
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3.1.7. DNA molecular weight markers 
1 kb DNA Ladder (15615-016) Invitrogen, Karlsruhe 
DNA Molecular Weight Marker IX Roche, Mannheim 
GeneRuler™ 100 bp DNA Ladder Plus Fermentas 
 
       
 DNA Molecular 
Weight Marker IX 
 
─ 1353 
─ 1078 
─ 872 
 
─ 603 
 
─ 310 
─ 281 
─ 234 
─ 194 
 
─ 118 
─ 72 
1 kb DNA Ladder 
(15615-016) 
GeneRuler™ 100 bp 
DNA Ladder Plus 
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3.2. Methods 
3.2.1. Animals and tissue collection 
The estrous cycle of five monozygotic twin pairs (Simmental cows, non-lactating), 
generated by embryo splitting, which had given birth to an average of 1.7 calves 
previously, was synchronized by a single intramuscular injection of 500 µg 
Cloprostenol (Estrumate®, Essex Tierarznei, München) at diestrus. Animals were 
observed for sexual behavior (i.e. toleration, sweating, vaginal mucus) to determine 
standing heat, which occurred around 60 h after Estrumate® injection. Seven days 
after standing heat, two in vitro produced bovine blastocysts (day 7 after in vitro 
fertilization) in 200 µl culture medium were transferred into the ipsilateral uterine horn 
of one twin of each pair. In vitro production of embryos was performed as described 
previously (Stojkovic et al., 1999) with minor modifications. The corresponding twin 
received a sham-transfer of the same amount of transfer medium without embryos as 
a control. On Day 18 of pregnancy, or of the estrous cycle, respectively, the animals 
were slaughtered. Blood samples for determination of serum progesterone levels 
were drawn just before slaughter. All animals displayed high progesterone values 
(mean 3.7 ng/ml), which did not differ significantly between both groups, indicating 
the presence of an endocrinologically active corpus luteum. The uterine horns were 
opened longitudinally with a scissors and intercaruncular endometrial tissue samples 
from defined uterine regions (for further details see fig. 3) were dissected using a 
scalpel. Pregnancy was confirmed by the presence of an apparently normal 
conceptus in the uterine lumen. The tissue samples were transferred into tubes 
containing 4 ml of RNAlater™ within 23 minutes after slaughter, stored overnight at 
4°C and then at -20°C until further processing. For gene expression analyses only 
those tissues samples of pregnant animals, which had been in contact with an 
embryo were used, i.e. the middle and caudal sections of the uterine horn ipsilateral 
to the ovary bearing the corpus luteum. From control animals the same uterine 
sections as for the corresponding twin were analyzed. All experiments with animals 
were carried out with permission from the local veterinary authorities. 
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Fig. 3: Definition of uterine regions for tissue collection 
 Ipsi referrs to the uterine horn ipsilateral to the ovary bearing the corpus 
luteum, contra referrs to the uterine horn contralateral to the ovary bearing the 
corpus luteum. 
 
3.2.2. Standard methods used in molecular biology 
3.2.2.1. Isolation of total RNA from bovine endometrial cells 
Total RNA was isolated using Trizol©Reagent, a monophasic solution of phenol and 
guanidine isothiocyanate, according to the manufacturer’s instructions. The tissue 
samples were homogenized in 1 ml Trizol©Reagent per 50-100 mg of tissue which 
leads to the denaturing of proteins (mainly due to the action of guanidine 
isothiocyanate). The homogenized samples were then incubated for 5 min at rt to 
permit complete dissociation of nucleoprotein complexes. Next, 0.2 ml chloroform per 
1 ml Trizol©Reagent were added, the sample tubes shaken vigorously by hand for 15 
seconds and afterwards incubated at 24°C for 5 min. Centrifugation of the samples at 
12,000 x g at 6°C for 15 minutes led to separation of the mixture in a lower phenol-
chloroform phase, an interphase and an upper aqueous phase. The organic phenol-
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cranial 
corpus 
ipsi- 
caudal 
contra- 
caudal 
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chloroform phase contains the proteins, whereas the RNA exclusively remains in the 
aqueous phase. The aqueous phase was therefore transferred into a fresh tube. The 
RNA was precipitated from the aqueous phase by addition of 0.5 ml isopropanol per 
1ml Trizol©Reagent. After incubation for 10 min at 24°C, the samples were 
centrifuged at 12,000 x g at 6°C for 10 min which led to formation of a sediment 
containing the RNA. The supernatant was then removed and the RNA sediment 
washed with 75% ethanol by adding 1 ml ethanol per 1 ml Trizol©Reagent and 
centrifugation at 7,500 x g at 6°C for 5 min. The supernatant was removed and the 
RNA sediment air dried. Then the RNA was dissolved in 100 µl deionized water per 1 
ml Trizol©Reagent.  
One microliter of the RNA solution was diluted 70-fold in 69 µl TE buffer to determine 
the concentration of RNA by UV-spectrometry and a 250 ng/µl dilution of the RNA 
was prepared to check the quality by agarose gel electrophoresis using a 0.8 % 1 x 
TBE gel. 
Afterwards the RNA samples were divided into several aliquots each comprising 
50 µg of total RNA. Deionized water was added to yield a total volume of 150 µl. 
Then 15 µl NaOAc and 15 µl isopropanol were added and after incubation for 10 min 
at rt the samples were stored until further processing at -20°C. 
3.2.2.2. Agarose gel electrophoresis 
Agarose gel electrophoresis is a method that separates nucleic acids according to 
their molecular weight. During the process of electrophoresis, the nucleic acids are 
forced to move through the pores of an agarose gel due to the application of 
electrical current. DNA fragments are visualized by staining with ethidium bromide, a 
fluorescent dye which intercalates between bases of DNA and RNA.  
To cast a gel, agarose powder was mixed with water to the desired concentration 
and heated in a microwave oven until completely melted. After cooling the solution to 
about 60°C, 10 x TBE buffer and ethidium bromide were added (final concentration of 
0.5 µg/ml). The solution was then poured into an electrophoresis chamber containing 
a sample comb and allowed to solidify at room temperature. Prior to analyzing RNA 
samples, the electrophoresis chamber was treated with 1 % SDS. Samples 
containing DNA or RNA (mixed with 2.5 x loading buffer) were then pipetted into the 
slots of the gel. The gel was then covered with TBE electrophoresis buffer, containing 
ethidium bromide in a final concentration of 0.5 µg/ml, and the electric current was 
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applied (3 V/cm for 18 min followed by 5 V/cm for 30 min respectively for up to 2.5 h). 
The agarose gels were prepared of standard agarose unless otherwise specified. All 
gels were documented using the Eagle Eye® II. 
3.2.2.3. Precipitation of DNA 
DNA precipitation is a method to purify and/or concentrate DNA or RNA. The 
precipitation was performed in an alcohol/water mixture in the presence of a high 
concentration of inorganic salt (NaOAc or NH4OAc) and involved the following steps: 
 
Sodium chloride precipitation 
1. Addition of 1/10 volume 3 M NaOAc (pH 5.2) and 1 volume isopropanol. 
2. Thorough mixture and subsequent incubation at room temperature for 30 min, 
if required, storage at -20°C until further processing. 
3. Microcentrifugation for 15 min at 12,000 x g – 25,000 x g and 6°C (RNA), 
respectively 18°C (DNA). 
4. Removal of the supernatant. 
5. Washing of the pellet with 500 µl 75% ethanol to desalt the DNA/RNA and 
centrifugation as described above. 
6. Aspiration of the liquid and air drying of the pellet. 
7. Resuspendation of the pellet to the required concentration in water or 
appropriate buffer. 
 
Ammonium acetate precipitation 
1. Addition of 1 volume 5 M NH4OAc 
2. Thorough mixture and subsequent incubation for 15 min on ice 
3. Microcentrifugation for 15 min at 25,000 x g and 4°C. 
4. Removal of the supernatant. 
5. Addition of 2.5 volume 2.5 M NH4OAc. 
6. Microcentrifugation for 5 min at 25,000 x g and 4°C. 
7. Removal of the supernatant. 
8. Washing of the pellet with 500 µl 75% ethanol to desalt the DNA/RNA and 
centrifugation as above. 
9. Aspiration of the liquid and air drying of the pellet. 
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10. Resuspendation of the pellet to the required concentration in water or 
appropriate buffer. 
3.2.2.4. Phenol/chloroform extraction 
Phenol/chloroform extraction is a technique used to remove proteins from nucleic 
acids and was performed as follows: 
1. Addition of an equal volume of phenol/chloroform/isoamylalcohol (25:24:1, TE 
saturated, pH 7.5) and thorough mixture. 
2. Centrifugation at 25,000 x g for 2 min (this led to phase separation in an upper 
aqueous phase, which contains the nucleic acids and a lower organic phase). 
3. Transfer the aqueous phase to a new reaction tube. 
4. To remove traces of phenol, add an equal volume of chloroform to the 
aqueous phase, mix, and centrifuge as above. 
5. Remove the aqueous layer to a new reaction tube. 
6. Isopropanol precipitation of the DNA as described in 3.2.2.3. 
3.2.3. Generation of a subtracted cDNA library 
RNA samples obtained from the twin pair 405/406 were chosen to prepare a 
subtracted library, enriched for genes upregulated in the bovine endometrium due to 
the presence of a conceptus. Animal 405 received two in vitro produced embryos, 
animal 406 served as control. The production of the subtracted library was done 
according to the suppression subtractive hybridization (SSH) method, which has 
been described in detail previously (2.4). Suppression subtractive hybridization was 
first described by Diatchenko and coworkers (1996) and later on modified by 
Bauersachs and coworkers (2003; 2004). 
A second library was constructed using a purchased subtracted cDNA  from the 
vertis AG, Freising (for details see 3.2.4). 
3.2.3.1. Synthesis of cDNA for subtractive hybridization 
First-strand synthesis 
Synthesis of cDNA was started with 50 µg total RNA (corresponding to approximately 
0.5-2.5 µg mRNA) which had been stored as isopropanol/NaOAc precipitation at 
−20°C. The RNA samples were incubated for 10 min at rt and then centrifuged at 
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12,000 x g for 15 minutes at 6°C. The supernatant was removed and the remaining 
RNA was sediment was washed by addition of 500 µl ethanol and an additional 
centrifugation at 7,500 x g for 5 min at 6°C. The supernatant was discarded and the 
RNA sediment air dried and afterwards dissolved in 13.5 µl deionized water. Then 
0.5 µl cDNA primer 1 (100 pmol/µl) was added and the samples were heat denatured 
at 80°C for 10 min to dissolve secondary structures of the RNA. After heat 
denaturing, samples were chilled using an ice/ethanol bath and the following reactors 
were added for first-strand synthesis: 
 0.5 µl  RNase-Inhibitor (40 U/µl) 
 5.0 µl  first-strand buffer (5x) 
 2.5 µl  DTT (100 mM) 
 1.0 µl  dNTP-Mix (10 mmol/l dATP, dGTP, dTTP, dCTP respectively) 
 2.0 µl  Superscript III (200 U/µl) 
The samples were incubated for 10 min at 37°C, followed by incubation at 45°C for 
80 min. Superscript III is a reverse transcriptase that synthesizes a complementary 
DNA strand from single-stranded RNA. The enzyme shows no RNaseH activity so 
full length cDNA is generated. RNase Inhibitor was added to prevent degradation of 
RNA by ubiquitously present RNases. 
Second-strand synthesis 
Synthesis of the second strand was performed immediately after first-strand 
synthesis had been accomplished. The samples were placed on ice and the following 
reactors were added: 
 86 µl  deionized water 
 30 µl  second-strand buffer (5x) 
 3 µl  dNTP-Mix (10 mmol/l dATP, dGTP, dTTP, dCTP respectively) 
 1 µl  DNA ligase (E. coli) (10 U/µl) 
 4 µl  DNA polymerase I (E. coli) (10 U/µl) 
 1 µl  RNaseH (E. coli) (2 U/µl) 
The reaction was performed at 16°C for 2.5 hours. Addition of a primer was not 
necessary because RNaseH is an endoribonuclease which specifically degrades the 
RNA strand of an RNA-DNA hybrid. The remaining pieces of RNA can be used by 
the DNA polymerase I as primers to start synthesis of the second strand of cDNA.  
After completion of the second-strand synthesis the enzymes were heat denatured at 
75°C for 10 min. Ribosomal and other residual RNAs were digested by addition of 
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3 µl RNase (0.5 mg/ml) for 90 min at 37°C. The double stranded cDNA was then 
incubated with 3.6 µl dNTP mix (10 mmol/l dATP, dGTP, dTTP, dCTP respectively) 
and 10 µl T4 DNA polymerase (1 U/µl) for 5 min at 16°C to yield blunt ends. To 
inactivate the T4-DNA polymerase, 10 µl EDTA (0.5 M) was added and the samples 
were incubated for 15 min at 75°C.  
To remove proteins, a phenol/chloroform extraction with subsequent DNA 
precipitation was performed as described in 3.2.2.4. The DNA sediment was 
dissolved in 10 µl TE buffer and 34 µl deionized water. One-point-five microliter 
(1/30) DNA solution was removed to check the efficiency of cDNA synthesis by 
agarose gel electrophoresis, performed after the following step, which involved 
digestion of the cDNA using a restriction enzyme. 
Because longer cDNA fragments do disturb the efficiency of suppressor PCR, the 
cDNA was digested with RsaI, a restriction enzyme with a four-base recognition 
sequence, to yield shorter cDNA fragments. Hence the following reactors were 
added: 
 0.5 µl  BSA (10mg/ml) 
 5.0 µl   buffer L 
 2.0 µl  RsaI (10 U/µl) 
The digestion was performed at 37°C and after 60 min an additional microliter of RsaI 
was added and the digestion was continued for 60 min; the enzyme was afterwards 
inactivated at 65°C for 20 min. 
The digested cDNA was precipitated (3.2.2.3) and the DNA sediment was dissolved 
in 5.5 µl 0.5 x TE buffer. For agarose gel electrophoresis 0.183 µl (1/30) DNA were 
taken out of the DNA solution. 
To check the efficiency of cDNA synthesis and the success of digestion with the 
restriction enzyme RsaI, an agarose gel electrophoresis (0.8% gel) was performed 
using DNA probes derived from the same sample before and after digestion with 
RsaI. 
3.2.3.2. Ligation of tester cDNA with the adapters 
Before subtractive hybridization the tester cDNA (derived from animal 405) needed to 
be ligated with two different adapters, adapter 1 / adapter 1 reverse and 
adapter 3 / adapter 3 reverse in two separate reactions. Additionally, a molecular 
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weight marker (DNA Molecular Weight Marker IX, M-IX) was also ligated with the 
adapters. The latter reaction served as control. 
First of all two different reactions with the following composition were prepared (each 
reaction was prepared three times): 
   
 
 
 
 
 
 
 
 
The six samples were placed into water tempered at 72°C, which was subsequently 
allowed to cool down at 10.5°C in order to yield double stranded adapters. Now 6 
reactions were prepared as follows: 
 
  
405 
1/1r 
405 
3/3r 
M-IX 
1/1r 
M-IX 
3/3r 
M-IX 
1/1r 
M-IX 
3/3r 
cDNA 405 2 µl 2 µl - - - - 
BM-IX - - 2 µl 2 µl 2 µl 2 µl 
T4-DNA-ligase (2000 U/µl) 0.2 µl 0.2 µl 0.2 µl 0.2 µl 0.2 µl 0.2 µl 
ligase buffer (10x) 0.5 µl 0.5 µl 0.5 µl 0.5 µl 0.5 µl 0.5 µl 
deionized water 2.3 µl 2.3 µl 2.3 µl 2.3 µl 2.3 µl 2.3 µl 
premix adapter 1/1r 5 µl - 5 µl - 5 µl - 
premix adapter 3/3r - 5 µl - 5 µl - 5 µl 
RsaI (10U/µl) 0.1 µl 0.1 µl 0.1 µl 0.1 µl - - 
 
Ligation was performed overnight at 16°C. To serve as additional control, a seventh 
sample (K-405) was created, by mixing one microliter 405 1 / 1r with one microliter 
405 3 / 3r prior to performing the ligation reaction. The next morning the samples 
were incubated at 70°C for 20 min to achieve heat inactivation of the enzymes.  
One microliter of K-405 was submitted to PCR. Therefore, the following reactors 
were added to the template:  
 2.5 µl  PCR buffer (10x) 
  
premix 
adapter 1/1r 
premix 
adapter 3/3r 
deionized water 3.5 µl 3.5 µl 
ligase buffer (10x) 0.5 µl 0.5 µl 
adapter 1 (40 pmol/µl) 0.5 µl - 
adapter 1 reverse (40 pmol/µl) 0.5 µl - 
adapter 3 (40 pmol/µl) - 0.5 µl 
adapter 3 reverse (40 pmol/µl) - 0.5 µl 
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 19.5 µl deionized water 
 0.5 µl  dNTP-Mix (10 mmol/l dATP, dGTP, dTTP, dCTP respectively) 
 1.0 µl  PCR-primer 1 (10 pmol/µl) 
 0.5 µl  Advantage2 DNA Polymerase Mix 
The polymerase chain reaction was performed in a Perkin Elmer 480 Cetus 
thermocycler with the following parameters: 75°C for 5 min; 30 cycles at 94°C for 
30 sec, 66°C for 30 sec, and 72°C for 90 sec; 72°C for 3 min. 
Agarose gel electrophoresis was applied to verify the effiency of the adapter ligation 
and of the control PCR. A 2% gel prepared out of small DNA agarose was used.  
3.2.3.3. Subtractive Hybridization 
First step of subtractive hybridization 
Prior to the first step of subtractive hybridization the DNA was precipitated to remove 
residual proteins that might hinder successful subtractive hybridization. One-pint-five 
microliter driver cDNA (derived from animal 406) was added to the sample containing 
tester cDNA ligated to adapter1 and adapter 1 reverse respectively ligated to adapter 
3 and adapter 3 reverse (1.5 µl each). This was equivalent to a 30-fold excess of 
driver cDNA. The samples were mixed and then a DNA precipitation (3.2.2.3) was 
carried out. After dissolving the sediment in 2.5 µl 0.1 x TE buffer, 0.5 µl 25 mM 
MgCl2 and 1 µl hybridization buffer for SSH (4x) were added. Subtractive 
hybridization was performed using the following parameters: 4°C for 9:35 h, 98°C for 
1.5 min, cooling down from 98°C to 68°C in 20 min and finally 68°C for 10 h.  
Second step of subtractive hybridization 
To initiate the second step of subtractive hybridization the two samples of the first 
step were mixed and allowed to hybridize at 68°C. After 24 hours the hybridization 
was stopped by adding 200 µl dilution buffer and incubation of the sample at 72°C for 
7 min. 
Suppressor PCR 
To selectively amplify those double stranded cDNA molecules that contain different 
adapters on each side, suppressor PCR was performed. As template, 2 µl of the 
hybridization reaction were used and the following reactors were added: 
 2.5 µl  PCR buffer (10x) 
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 19.5 µl deionized water 
 0.5 µl  dNTP-Mix (10mmol/l dATP, dGTP, dTTP, dCTP respectively) 
 1.0 µl  PCR primer 1 
 0.5 µl   Advantage2 DNA Polymerase Mix 
Primary PCR was performed with the following parameters: 75°C for 5 min; 29 cycles 
at (94°C for 30 sec, 66°C for 30 sec, 72°C for 1.5 min), 72°C for 3 min. The PCR 
product was diluted 10-fold with TE buffer and 1 µl of the solution was subsequently 
used as template for secondary PCR. Secondary PCR was performed using nested 
primers thereby reducing the possibility to obtain unspecific PCR products. The 
following reactors were added:  
 2.5 µl  PCR-buffer (10x) 
 18.5 µl deionized water 
 0.5 µl  dNTP-Mix (10mmol/l dATP, dGTP, dTTP, dCTP respectively) 
 1.0 µl  nested primer 1 (10 pmol/µl) 
 1.0 µl  nested primer 2 (10 pmol/µl) 
0.5 µl  Advantage2 Polymerase Mix 
The following parameters were employed: 96°C for 1 min, 12 cycles at (94°C for 
30 sec, 68°C for 30 sec, 72°C for 1.5 min), 72°C for 3 min. All PCR reactions are 
done in a Perkin Elmer Cetus thermal cycler. 
After PCR reaction was completed the PCR product was analyzed by 1 % agarose 
gel electrophoresis.  
To eliminate Taq polymerase made use of for PCR, a phenol/chloroform extraction 
was performed (3.2.2.4). The DNA sediment was dissolved in 5 µl TE buffer and 
20 µl water.  
3.2.3.4. Ligation with vector DNA 
The next steps involved ligation of the PCR products with vector DNA and 
subsequent introduction of the ligation reaction into bacteria. The plasmid 
pBSIIKMO, a derivative of pBluescript II SK, served as vector DNA. 
cDNA preparation  
First of all the PCR products were digested with BssHII. The recognition site of this 
restriction enzyme (“GCGCGC”) is located inside the adapter sequence and the 
resulting sticky ends are compatible with the AscI recognition site located in the 
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vector. Digestion was performed by addition of 3 µl NEBuffer3 and 2 µl BssHII (4 
U/µl) and subsequent incubation at 50°C for 2 h, followed by heat inactivation of the 
restriction enzyme at 75°C for 20 min. 
In the next step, cDNA fragments counting less than 100 to 200 base pairs had to be 
removed. Those short fragments are on the one hand primer oligonucleotides used 
as primers for suppressor PCR and emerge on the other hand from the former 
digestion with BssHII and resemble the outer part of the adapters. Removal was 
achieved by a preparative agarose gel electrophoresis as follows: ten microliter 
loading buffer for agarose gel electrophoresis were added to the PCR products 
obtained from suppressor PCR, which were then loaded onto a 1% low melting 
agarose gel. After electrophoresis, the gel below 100 to 200 base pairs according to 
the molecular weight marker was cut off and discarded. The remaining gel, 
containing the cDNA longer than 100 to 200 base pairs was transferred back to the 
electrophoresis chamber and electrophoresis was done again but with inverse 
polarity. Electrophoresis was stopped before the cDNA arrived at the slots of the gel. 
Then the cDNA band was cut off and cDNA was isolated from the gel using the 
QIAquick Gel Extraction Kit according to the manufacturer’s recommendations. The 
principle of this kit is a silicia gel membrane, which binds DNA in high-salt buffer. 
Elution of the DNA is performed using low-salt buffer or water. The purification 
procedure removes the agarose from the DNA sample. The purified DNA was 
analyzed by 1% agarose gel electrophoresis. 
Vector preparation 
Throughout the next step, the vector DNA was digested with AscI to yield sticky 
ends. These sticky ends are compatible with the ends resulting from the BssHII 
digestion of the cDNA. Digestion was performed under the following conditions:  
 6 µl  pBSIIKfMO (208 ng/µl) 
 3 µl  NEBuffer4 
 20 µl  deionized water 
 0.3 µl  BSA (10 mg/ml) 
 1 µl  AscI (10 U/µl) 
The sample was incubated at 37°C. After 60 min 1 µl AscI (10 U/µl) was added and 
the sample was incubated at 37°C for additional 60 min. Afterwards the enzyme was 
heat inactivated at 65°C for 20 min. 
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To avoid self-ligation of the plasmid DNA, the phosphate group of the 5´ end of the 
vector needed to be removed. This was achieved by addition of 5 µl Shrimps-AP 
(1 U/µl) and 4 µl dephosphorylization buffer (10x) and subsequent incubation at 37°C 
for 20 min. The enzyme was inactivated at 70°C for 20 min.  
Ligation reaction and introduction into E. coli SURE© 
During the ligation reaction a ratio of cDNA to plasmid DNA of 1:2 is required. The 
average length and concentration of cDNA or plasmid DNA, respectively, was 
estimated on the basis of the gel electrophoresis photos and the required amounts of 
cDNA or plasmid DNA were calculated. Two microliter plasmid DNA (25 ng/µl), with 
an average length of 300 bp and 0.66 µl cDNA (5 ng/µl), with an average length of 
400 bp, were mixed and incubated at 65°C for 5 min and afterwards chilled on ice. 
Then 0.2 µl T4-DNA-Ligase (2000 U/µl), 1 µl ligase buffer (10x) and 5.8 µl deionized 
water were added and the reaction was performed at 16°C for 4 hours followed by 
heat inactivation at 70°C for 20 min.  
The ligation reaction was introduced directly into E. coli SURE® electroporation-
competent cells by electroporation. One microliter ligation reaction was added to 50 
µl E. coli SURE©, which had been thawed on ice, and incubated for 2 min on ice. 
The cell-DNA mixture was then transferred into a chilled electroporation cuvette and 
electroporation was performed at 12.5 kv/cm field strength using an E. coli Pulser©. 
Afterwards the bacteria were immediately transferred into a 1.5 ml reaction tube 
containing 840 µl chilled SOC medium and incubated at 37°C for 30 min. 
One hundred microliter SOB medium were added to 5 µl respectively 15 µl of the 
bacteria and plated. After addition of 150 µl glycerol (final concentration 15%), the 
remaining cells were transferred to a cryotube, frozen on dry ice and stored at -80°C 
until further processing. The agar plates were incubated over night at 37°C. The next 
morning, the number of colonies grown over night was counted and the average 
number of colonies present in the subtracted library was calculated. 
Isolation of plasmid DNA 
The colonies were washed off from the agar plate using 10 ml LB-medium. The 
suspension was then transferred into a 15 ml centrifuge tube. Centrifugation at 8,400 
x g for 5 min at 4°C led to the formation of a sediment containing the bacteria. The 
supernatant was discarded and the plasmid DNA was isolated using the QIA prep 
Spin Miniprep Kit according to the manufacturer’s instruction.  
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3.2.4. cDNA library construction from subtracted cDNA produced by the 
vertis Biotechnologie AG 
Subtracted cDNA enriched for cDNAs of genes upregulated due to the presence of a 
conceptus during the peri-implantation period was purchased from the vertis AG 
(Freising). Subtraction was performed as previously described by Ros and 
coworkwers (2004) using the same RNA samples as used for construction of the 
library according the SSH method in our laboratory.  
cDNA synthesis was started using 3.5 µg total RNA. First-strand synthesis was 
performed using different oligo(dT)-Not I-primer for the preparation of the driver and 
tester cDNA and M-MLV-RNase Hֿ Reverse Transcriptase. The linker primer used 
for synthesis of the tester cDNA contained a Not I recognition site. Second-strand 
synthesis was performed using different “random linker primer” for tester and driver 
cDNA preparation and the Klenow DNA-polymerase. The resulting cDNA was then 
amplified with long and accurate PCR (LA-PCR). For subtraction, single stranded 
(ss) cDNA was prepared from the tester (sense strand) and driver (antisense strand) 
cDNA. A 10-fold excess of antisense ss-driver was then hybridized with the sense-
tester. Reassociated tester/driver ds-DNA was separated from the remaining ss-
tester cDNA (subtracted cDNA) by passing the mixture over a hydroxylapatite 
column. After hydroxylapatite chromatography, the ss-tester cDNA was amplified with 
the tester-specific primer using LA-PCR. A second round of subtraction was 
performed. 
Cloning of the cDNA was performed in our laboratory as described in 3.2.3.4. The 
only difference consisted in the preparation of the vector DNA. Instead of digestion 
with AscI the vector DNA was first digested with Eco RI to generate Eco RI 
overhangs at the 5´-ends followed by digestion with Not I. 
3.2.5. Preparation of cDNA arrays 
Amplification of cDNA inserts via PCR 
A part of the subtracted libraries was plated onto agar plates composed of Luria broth 
medium and ampicillin. Due to the fact that the agar plates contain ampicillin, only 
bacteria which are ampicillin resistant, like bacteria containing the plasmid pBSIIKֿ 
MO, were able to grow on these plates. After incubation of the plates overnight at 
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37°C, 3072, respectively 1536 clones were randomly picked from the SSH and vertis 
library, and grown overnight in 100 µl Luria broth medium in 96-well microtiter plates. 
Two microliter bacterial suspensions were diluted 20-fold in TE buffer and 
subsequently incubated at 96°C for 20 min to lyse the bacterial cells. Two microliter 
of this solution was used as template to amplify the cDNA insertions via PCR in 96-
well cycle plates. Each PCR reaction was performed using the following reactors:  
 0.2 µl  FIREPol® 
 0.4 µl  NLT7 primer (15 pmol/ml) 
 0.4 µl  LT3 primer (15 pmol/ml) 
 0.4 µl  dNTP-Mix (10 mmol/l dATP, dGTP, dTTP, dCTP respectively) 
 14.6 µl deionized water 
 2 µl  reaction buffer (10x) for FIREPol® 
and the following PCR parameters: 96°C for 2 min, 25 cycles at (94°C for 25 sec, 
64°C for 25 sec, 72°C for 90 s), 15 cycles at (94°C for 25 sec, 62°C for 25 sec, 72°C 
for 90 sec) and 72°C for 300 sec. All PCR reactions were done in a T1 Thermocycler 
T3 and all PCR products were analyzed by 0.8% agarose gel electrophoresis. 
Spotting the PCR products onto nylon membranes 
In the next step, the PCR products were spotted onto positively charged nylon 
membranes (Nytran® SuperCharge). Prior to the spotting procedure, the nylon 
membranes were rinsed for 5 min in water, 5 min in ethanol (100%) and afterwards 
air dried in order to remove any potential dirt.  
Fifteen microliter of the PCR reactions were transferred to 384 well microtiter plates 
containing 15 µl of 2-fold spotting buffer with the following composition:  
 40 mmol/l  Tris-HCl (pH 8.4) 
 2 M   NaCl 
 2 mM    EDTA 
 0.001%  bromphenolblue 
Now the PCR products were spotted onto nylon membranes using an Omnigrid 
Accent microarrayer and solid pins (0.015 inch in diameter). PCR products (n=1536) 
were spotted within an area of 20 x 50 mm. Spotting was performed six times for 
each PCR product on the same position to achieve sufficient and equal application. 
Up to fifty arrays, each containing 1536 cDNA fragments can be produced 
simultaneously. After spotting was completed, the spotted DNA was denatured on 
the arrays by incubation on filter paper soaked with 0.5 N NaOH for 20 min at room 
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temperature. DNA was fixed by baking at 80°C for 30 min and UV crosslinking (120 
mJ/cm2) leading to hydrophobic and covalent linkage, respectively. 
3.2.6. Array hybridization with 33P-labeled cDNA probes 
RNA of all 10 animals (pregnant n=5, non-pregnant n=5) was converted to double 
stranded cDNA which was subsequently labeled with 33P-dCTP and subjected to 
array hybridization. 
Synthesis of cDNA 
Fifty microgram total RNA was subjected to cDNA synthesis. Prior to conversion into 
cDNA the RNA was precipitated using NH4OAc (3.2.2.3). After dissolving the RNA 
sediment in 13.5 µl deionized water, 0.5 µl cDNA primer 2 (100 pmol/µl) was added 
and the samples were heat denatured at 80°C for 10 min. After heat denaturing the 
samples were chilled in an ice/ethanol bath. For first-strand synthesis the following 
reactors were added:  
 2 µl  Superscript III (200 U/µl) 
 0.5 µl  RNase-Inhibitor (40 U/µl) 
 1 µl  dNTP-Mix (10 mmol/l dATP, dGTP, dTTP, dCTP, respectively) 
 2.5 µl  DTT (100 mM) 
 5 µl  first-strand buffer (5x) 
After incubation at 37°C for 10 min to allow annealing of the primer, reverse 
transcription was performed at 45°C for 80 min. 
Synthesis of the second strand was performed at 16°C for 2.5 hours using the 
following reactors: 
86 µl  deionized water 
 30 µl  second strand buffer (5x) 
 3 µl  dNTP-Mix (10mmol/l dATP, dGTP, dTTP, dCTP respectively) 
 1 µl  E. coli DNA-Ligase (E. coli)(10 U/µl) 
 4 µl  DNA-Polymerase I (E. coli) (10 U/µl) 
 1 µl  RNaseH (E. coli) (2 U/µl) 
After synthesis of double stranded cDNA was completed, the enzymes were heat 
inactivated at 75°C for 15 min. Residual RNA was digested at 37°C for 90 min using 
3 µl RNase (0.5 mg/ml).  
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Microspin™ S200-HR Columns were used to remove residual primers according to 
the manufacturer’s instructions.  
The purified DNA was then precipitated using NaOAc and isopropanol (3.2.2.3) and 
the sediment was dissolved in 20 µl 0.5-fold TE.  
The quality of the cDNA was checked by 0.8 % agarose gel electrophoresis. 
Radioactive labeling of the cDNA 
33P-labeled cDNA probes were generated from double stranded cDNA corresponding 
to 7.5 to 15 µg total RNA using the High Prime DNA Labeling Kit. The method of 
random primed DNA labeling, which was originally developed by Feinberg and 
Vogelstein (Feinberg and Vogelstein, 1983; Feinberg and Vogelstein, 1984), is based 
on the hybridization of oligonucleotides of all possible sequences to the denatured 
DNA to be labeled. The complementary DNA strand is synthesized by Klenow 
polymerase using the 3`OH termini of the random oligonucleotides as primers. 
Modified deoyxribonuclease-triphosphates (i.e. α[33P]dCTP) present in the reaction 
are incorporated into the newly synthesized complementary DNA strand.  
The cDNA was heat denatured at 96°C for 10 min and then chilled on ice. The 
labeling reaction was performed at 37°C for at least 4 hours using the following 
reactors: 
 4 µl  High Prime DNA Labeling Mix (5x) 
 90 µCi [α-33P]dCTP 
 0.375 µl dNTP-Mix (0.3 mmol/l dCTP and 20 mmol/l dATP, dGTP, dTTP, 
respectively)  
The reaction was heat inactivated at 65°C for 20 min. Then 50 µl TE and 30 µl 
human C0T-1 DNA were added. Human C0T-1 DNA mainly comprises repetitive 
DNA sequences and was used to suppress cross-hybridization to repetitive 
sequences during the following process of hybridzation. The reactions were then 
purified using ProbeQuant™ G-50 Micro Columns according to the manufacturer’s 
instructions, to remove unincorporated nucleotides and primers from the labeling 
reaction. Labeling efficiency was estimated by comparing the impulse per seconds 
(ips) of the purified labeling reaction and the column residue. The optimal ratio of 
labeling reaction to column residue is 3:1.  
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Prehybridization of arrays 
Prehybridization was done for up to 6 arrays together in a glass hybridization bottle of 
15 cm length and involved the following steps: 
 2 x 10 min 10 ml 1 x PBS / 10% SDS at 65°C 
 1 x 1 h 10 ml 1 x PBS / 10% SDS at 65°C 
 1 x 10 min 10 ml 1 x PBS / 10% SDS at 85°C 
 2 x 10 min 10 ml 0.1 x PBS / 1% SDS at 85°C 
 3 x 10 min 10 ml 1 x PBS / 10% SDS at 65°C 
SDS is an anionic detergent, which can bind via its hydrophilic tails to the nylon 
membrane. This blocking procedure was necessary, because otherwise DNA of the 
hybridization probe would bind in a non-specific manner to free binding sites of the 
membrane during array hybridization. 
Hybridization 
Hybridization was performed in plastic vials containing 3 ml hybridization solution (1 x 
PBS/10% SDS and labeled probe) for 45 hours at 65°C. Hybridization probes were 
denatured for 15 min at 96°C immediately before adding to the hybridization solution. 
After hybridization, 6 arrays were put together in a 15 cm glass hybridization bottle 
and washed as follows to remove non hybridized cDNA fragments:  
 3 x 5 min 10 ml 1 x PBS/10% SDS at 65°C 
 3 x 10 min 10 ml 1 x PBS/10% SDS at 65°C 
 3 x 10 min 10 ml 0.1 x PBS/1% SDS at 65°C 
 2 x 10 min 10 ml 1 x PBS/1% SDS/2 mM EDTA at room temperature 
Filters were dried at 80°C for 20 min and then exposed to an imaging plate BAS-SR 
2025. This imaging plate has a flexible polyester base coated with highly dispersed 
barium fluorohalide phosphor crystals. When a radioactively labeled sample is 
exposed, the energy from that sample is transferred to the phosphor crystals and 
stored as trapped electrons. After optimal exposition length the imaging plate is 
scanned with a phosphor imager, Storm 860. Scanning the exposed imaging plate 
releases the trapped electrons resulting in the emission of light at about 400 nm. This 
process is known as photo-stimulated luminescence. The blue light emitted is 
collected to produce the digitized image. 
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3.2.7. Analysis of array data 
Array analysis was done using AIDA Image Analyzer software (Version 4.00). 
Background, i.e. fluorescence due to unspecific binding of cDNA, was subtracted 
with the function “weighted image regions”. For further analysis raw data were 
exported to Microsoft Excel and normalized to the median signal intensity of all cDNA 
clones which showed a difference in signal intensity of less than 2-fold. Normalization 
means to adjust microarray data for effects which arise from variation in the 
technology rather than from biological differences between the RNA samples. Pair-
wise comparison (pregnant-control) was performed within twin pairs, thus eliminating 
changes in gene expression due to a different genetic background of individuals. 
Complementary cDNA clones, which exhibit a difference in signal intensity of 2-fold 
or more in four out of five twin pairs were assumed to be upregulated at the pre-
implantation period and subjected to further analysis, i.e. DNA sequencing. To test 
significance of expression differences a paired Student’s t-test was performed and 
the coefficient of variation (CV) of the expression ratios between pregnant and non-
pregnant animals was calculated. Due to the nature of subtracted libraries for many 
genes (37) more than one cDNA fragment was present on the arrays and for these 
genes the mean of the signal ratios was calculated. 
3.2.8. Sequencing of cDNAs with differential hybridization signals and data 
analysis 
Those cDNA clones which showed a difference in signal intensity of 2-fold or more in 
at least four out of five twin pairs were sequenced directly from spotting solutions by 
automated DNA sequencing (3100-Avant Genetic Analyzer). The DNA sequencing 
(i.e. the determination of the precise sequence of nucleotides in a sample of DNA) 
was carried out by the AG Blum (AG Dr. H. Blum, LAFUGA, Gene Center, Munich). 
Prior to sequencing, a microdialysis was performed to remove hampering salts, 
nucleotides and PCR primers from the spotting solution. A petri dish was filled with 
40 ml 0.25 x TE buffer, the dialysate. A MF-Millipore membrane filter (0.025 µm) was 
then floated on the surface of the dialysate and 2.5 µl spotting solution were 
deposited on the membrane. A tight fitting lid was placed on the petri dish to prevent 
evaporation. After 1 h the desalted sample was recovered and transferred into a 
reaction tube containing 1 µl PM0- or T7ex- primer (3.5 pmol/µl) and 3.5 µl deionized 
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water. Then 1 µl DYEnamic ET Terminator Cycle Sequencing Kit and 3 µl better 
buffer special were added and sequence reaction was performed using the following 
parameters: 96°C for 120 s and 35 cycles at (96°C for 30 s, 54°C for 30 sec, 60°C for 
30 s). In this sequence reaction, the template was supplied with a mixture of 
deoxynucleotides (dATP, dCTP, dGTP, dTTP) in ample quantities, a mixture of 
dideoxynucleotides that lack the 3`-OH, each present in limiting quantities and each 
labeled with a different fluorescencent dye and a thermostable polymerase. Because 
all four deoxynucleotides are present, chain elongation proceeds normally until, by 
chance, DNA polymerase inserts a dideoxnucleotide instead of the normal 
deoxynucleotides which leads to chain termination. 
Resulting sequences were compared with public sequence databases using the basic 
local alignment search tool at the National Center for Biotechnology Information 
(www.ncbi.nlm.nih.gov/blast/blast.cgi). cDNAs without similar entries in the “ref” or 
“nr” database subsets were in addition compared with the “est” database or the raw 
version of the bovine genome (http://pre.ensembl.org/Multi/blastview?species=Bos_ 
taurus). Based on the data for the human orthologous genes simplified Gene 
Ontologies were built of the data obtained with the Gene Ontology filter function of 
the Bibliosphere software in order to categorize the genes regarding their molecular 
function or the biological processes they are involved in, respectively. Resulting data 
were supplemented with additional information from Entrez Gene 
(www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene), and from the literature. 
Bibliosphere was further used to identify relationships between the identified genes 
based on co-citations in NCBI Pubmed. Co-citations were limited to “sentence level”, 
i.e. two genes are co-cited in the same sentence. 
3.2.9. Real-time RT-PCR 
One microgram of each sample of total RNA was reverse transcribed in a total 
volume of 60 µl, containing 1x buffer (Promega, Madison, USA), 0.5 mM dNTPs 
(Roche, Mannheim), 2.5 µM hexamer primers (Gibco BRL, Grand Island, USA), and 
200 U M-MLV Reverse Transcriptase, RNase H Minus, Point Mutant (Promega, 
Madison, USA). Primers were designed to amplify specific fragments referring to 
selected regulated genes:  
C1R (for 5´-AGGGGATAGTGGAGGGGTC; 
 rev 5´-GGACATTGGTGTAAAACCCG [117 bp]), 
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C1S (for 5´-AACAGGAGTGGGTCATCCAG; 
rev 5´-CGGCTGTGTTGGTCTTTCAG [149 bp]), 
DTX3L (for 5´-AAAGGATGTCTTGAGCCAAGC; 
   rev 5´-CTCCAGAAATGACAACCTTGC 39 bp]), 
HSXIAPAF1 (for 5´-GAGGAGGCTCTGAGCTTGC; 
 rev 5´-GCAGAGAAAGATGTCCGTCC [143 bp]), 
IFITM3 (for 5´-CGTGTGGTCCCTGTTCAAC; 
   rev 5´-CCATCTTCCGGTCCCTAGAC [95 bp]), 
ISG15 (for 5´-GACAGCAGGGAGGTGCTG; 
  rev 5´-ACCCTTGTCGTTCCTCACC [203 bp]), 
SERPING1 (for 5´-ACCAACCTCAGGATCAGGC; 
rev 5´-CTATCTTCCACTTGGCGCTC [97 bp]) 
UBE1L (for 5´-GTGTTCATACCGCACGTGAC, 
   rev 5´-GGTTGTGGCAGGAATGTACC [105 bp]) 
UTMP (for 5´-ATATCATCTTCTCCCCCATGG; 
  rev 5´-GTGCACATCCAACAGTTTGG [126 bp]), and the  
Ubiquitin mRNA as a housekeeping gene (for 5´-AGATCCAGGATAAGGAAGGCAT; 
rev 5´-GCTCCACCTCCAGGGTGAT [198 bp]) (referring to Neuvians et al., 2003). All 
amplified PCR fragments were sequenced with forward and reverse primers (3100-
Avant Genetic Analyzer, Applied Biosystems, Langen) to verify the resulting PCR 
product. Thereafter the specific melting point of the amplified product served as 
verification of the product identity (Ulbrich et al., 2004). For each of the following real-
time PCR reactions, 1 µl of cDNA was used to amplify specific target genes. 
Quantitative real-time PCR reactions using the LightCycler® DNA Master SYBR 
Green I protocol (Roche, Mannheim) were performed as described previously 
(Ulbrich et al., 2004). In each PCR reaction 17 ng/µl cDNA were introduced and 
amplified in a 10 µl reaction mixture (3 mM MgCl2, 0.4 µM primer forward and reverse 
each, 1x Light Cycler DNA Master SYBR Green I, Roche, Mannheim, Germany) 
using a real-time LightCycler instrument (Roche, Mannheim). The annealing 
temperature was 60°C for all reactions. To ensure an accurate quantification, a high 
temperature fluorescence measurement was undertaken in a fourth segment of the 
PCR (C1R and UTMP 80°C, C1S and IFITM3 81°C, DTX3L and HSXIAPAF1 75°C, 
ISG15 87°C, SERPING1 83°C, UBE1L 82°C and Ubiquitin 78°C, respectively. The 
cycle number (CP) required achieving a definite SYBR Green fluorescence signal 
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was calculated by the second derivative maximum method (LightCycler software 
version 3.5.28). The CP is correlated inversely with the logarithm of the initial 
template concentration. As negative controls, water instead of cDNA was used. 
All Real-time RT-PCR experiments were kindly carried out by Dr. S.E. Ulbrich 
(Physiology-Weihenstephan, Technical University of Munich). 
3.2.10. Data Analysis of Real-time RT-PCR 
The cycle number (CP) required to achieve a definite SYBR Green fluorescence 
signal was calculated by the second derivative maximum method (LightCycler 
software version 3.5.28) (Ulbrich et al., 2004). The CP is correlated inversely with the 
logarithm of the initial template concentration. To verify the equal relative quantity of 
the reverse transcribed cDNA PCR for the housekeeping gene Ubiquitin mRNA was 
carried out. The CP determined for the target genes were normalized against 
Ubiquitin (∆CP). Differences between pregnant (ET) and control animals are stated 
as ∆∆CP (Livak and Schmittgen, 2001). From the ∆∆CP of every twin pair the fold-
change was calculated. Significance of differences between groups was tested using 
a paired Student’s t-test. 
3.2.11. In situ Hybridization 
Formalin-fixed (3.7 %), paraffin-embedded samples were used to localize mRNA 
transcripts for C1S, C1R, DTX3L, HSXIAPAF1, IFITM3, SERPING1, and UBE1L 
within bovine uterine tissue samples (caudal section of the ipsilateral horn) collected 
at day 18 of gestation. Buffers (50 mM Tris-buffered saline [TBS] and 0.1 M sodium 
phosphate buffer) were adjusted to a pH of 7.4 unless otherwise noted. All solutions 
for in situ hybridization were prepared using DEPC-treated water and glassware 
sterilized at 200 °C. In addition, all steps prior to and during hybridization were 
conducted under RNase-free conditions. Sections were deparaffinized with xylene (3 
x 10 min), immersed in isopropanol (2 x 5 min) and then allowed to air dry. Dried 
sections were submerged in 2 x saline sodium citrate (SSC, pH 7.0) and preheated in 
a Bain-Marie water bath (80 °C) for 10 min followed by gradual cooling off for 20 min 
at room temperature. Slides were then washed in distilled water (2 x 5 min), TBS (2 x 
5 min) and permeabilized for 20 min with 0.05% proteinase E (VWR, Ismaning, 
Germany) in TBS at room temperature. Sections were relocated in TBS (2 x 5 min) 
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followed by distilled water (2 x 5 min) and post-fixed for 10 min in 4 % 
paraformaldehyde/PBS (pH 7.4). After washing in PBS (2 x 5 min) and distilled water, 
slides were dehydrated in an ascending graded series of ethanol and air-dried. 
Hybridization was carried out by overlaying the dried sections with 40 µl of the 
corresponding biotinylated oligonucleotide probe (100 pmol/µl), diluted 1:20 in in situ 
hybridization solution (DAKO, Munich), and incubating them in a humidified chamber 
(using cover slips to prevent drying-out) at 38 °C overnight. RNase-free hybridization 
solution (DAKO, Munich) contained 60 % formamide, 5 x SSC, hybridization 
accelerator, RNase inhibitor, and blocking reagents. Subsequently, slides were 
washed in 2 x SSC (2 x 15 min, preheated to 38 °C), distilled water (2 x 5 min) and 
TBS (2 x 5 min). Detection of hybridized probes was performed using HRP-labeled 
ABC kit reagents developed by DAB (DAKO, Munich) according to the 
manufacturer’s instructions. Negative controls were done omitting the oligonucleotide 
probe and hybridization with sense oligonucleotide probes (complementary 
sequences of the antisense oligonucleotides). The sequences of the antisense 
oligonucleotides were as follows:  
C1R: 5´-GGACATTGGTGTAAAACCCG,  
C1S: 5´-CTGGATGACCCACTCCTGTT,  
DTX3L: 5´-GCTTGGCTCAAGACATCCTTT,  
HSXIAPAF1: 5´-GCAGAGAAAGATGTCCGTCC,  
IFITM3: 5´-CCATCTTCCGGTCCCTAGA,  
SERPING1: 5´ CTATCTTCCACTTGGCGCTC, and  
UBE1L: 5´-GTCACGTGCGGTATGAACAC. 
All in situ hybridization experiments were kindly carried out by M. Vermehren and 
Prof F. Sinowatz (Institute of Veterinary Anatomy, Histology and Embryology, 
Ludwig-Maximilians University). 
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4. Results 
To gain deeper insight into the molecular mechanism underlying the embryo-
maternal cross-talk two subtracted cDNA libraries enriched for genes upregulated in 
the bovine endometrium due to the presence of a conceptus were analyzed using 
array hybridization. One cDNA library was constructed according the SSH method 
(Diatchenko et al., 1996) as described previously by Bauersachs and coworkers 
(2003), with minor modifications, a second cDNA library was constructed of 
subtracted cDNA purchased from the vertis Biotechnologie AG. For both approaches 
intercaruncular endometrial tissue samples obtained from one monozygotic twin pair 
were utilized. Array hybridization was performed using RNA samples obtained from 
five monozygotic twin pairs. The use of monozygotic twins is a unique possibility to 
eliminate genetic variability as a factor potentially causing differences in 
transcriptome profiles. The expression of nine selected genes was confirmed by real-
time RT-PCR. Furthermore, the localization of mRNA expression within the 
endometrium was determined by in situ hybridization for seven selected genes. The 
experimental strategy is illustrated fig. 4.  
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Fig. 4: Overview of the experimental design for the identification of 
specific transcriptome patterns at day 18 of pregnancy. The use of 
monozygotic twins eliminates genetic variability as a factor potentially 
causing differences in transcriptome profiles. 
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4.1. Isolation of total RNA from bovine endometrial cells 
Total RNA was isolated from intercaruncular endometrial tissue samples obtained 
from five monozygotic twin pairs. A 250 ng/µl dilution of the RNA was prepared to 
check the quality by agarose gel electrophoresis using a 0.8 % 1 x TBE gel. Fig. 5 
shows such an agarose gel electrophoresis of total RNA isolated from bovine 
endometrial cells. The isolated RNA was of consistent high quality. The two bands of 
intense fluorescence represent the 28 S ribosomal RNA (at approximately 1636 bp) 
and 18 S ribosomal RNA (at approximately 1018 bp). The band representing the 28 
S rRNA shows a more distinct fluorescence than the band representing the 18 S 
rRNA. This is an indicator for the integrity of the total RNA. The mRNA is separated 
in the form of an even smear. 
 
 
 
Fig. 5: Total RNA isolated from bovine endometrial cells 
Each of the lanes 2 - 7 comprises 250 ng isolated RNA from bovine 
endometrial cells. The two bands of intense fluorescence represent the 28 S 
rRNA (at approximately 1636 bp) and 18 S rRNA (at approximately 1018 bp). 
Lanes 1 and 8 comprise the DNA molecular weight marker 1 kb DNA Ladder. 
 
1636 bp 
1018 bp 
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4.2. Generation of subtracted cDNA libraries 
To enrich cDNA fragments of genes upregulated in the bovine endometrium due to 
the presence of a conceptus two subtracted cDNA libraries were produced. One 
cDNA library was constructed according the SSH method (Diatchenko et al. 1996) as 
described previously by Bauersachs and coworkers (2003), with minor modifications. 
The second cDNA library was constructed of subtracted cDNA generated by the 
vertis Biotechnologie AG. For both approaches intercaruncular endometrial tissue 
samples obtained from one monozygotic twin pair were utilized. 
4.2.1. Synthesis of cNDA for subtractive hybridization 
cDNA for subtractive hybridization was synthesized from total RNA isolated from the 
monozygotic twin pair 405/406. Because longer cDNA fragments do disturb the 
efficiency of suppressor PCR, the synthesized cDNA was digested with RsaI, a 
restriction enzyme with a four-base recognition sequence, to yield shorter cDNA 
fragments. To check the efficiency of cDNA synthesis and the success of digestion 
with the restriction enzyme RsaI, an agarose gel electrophoresis (0.8% gel) was 
performed using DNA probes derived from the same sample before and after 
digestion with RsaI. Fig. 6 shows such an agarose gel electrophoresis. Lanes 2 and 
4 comprise full length cDNA, lanes 3 and 5 comprise cDNA after digestion with RsaI. 
The full lenght cDNA is separated as an even smear reaching from approximately 
200 base pairs to more than 10,000 base pairs. There are no discrete bands visible, 
meaning that only the mRNA was amplified by the poly(A)-specific cDNA primer 1. 
The cDNA after digestion with RsaI shows a shorter average length, indicating that 
the digestion with RSAI was successful. 
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Fig. 6: Synthesis of cDNA and digestion with RsaI 
Lanes 2 and 4 comprise full length cDNA; lanes 3 and 5 comprise cDNA after 
digestion with RsaI. Lane 1 comprises the DNA molecular weight marker 1 kb 
DNA Ladder (15615-016) and lane 6 comprises the DNA molecular weight 
marker GeneRuler™ 100 bp DNA Ladder Plus 
4.2.2. Ligation of the tester cDNA with the adapters 
Before subtractive hybridization the tester cDNA (derived from animal 405) needed to 
be ligated with two different adapters, adapter 1 / adapter 1 reverse and 
adapter 3 / adapter 3 reverse in two separate reactions. Additionally, a molecular 
weight marker (DNA Molecular Weight Marker IX, M-IX) was also ligated with the 
adapters. The latter reaction served as control. Additionally a control PCR was 
performed. As template a mixture of the two different ligation reactions (tester cDNA 
with adapter 1 / adapter 1 reverse and adapter 3 / adapter 3 reverse) was used. 
Agarose gel electrophoresis was applied to verify the effiency of the adapter ligation 
and of the control PCR. A 2% gel prepared out of small DNA agarose was used (see 
fig. 7). Lanes 2 and 3 comprise the DNA Molecular Weight Marker IX, lanes 4 and 5 
comprise the DNA Molecular Weight Marker IX ligated with the adapters. It is obvious 
that ligation of the DNA Molecular Weight Marker IX with the adapters was doing 
well, as a distinct shift in the average length of the DNA Molecular Weight Marker IX 
can be seen. The small bands at the end of the gel represent excessive adapter 
  1      2       3      4      5     6 
Results 
68 
molecules which have not been ligated. The control PCR was also successful, since 
the intense smear of lines 6 and 7 represents the PCR product. 
 
 
 
Fig. 7: Ligation of tester cDNA with the adapters 
Lanes 2 and 3 comprise the DNA Molecular Weight Marker IX, lanes 4 and 5 
comprise the DNA Molecular Weight Marker IX ligated with the adapters. 
Lanes 7 and 8 comprise the PCR product obtained by the control PCR. Lane 1 
comprises the DNA molecular weight marker DNA Molecular Weight Marker IX 
and lane 9 comprises the DNA molecular weight marker GeneRuler™ 100 bp 
DNA Ladder Plus. 
4.2.3. Suppressor PCR 
To selectively amplify those double stranded cDNA molecules that contain different 
adapters on each side after subtractive hybridization, suppressor PCR was 
performed. As template, 2 µl of the hybridization reaction were used. After PCR 
reaction was completed the PCR product was analyzed by 1 % agarose gel 
electrophoresis (see fig. 8). Lanes 2 – 5 comprise the PCR products obtained from 
primary PCR, lanes 6 – 9 comprise the PCR products obtained from secondary PCR. 
All PCR products are separated as a smear. The products obtained from secondary 
PCR show a more intense fluorescence than those obtained from primary PCR. The 
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PCR products acquired from secondary PCR contain some, more or less, distinct 
bands.  
 
 
 
Fig. 8: Suppressor PCR 
Lanes 2 – 5 comprise the PCR products obtained from primary PCR, lanes 8 – 
11 comprise the PCR products obtained from secondary PCR. Lanes 1 and 11 
comprise the DNA molecular weight marker GeneRuler™ 100 bp DNA Ladder 
Plus. 
4.2.4. Ligation with vector DNA and introduction into E.coli Sure® 
The PCR products obtained by suppressor PCR were ligated with vector DNA and 
the ligation reaction was subsequently introduced into bacteria.  
First of all the PCR products were digested with BssHII. After digestion with the 
restriction enzyme, cDNA fragments counting less than 100 to 200 base pairs were 
removed by preparative agarose gel electrophoresis. The cDNA was then isolated 
from the gel using the QIAquick Gel Extraction Kit. An aliquot of the purified cDNA 
was analyzed by 1% agarose gel electrophoresis (see fig. 9). Lanes 2 and 3 
comprise an aliquot of the cDNA isolated from the preparative agarose gel. The 
cDNA is separated as an even smear, indicating that the isolation from the agarose 
gel was complete. 
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Fig. 9: Analysis of cDNA after isolation from agarose gel 
Lanes 2 and 3 comprise the cDNA isolated from agarose gel, lanes 1 and 4 – 
6 comprise the DNA molecular weight marker GeneRuler™ 100 bp DNA 
Ladder Plus. 
 
The prepared cDNA was then ligated with the vector and the ligation reaction was 
introduced directly into E. coli SURE® electroporation-competent cells by 
electroporation. A definite part of the bacteria was then plated onto agar plates which 
were incubated over night. The next morning the number of colonies grown over 
night was counted and the average number of colonies present in the subtracted 
library was calculated (96,000 colonies at all). 
An aliquot of the plasmid DNA was analyzed by (1%) agarose gel electrophoresis in 
comparison to the plasmid DNA of the empty vector in order to check the effiency of 
the ligation reaction (see fig. 10). Lane 2 comprises plasmid DNA of the empty 
vector, lanes 3 and 4 comprise plasmid DNA ligated with cDNA. The plasmid DNA 
ligated with the cDNA shows an greater average lenght than the DNA of the empty 
plasmid vector, indicating that the ligation reaction was successful. 
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Fig. 10: Analysis of plasmid DNA 
Lane 2 comprises plasmid DNA of the empty vector, lanes 3 and 4 comprise 
plasmid DNA ligated with cDNA. Lanes 1 and 5 comprise the DNA molecular 
weight marker GeneRuler™ 100 bp DNA Ladder Plus. 
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4.3. Preparation of cDNA arrays 
A total of 4608 individual clones, 3072 from the “SSH library” and 1536 from the 
“vertis library” were picked and their cDNA inserts were amplified via PCR and 
analyzed by agarose gel electrophoresis. The amplified cDNA fragments were used 
to prepare three cDNA arrays, two “SSH arrays” and one “vertis array”, each 
containing 1536 PCR products. 
Fig. 11 shows an agarose gel electrophoresis of the PCR products obtained by 
amplification of the cDNA inserts via PCR. In all 96 reactions a specific PCR product, 
represented by a distinct band, could be obtained.  
 
 
 
Fig. 11: Amplification of cDNA inserts via PCR 
Lanes 2 – 17 comprises the PCR products resulting from amplification of cDNA 
fragments via PCR, lanes 1 comprise the DNA molecular weight marker GeneRuler™ 
100 bp DNA Ladder Plus. 
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4.4. cDNA synthesis for array hybridization 
RNA from intercaruncular endometrial tissue samples of the caudal part of the 
ipsilateral uterine horn of all 10 animals (pregnant n=5, non-pregnant n=5) was 
converted to double stranded cDNA. The quality of the cDNA was checked by 0.8 % 
agarose gel electrophoresis (see fig. 12). The synthesized cDNA is separated as a 
smear.  
 
 
  
Fig. 12: cDNA synthesis for array hybridization 
Lanes 2 – 13 comprise cDNA, lanes 1 and 14 comprise the DNA molecular 
weight marker GeneRuler™ 100 bp DNA Ladder Plus. 
 
4.5. Array hybridization 
The cDNA synthesized for array hybridization was labeled with 33P-dCTP and 
subjected to array hybridization. Relative gene expression levels pregnant versus 
non-pregnant were determined for each individual cDNA fragment by pair wise 
comparison within twin pairs, thus eliminating changes in gene expression due to a 
different genetic background of individuals. A total of 376 cDNA fragments displayed 
a difference in signal intensity of 2-fold or more in at least four out of five twin pairs 
(see fig. 13). These cDNA fragments were assumed to be upregulated in the 
endometrium at the pre-implantation period. 
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Fig. 13: Scatter Plot of mean normalized signal intensitites of all upregulated 
cDNA fragments (≥ 2-fold) in at least four out of five twin pairs 
 
 
    
pregnant              non-pregnant 
Fig. 14: Corresponding sections of a microarray hybridized with two different 
cDNA probes: Obvious difference in signal intensity 
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4.6. Sequence analysis of differentially expressed cDNA framents 
Those cDNA fragments displaying a difference in signal intensity of two-fold or more 
in at least four out of five twin pairs (i.e. 376 fragments) were subjected to sequence 
analysis, which revealed 87 different genes or mRNAs. For 37 genes more than one 
cDNA fragment was found and for these genes the mean of all signal ratios was 
calculated. The genes most abundantly represented on the cDNA arrays were ISG15 
(n=48), BST2 (n=28), KIAA 1404 (n=25), IFITM1 (n=17), IFITM3 (n=17), and OAS1 
(n=16). Eighty genes corresponded to genes with known or inferred function, either 
the bovine gene or the human orthologue. For 7 genes a match with bovine 
expressed sequence tags was obtained only. Table 1 lists the results of the 
sequence analysis. The common name, the Gene ID, the GenBank accession 
number, whether stimulated by type I interferons, the results of Gene Ontology 
classification, the expression ratio, the t-test p-value, and the coefficient of variation 
(CV) is shown. 
Fifteen genes displayed a difference in signal intensity of two-fold or more in only four 
out of five twin pairs (i.e. CNDP2, CTGF, CTMP, GRIM19, HLA-A, HLA-C, IFIT2, 
IGFBP-2, MTMR6, MYO6, IDH1, PENK, RNH, SAMD9, and SLC15A3). These genes 
were consistently represented by one cDNA fragment on the array and the signal 
ratio for the fifth twin pair ranged from 1.1 to 1.96. For three of these genes the t-test 
p-value was slightly higher than 0.05 (i.e. IFIT2, HLA-C, and SAMD9), but they were 
still assumed to be upregulated and included in further analyses. There was only one 
more gene, i.e. LY6G6C, exhibiting a p-value of more than 0.05. The mean 
coefficient of variation of expression ratio between pregnant and non-pregnant was 
41%. 
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4.7. Categorization of the identified genes regarding their function 
The expression of 38 genes is known to be stimulated by type I interferons (see table 
1), corresponding to almost one half of the identified genes whose function is known 
or inferred. To get an overview of the identified genes regarding their function a 
simplified Gene Ontology classification was built based on the human orthologous 
genes. The results are visualized in figures 15 - 17, whereat figure 15 gives an 
overwiev of the classification of the identified genes into functional categories, and 
figures 16 and 17 list in more detail the results of the categorization according to the 
molecular function of the identified genes or the biological process they are involved 
in, respectively. 
The majority of genes was assigned either to one of the biological processes 
“regulation of gene expression”, “cell communication”, “cell growth, proliferation and 
differentiation”, or exhibits “cell adhesion molecule activity” or an “immune-related 
function”. 
 
 
Fig. 15: Classification of the identified genes into functional categories. 
Multiple naming is possible. 
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Fig. 16: Gene Ontology “Molecular Function” 
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Fig. 17: Gene Ontology “Biological Process” 
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Table 2 lists in more detail important biological processes or functional groups and 
the corresponding genes with their fold upregulation. Besides many genes involved 
in signal transduction, there were seven genes coding for products with GTPase 
activity, five potential members of the ISG15ylation system, four members of the 
complement system (including the C1 inhibitor SERPING1), and also two genes 
involved in or related to the IGF system, respectively (IGFBP2 and CTGF). With 
respect to the process “cell proliferation” three of the seven genes are described to 
negatively regulate this process. In contrast, three out of six apoptosis-related genes 
positively regulate cell death. The categories “proteolysis and peptidolysis”, “cell 
adhesion”, and “morphogenesis” contain some genes, which code for proteins that 
are particularly important for remodeling of the endometrium, like MMP19, TIMP2, 
and CTGF. 
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Table 2: Important biological processes or functional groups and the 
corresponding genes with their fold upregulation 
Biological Process/Molecular 
Function 
Gene name 
Fold 
up 
 
Biological Process/Molecular 
Function 
Gene name 
Fold 
up 
signal transduction HLA-A 2.6  ADP ribosylation PARP12 4.4 
 HLA-C 2.7  cell communication CTGF 3.2 
 IFITM1 8.5   GPLD1 5.4 
 MS4A8B 5.8   MFGE8 6.9 
 MX1 11.2   MS4A8B 5.8 
 PENK 4.0   PENK 4.0 
SP110 5.8   SCOTIN 3.7 hematopoietin/interferon-class 
(D200-domain) cytokine receptor 
signal transducer activity 
STAT1 4.6  cell-cell signaling BST2 18.1 
BST2 18.1   ISG15 (G1P2) 41.4 I-kappaB kinase/NF-kappaB 
cascade STAT1 4.6   PENK 4.0 
 SCOTIN (+) 3.7  regulation of transcription GRIM19 (-) 2.4 
GTPase activator activity ARHGEF12 6.0   GTF2IRD1 19.5 
GTPase activity DKFZP564J0863 6.4   IFI16 (-) 15.2 
 GBP1 5.3   IRF1 3.0 
 GBP3 7.2   POLR2I 21.3 
 GBP4 7.5   SP110 5.8 
 GBP5 3.4   SP140 2.7 
 MX1 11.2   STAT1 4.6 
 MX2 19.4  proteolysis and peptidolysis   
protein modification    metallopeptidase activity CNDP2 2.3 
ISGylation DTX3L 3.8   MMP19 3.9 
 IFITM1 8.5  peptidase activity C1R 4.0 
 IFITM3 6.3   C1S 3.8 
 ISG15 (G1P2) 41.4  protease inhibitor activity C4A 8.3 
 UBE1L 11.3   SERPING1 2.6 
phosphorylation MTMR6 2.5   TIMP2 3.8 
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 STAT1 4.6  cell-matrix adhesion GPLD1 5.4 
Biological Process/Molecular 
Function 
Gene name 
Fold 
up 
 
Biological Process/Molecular 
Function 
Gene name 
Fold 
up 
cell adhesion CLEC4F 4.1   MX1 (+) 11.2 
 CTGF 3.2   P8 2.7 
 MFGE8 6.9   STAT1 4.6 
transport ATP1B2 15.5  morphogenesis CTGF 3.2 
 FABP3 10.7   IGFBP2 2.6 
 GRIM19 2.4   MMP19 3.9 
LBP 3.5   P8 2.7  
 NBR2 2.7  growth P8 2.7 
SLC15A3 5.4  insulin-like growth factor binding CTGF 3.2  
 STAT1 4.6   IGFBP2 2.6 
cell proliferation BST2 18.1  complement activation C1R 4.0 
 FABP3 (-) 10.7   C1S 3.8 
 IFI16 15.2   C4A 8.3 
 IFITM1 (-) 8.5   SERPING1 2.6 
 IFITM3 (-) 6.3  helicase activity DDX58 10.7 
 IRF1 3.0   IFIH1 12.3 
 STAT1 4.6   LGP2 4.5 
cell cycle IFITM1 8.5  reproduction MFGE8 6.9 
 IFITM3 6.3  angiogenesis MMP19 3.9 
 IRF1 (-) 3.0     
 STAT1 4.6     
apoptosis GRIM19 (+) 2.4     
 HSXIAPAF1 (+) 9.7     
 IFIH1 16.3     
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4.8. Comparison of the “vertis library” and the “SSH library” 
A total of 376 cDNA fragments displayed a difference in signal intensity of 2-fold or 
more in at least four out of five twin pairs; 210 cDNA fragments were located on one 
of the two “SSH arrays”, the remaining 166 cDNA fragments were located on the 
“vertis array” (view table 3). 
The analysis of the “SSH library” revealed 71 different genes or mRNAs, 35 different 
genes or mRNAs could be identified analyzing the “vertis library”. Table 3 gives an 
overview of the results obtained by array hybridization and sequence analysis. 
 
 
 
 
 
 
Table 3: Results obtained by array hybridization and sequence analysis 
Altogether, the sequence analysis revealed a total of 87 different genes or mRNAs; 
19 cDNAs were present in both libraries, 52 cDNAs were only present in the SSH 
library, respectively 16 cDNAs were only present in the vertis library (view fig. 18). 
 
 
 
 
 
 
 
     Fig. 18: Extent of overlap between the SSH library and the vertis library 
Altogether 87 different cDNAs were identified. From these 87 cDNAs, 
19 cDNAs were present in both libraries, 52 cDNAs were only present 
in the SSH library and 16 cDNAs were only present in the vertis library. 
 
In general, cDNAs that were represented by three or more cDNA clones, either on 
the “SSH array” or “vertis array”, were present in both arrays. In contrast, cDNAs that 
were represented by one or two cDNA clones, either on the “SSH array” or “vertis 
  SSH library vertis library 
number of individual cDNA clones 
analyzed  
3072 1536 
number of cDNA clones showing a 
difference in signal intensity of 2-fold or 
more in at least 4 out 5 twin pairs 
210 166 
number of different cDNA clones  71 35 
 
SSH library vertis library 
52 19 16 
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array”, were only present on one array in the majority of cases. However, some 
cDNAs (i.e. KIAA1404, ISG12, G1P3, and PENK) were identified to be present only 
on one array, even though they were represented by five or more cDNA fragments 
(view table table 4). 
 
 
 SSH library vertis library 
KIAA1404 - 15 
OAS1 14 3 
ISG12 13 - 
G1P3 11 - 
PENK 5 - 
 
Table 4: cDNAs identified to be present in only one library, even though 
they were represented by five or more cDNA fragments on the array 
The percentage of cDNA clones showing a difference in signal intensity of 2-fold or 
more in at least four out of five twin pairs was substantially higher in the vertis library 
than in the SSH library (10.8% versus 6.8%) but redundancy of the identified genes 
was also much higher in the vertis library. Thus, the number of differentially 
expressed genes in relation to the total number of analyzed cDNA clones was almost 
the same in both libraries (2.3% in the SSH library versus 2.2% in the vertis library) 
Fig. 19 shows the high abundance of certain genes in the vertis library as compared 
to the SSH library. In the vertis library five genes represent more than 50 % of the 
differentially expressed cDNA clones, whereas such a predominance of certain 
genes is not observed in the SSH library. 
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Fig. 19a: vertis library 
 
 
Fig. 19b: SSH library 
Fig. 19: Proportional frequency distributions of the identified genes in relation 
to the total number of cDNA clones showing a difference in signal intensitiy of 
> 2.0 fold in at least four out of five twin pairs  
(EST: expressed sequence tags; not seq.: no match with neither of the utilized databases; 
n=1, 2, 3, or 4: genes which were represented by 1, 2, 3, or 4 cDNA fragments on the array) 
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4.9. Validation and precise quantification of mRNA expression by 
quantitative real-time RT-PCR for selected genes 
For nine selected genes (C1S, C1R, DTX3L, HSXIAPAF1, IFITM3, ISG15, 
SERPING1, UBE1L and UTMP) the mRNA expression in the bovine endometrium 
was quantified by the use of quantitative real-time RT-PCR (qPCR) to verify the 
results obtained by array hybridization and to perform more precise quantitative 
measurements for these genes. The same 10 RNA samples as for hybridization 
experiments were used. In addition to the fold-upregulation revealed by qPCR and by 
array hybridization table 5 shows the mean of the crossing points (CP), the mean of 
the CP normalized to the ubiquitin mRNA (∆CP), and the expression difference in 
form of the ∆∆CP. On the basis of the CP the expression level of the mRNAs can be 
estimated (low CP = high and high CP = low expression). The abundance of all 
investigated transcripts was significantly higher in the pregnant stage. The highest 
expression ratio (186-fold) was found for the ISG15 mRNA. The ratios found by 
qPCR were in most cases slightly higher and in some cases, e.g. UTMP and ISG15 
clearly higher compared to those obtained by array hybridization. The results are 
further visualized in fig. 20. 
 
 
CP 
Mean/SEM 
∆CP 
Mean/SEM 
∆∆CP 
Mean/ 
SEM 
Fold up 
Mean/SEM 
t-test p value 
Gene Contr ET Contr ET ET qPCR Array qPCR Array 
Ubiquitin 19.2 ±0.2 19.5 ±0.4 - - - - - - - 
C1R 22.1 ±0.3 20.2 ±0.2 2.8 ±0.3 0.7 ±0.3 2.1 ±0.3 4.7 ±0.9 4 ±0.6 0.001 <0.001 
C1S 23.4 ±0.4 21.3 ±0.6 4.1 ±0.4 1.9 ±0.4 2.3 ±0.4 5.6 ±1.4 3.8 ±0.2 0.003 0.005 
DTX3L 23.7 ±0.3 20.9 ±0.7 4.5 ±0.4 1.5 ±0.3 3 ±0.3 8.8 ±1.6 3.8 ±0.5 <0.001 <0.001 
HSXIAPAF1 22.7 ±0.3 19.5 ±0.6 3.4 ±0.4 0.1 ±0.3 3.3 ±0.4 12.1 ±3.3 9.7 ±1.3 <0.001 0.004 
IFITM3 19.7 ±0.3 16.8 ±0.4 0.5 ±0.4 -2.6 ±0.1 3.1 ±0.4 9.8 ±2.6 6.3 ±0.2 <0.001 0.003 
ISG15 30.4 ±0.5 23.1 ±0.5 11.2 ±0.4 3.7 ±0.3 7.5 ±0.2 185.6 ±27.7 41.4 ±6.8 <0.001 0.001 
SERPING1 30.9 ±0.4 29 ±0.4 11.7 ±0.4 9.6 ±0.3 2.1 ±0.4 5.2 ±1.9 2.6 ±0.3 0.004 0.040 
UBE1L 24.6 ±0.4 20.3 ±0.5 5.3 ±0.4 0.8 ±0.3 4.5 ±0.3 25.6 ±6.8 11.3 ±1.7 <0.001 0.005 
UTMP 26.8 ±1.4 22.3 ±0.8 7.6 ±1.4 2.8 ±0.7 4.8 ±1.3 163.9 ±147.8 7.6 ±3.3 0.012 0.009 
CP: crossing point; ∆CP: CP-CPubi; ∆∆CP: ∆CPET - ∆CPContr 
Table 5: Validation of array results by quantitative real-time RT-PCR 
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Fig. 20: Validation of array results by quantitative real-time RT-PCR. The mean 
fold-upregulation revealed by qPCR and by array hybridization is shown. The 
error bars represent the SEM. 
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4.10. Localization of mRNA expression for selected genes by in situ 
hybridization 
For seven selected genes (C1S, C1R, DTX3L HSXIAPAF1, IFITM3, SERPING1, and 
UBE1L) in situ hybridization with bovine endometrial tissue sections was performed 
to localize the mRNA expression in this complex tissue. A specific pattern of mRNA 
distribution was found for each of these genes (fig. 21 - 23). The hybridization signal 
was always confined to cells of the endometrium and was absent in the myometrium 
and the serosa. No specific signals were observed in sections hybridized with the 
sense strand or in sections incubated with buffer only instead of the oligonucleotide 
probe (not shown). Table 6 summarizes the results of the in situ hybridization 
experiments. The mRNAs for DTX3L, IFITM3, HSXIAPAF1, and UBE1L, which were 
selected due to their potential role in the ISG15ylation system showed a very similar 
expression pattern with strong signals in the luminal epithelium (except for DTX3L), 
in the superficial and deep uterine glands and weak expression in stromal cells. The 
three members of the complement system showed also a similar expression pattern. 
Co-localization was found in the luminal epithelium and the superficial glands. 
Specific expression of SERPING1 mRNA was not detectable in stromal cells. 
 
glandular epithelium 
Gene 
luminal 
epithelium 
superficial 
glands 
deeper 
glands 
stromal 
cells 
DTX3L + ++ + (+) 
IFITM3 +++ ++ ++ + 
UBE1L +++ ++ ++ (+) 
HSXIAPAF1 +++ +++ +++ (+) 
C1R +++ +++ +++ + 
C1S ++ ++ - (+) 
SERPING1 + ++ + - 
 
- no staining, (+) weak staining, + moderate staining, ++ distinct staining, +++ strong 
staining 
Table 6: Results of in situ hybridization with bovine endometrium 
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C1R        C1R 
 
   
C1S       C1S 
 
   
SERPING1      SERPING1 
 
Fig. 21: In situ hybridization for the detection of C1S, C1R, and SERPING1 
mRNA. On the left hand site endometrial sections near the epithelial surface 
are shown, on the right hand site endometrial sections near the deep uterine 
glands are shown. Magnification: 50-fold. 
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IFITM3      IFITM3 
 
   
UBE1L       UBE1L 
 
 
   
DTX3L       DTX3L 
Fig. 22: In situ hybridization for the detection of IFITM3, UBE1L, and DTX3L 
mRNA. On the left hand site endometrial sections near the epithelial surface 
are shown, on the right hand site endometrial sections near the deep uterine 
glands are shown. Magnification: 50-fold. 
Results 
95  
   
HSXIAPAF1        HSXIAPAF1 
 
Fig. 23: In situ hybridization for the detection of HSXIAPAF1 mRNA. On the left 
hand site an endometrial section near the epithelial surface is shown, on the 
right hand site an endometrial section near the deep uterine glands is shown. 
Magnification: 50-fold. 
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5. Discussion 
The objective of the present study was to elucidate changes in gene expression of 
the bovine endometrium due to the presence of a conceptus during the pre-
implantation stage, i.e. day 18 of gestation. Only few other studies have been 
conducted so far to investigate genes involved in the process of embryonic 
implantation in the rhesus monkey (Sun et al., 2004) and in mice (Yoshioka et al., 
2000; Reese et al., 2001), and this is to our knowledge the first study of this kind in 
the bovine species. A combination of subtracted cDNA libraries and cDNA array 
hybridization was applied to detect cDNAs of genes differentially expressed in the 
bovine endometrium of pregnant versus control animals at day 18 of gestation. One 
subtracted cDNA library was constructed according to the SSH method and a second 
one was constructed of subtracted cDNA purchased from the vertis Biotechnologie 
AG. A total of 4068 individual cDNA clones were randomly picked from the 
subtracted libraries and analyzed by array hybridization using 33P-dCTP labeled 
cDNA probes derived from endometrial tissue samples obtained from five 
monozygotic twin pairs. The usage of monozygotic twin pairs as biological model is a 
unique possibility to eliminate genetic variability as a factor potentially affecting the 
results of gene expression analyses as depicted in chapter 2.6. Eighty-seven 
different genes were detected as upregulated in the bovine endometrium of pregnant 
versus control animals at day 18 of gestation. Upregulation was assumed for all 
genes with a difference in signal intensity of two-fold or more in at least four out of 
five twin pairs. Significance of changes in gene expression levels was tested using a 
paired Student’s t-test and considered to be significant when displaying a p-value of 
less than 0.05. Although four genes exhibited a p-value slightly higher than 0.05, they 
were assumed to be of interest, either because of their more than two-fold 
upregulation in four out of five twin pairs (IFIT2, HLA-C, SAMD9) or because of the 
high level of the average upregulation (LY6G6C). In addition, the coefficient of 
variation of the mean fold change was calculated. The moderate variation of 
expression ratios between pregnant and non-pregnant animals (mean coefficient of 
variation 41%) indicates consistent mechanisms of gene regulation. In view of the 
fact that the microarray data were adjusted for effects arising from variation in the 
technology (a process referred to as normalization, see chapter 3.2.7), the coefficient 
of variation is an indicator for the biological difference existing between the RNA 
samples obtained from the five twin pairs. 
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Real-time RT-PCR was used to confirm the expression data obtained by array 
hybridization for selcected genes. The ratios found by qPCR were in most cases 
slightly higher and in some cases, e.g. UTMP and ISG15 clearly higher compared to 
those obtained by array hybridization. This phenomen can easily be explained: for 
array hybridization, a double stranded hybridization probe was used. Although 
hybridization to the cDNA fragments on the array should be preferred, re-association 
to double stranded cDNA in the hybridization solution can occur. The rate of re-
association depends on the concentration of each cDNA, which is higher in the probe 
where the particular cDNA is more abundant. Additionally, background subtraction 
using the function “weighted image regions” contributes to the small variation in 
expression ratios found by array hybridization and qPCR. Overall, the results of 
qPCR and array hybridization correlated very well. 
In situ hybridization was applied to detect the site of mRNA expression of certain 
genes within the endometrium. Interestingly, strong expression of interferon 
stimulated genes was detected in the luminal and superficial glandular epithelium 
(e.g. IFITM3 and UBE1L). This contradicts the common view, that the expression of 
interferon stimulated genes is downregulated in the luminal and superficial glandular 
epithelium by IRF-2, a potent transcriptional repressor (view 2.2). One might 
hypothesize that certain interferon stimulated genes like IFITM3 and UBE1L are 
missing an IRF-2 response element and thereby are not influenced by the 
transcriptional repressor activity of IRF-2. Yet, this remains to be proven. 
Genes known to be stimulated by type I interferons 
The expression of 38 of the identified genes is known to be stimulated by type I 
interferons (overview see fig. 24). The large number of genes inducible by type I 
interferons reflects the response to IFNτ, which is the embryonic pregnancy 
recognition signal in ruminants. It is through the interferon stimulated genes that 
interferons generate diverse cellular and physiological states involving antiviral, 
apoptotic, antitumor, and immune modulatory activities. Some of these genes have 
already been described in the context of early pregnancy in ruminants, e.g. ISG15 
(Austin et al., 1996; Johnson et al., 1998; Austin et al., 2004) OAS1 (Schmitt et al., 
1993), IRF1 (Spencer et al., 1998), IFITM1 and IFITM3 (Pru et al., 2001), MX protein 
(Ott et al., 1998; Hicks et al., 2003), IFIT1 (Kim et al., 2003), ISG12 (Kim et al., 
2003), MHC class I genes and B2M (Choi et al., 2003), but only little information 
exists concerning the putative roles of these ISGs in the context of early pregnancy. 
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The genes listed in Fig. 24 are now discussed in detail, either in this section, or, 
those marked with an asterisk, in one of the following sections below. 
 
 
 
 
Fig. 24: Overview of genes known to be stimulated by type I IFNs 
The genes are discussed in detail, either in this section, or, those marked with 
an asterisk, in one of the following sections below. 
The gene product of DDX58 belongs to the DEAD box proteins, which are 
characterized by the conserved motif Asp-Glu-Ala-Asp (DEAD) and are putative RNA 
helicases. DEAD box proteins are implicated in a number of cellular processes 
involving alteration of RNA secondary structure, such as translation initiation, nuclear 
and mitochondrial splicing, and ribosome and spliceosome assembly. Based on their 
distribution patterns, some members of this family are believed to be involved in 
embryogenesis, spermatogenesis, and cellular growth (Entrez Gene), further, DDX58 
is believed to play some role in inflammatory reactions in the urinary tract epithelium 
(Imaizumi et al., 2004). 
Interferon alpha and beta are known to induce transcription of Homo sapiens 
interferon alpha-inducible protein (clone IFI-6-16), G1P3, while interferon gamma is a 
poor transcription inducer for this gene. In HeLa cells, G1P3 mRNA can constitute as 
much as 0.1 % of the total mRNA after interferon stimulation. The encoded product 
was shown to be a 34 kDa glycosylated protein, which is localized at mitochondria 
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and is highly expressed in gastric cancer cell lines and tissues. The protein exhibits 
anti-apoptotic functions through inhibiting caspase-3 and might therefore function as 
cell survival protein by inhibiting mitochondrial-mediated apoptosis (Tahara E Jr et 
al., 2005). Genomic and cDNA sequence indicate that the mRNA encodes a 
hydrophobic polypeptide of 130 amino acids with a putative N-terminal signal 
sequence (Kelly et al., 1986). Despite a gene disruption study, cellular and 
biochemical roles for the G1P3 gene product have not been identified (Porter and 
Itzhaki, 1993). 
The guanylate-binding proteins (GBPs) form a group of interferon inducible GTP-
binding proteins, which belong to the family of dynamin-related proteins. A unique 
feature of the GBPs is their ability to hydrolyze GTP to GDP and GMP (Praefcke et 
al., 2004), and four members of this gene family, GBP1, GBP3, GBP4 and GBP5, 
were found to be upregulated. GBP1 mRNA has been shown to be specifically 
induced during the midsecretory phase of the menstrual cycle in humans, which 
coincidences with the putative window of implantation. In situ hybridization revealed 
that GBP1 mRNA expression is localized to glandular epithelial cells as well as to 
stromal cells. Treatment of human endometrial adenocarcinoma cells with IFN-
gamma or IFN-alpha markedly induced the expression of GBP1 mRNA; IFN-gamma 
was, however, a more potent inducer of GBP1 than IFN-alpha (Kumar et al., 2001). 
In consideration of the important role of GTPases in cell proliferation, differentiation, 
signal transduction, and intracellular protein transport (Cheng et al., 1985; Cheng et 
al., 1991; Schwemmle and Staeheli, 1994), the unique expression of GBP1 
overlapping the putative window of implantatin in humans and the increased 
expression in endometrium of day 18 pregnant animals shown for GBP1 and GBP3-5 
in the present study suggests, that this gene family could play an important role in the 
process of implantation. Moreover GBP1 and GBP4 mRNA were identified to be 
upregulated in intercaruncular endometrium of pregnant heifers after artificial 
insemination (Bauersachs, personal communication). 
The IFIH1 gene encodes an early type I interferon-responsive gene (Kang et al., 
2004), consisting of a caspase recruitment domain (CARD) and a RNA helicase 
domain. The gene product belongs, like DDX58, to the DEAD box proteins, which are 
implicated in a number of cellular processes, as already mentioned above (Entrez 
Gene).  
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The mRNAs of four interferon induced proteins with tetratricopeptide repeats were 
identified: IFIT1, IFIT2, IFIT3, and IFIT5. The gene product of IFIT1, the interferon 
induced protein with tetratricopeptide repeats 1, is a protein with a molecular mass of 
56 kDa and unknown function. Microinjection of labeled protein into Xenopus laevis 
oocytes indicates that the protein is cytoplasmatic (Wathelet et al., 1986) and, 
furthermore, it has been shown that IFNs alpha, beta or gamma are able to activate 
the expression of this gene in human fibroblasts as well as in lymphoblastoid cells 
(Chebath et al., 1983). An IFIT1 protein-protein interaction study has shown that 
IFIT1 may interact with Rho/Rac guanine nucleotide exchange factor and regulate 
the activation of Rho/Rac proteins. In addition, IFIT1 is the first gene described as 
candidate gene for systemic lupus erythematosus (Ye et al., 2003). IFIT2 encodes a 
polypeptide of 54 kDa, whose function remains to be determined (Entrez Gene). 
IFIT1 and IFIT2 are very closely related at the mRNA and protein level, additionally 
they possess similar promoters, which suggests that IFIT1 and IFIT2 are members of 
a gene family, which probably arose from duplication of an ancestor gene (Wathelet 
et al., 1988). Additionally it has been shown, that four members of the human gene 
family, IFIT1-4, are clustered together at chromosome 10q23.3 and the upstream 
regulatory region of these genes shows a conservation in structure, each containing 
two interferon-stimulated response elements upstream of a conserved TATA box. It 
is proposed that the four members of the family evolved by a series of duplication 
events from a common gene of origin (de Veer et al., 1998).  
The cDNA of ISG12, encoding a putative interferon stimulated protein of 12 kDa, was 
originally cloned as an estrogen-induced gene in human breast epithelial cell line, 
MCF7, and designated as p27. Even though it was demonstrated that the level of 
expression of ISG12 mRNA is induced by estrogen in MCF7 cells, and high 
expression levels of ISG12 mRNA are found in many breast carcinomas, ISG12 
expression does not correlate with the presence of the estrogen receptor, neither in 
the cell lines tested nor in breast carcinomas (Rasmussen et al., 1993). It has then 
been shown by quantitative RT-PCR that ISG12 is an interferon induced gene, 
whereat IFN-alpha is a strong, and IFN-gamma a slight inducer of ISG12 mRNA 
expression (Gjermandsen et al., 2000). The promoter region of the ISG12 gene 
contains putative interferon inducible elements, i.e. ISRE, IRF1/IRF2 and STAT and 
the subcellular localization of ISG12 was localized to the nuclear membrane 
(Martensen et al., 2001). Li et al. (2001) showed that ISG12 expression is strongly 
Discussion 
101  
enhanced in human endometrium during the midsecretory phase of the menstrual 
cycle in humans, overlapping with the putative window of implantation. The authors 
also observed a synergistic interaction between IFN-alpha and estrogen receptor 
signaling pathways that led to maximal induction of ISG12 mRNA in Ishikawa cells (a 
human endometrial adenocarcinoma cell line). However, further experiments are 
needed to shed light on its function especially with regard to embryonic implantation. 
The gene LY6G6C, lymphocyte antigen 6 complex locus G6C, belongs to the 
lymphocyte antigen-6 (LY-6) superfamily and its expression in the bovine 
endometrium is known to be enhanced during the secretory phase of the estrous 
cycle (Bauersachs et al., 2005). Members of the LY-6 superfamily are cysteine-rich, 
generally GPI-anchored cell surface proteins, which have definite or putative 
immune-related roles and are important in leukocyte maturation. The gene LYG6C is 
located in the human major histocompatibility complex class III region (Ribas et al., 
1999), and elevated expression has been shown in patients suffering from systemic 
lupus erythematosus (Tang et al., 2004). Secretion of human leukocyte antigen-G by 
human embryos is associated with a higher in vitro fertilization pregnancy rate as 
shown by Yie et al. (2005), even though a precise function of LY6G6C is not known. 
Two members of the MX proteins were identified: MX1 and MX2. MX proteins are 
large GTPases, belonging to the dynamin superfamily (van der Bliek, 1999), which 
are specifically induced by IFN-alpha/beta (Simon et al., 1991), and in mammals two 
or more genes have been identified (Horisberger and Gunst, 1991). As with other 
dynamin-like proteins, the MX family contains a N-terminal GTPase domain and a 
variable C terminus, which modifies the function and location of the different MX 
proteins (Pavlovic et al., 1993). The protein encoded by the Bos taurus myxovirus 
(influenza) resistance 1 (MX1) gene is similar to the mouse MX1 protein, as 
determined by its antigenic relatedness, induction conditions, physicochemical 
properties, and amino acid analysis. MX1 is located in the cytoplasm and known to 
exert an antiviral effect by targeting specific, yet poorly defined steps of the viral 
replication cycle (Pavlovic et al., 1992). The MX2 protein has similar, yet distinct 
properties compared to MX1: it has a nuclear and cytoplasmatic form and is also 
upregulated by interferon alpha but does not exhibit the antiviral activity of MX1. MX1 
and MX2 belong to the same gene family as the guanylate binding proteins, 
suggesting an important, yet undefined role for large GTPases in the process of 
implantation. The MX protein is furthermore assumed to function as a conceptus-
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induced component of the anti-luteolytic mechanism and/or regulator of endometrial 
secretion or uterine remodeling (Hicks et al., 2003). 
The expression of OAS1 and OAS2 mRNA was shown to be enhanced. The 2´,5´-
oligoadenylate synthetases (OAS) represent a family of interferon induced proteins, 
and in humans three forms of OAS, corresponding to proteins of 40/46 (OAS1), 
69/71 (OAS2), and 100 kDa (OAS3), have been described. These OAS share a 
homologous region of about 350 amino acids, which could represent the functional 
domain. OAS1 contains one single domain, whereas OAS2 and OAS3 contain two 
and three adjacent domains, respectively. In humans, it has been shown that the 
three OAS genes are clustered, which might reflect their evolutionary relationship, 
possibly through the duplication of the conserved functional domain (Hovnanian et 
al., 1998). Oligoadenylate synthetases catalyze the synthesis of 2´-5´-linked 
oligoadenylates from ATP (Justesen et al., 2000), which in turn can bind to the latent 
RNase L, which, in the presence of double stranded RNA, subsequently dimerizes 
into the active form. Thereby this enzyme family plays a role in viral infection 
resistance by degrading viral RNAs (Dong and Silverman, 1995). Concerning 
reproductive processes, the 2’, 5’-oligoadenylate synthetase is hypothesized to affect 
PGF2α secretion by the endometrial epithelium, possibly by altering arachidonic acid 
metabolism (Schmitt et al., 1993). 
Of particular interest among the interferon stimulated genes is ISG15, and recently 
several studies were dedicated to clarify the role of ISG15 at the embryo-maternal 
interface (Johnson et al., 1998; Austin et al., 2004; Joyce et al., 2005). ISG15, one of 
the most markedly upregulated genes in the present study, encodes an ubiquitin-like 
protein that is conjugated to intracellular proteins (Narasimhan et al., 1996). The 
function of ubiquitin is well characterized and includes targeting cellular proteins for 
degradation by the 26S proteasome complex (Alberts et al., 2004). Proteins become 
ubiquitinated through a multienzyme ATP-dependent conjugation process, which 
requires the sequential action of three enzymes: E1, the ubiquitin activating enzyme, 
E2, the ubiquitin conjugating enzyme, and E3, the ubiquitin ligase (Haas and 
Siepmann, 1997). Recently identified proteins that become conjugated to ISG15 
include several serine proteinase inhibitors (Hamerman et al., 2002) and signal 
transduction proteins like phospholipase C gamma1, JAK1, ERK1, and STAT1 
(Malakhova et al., 2003; Malakhov et al., 2003). Because conjugated ISG15 remains 
in the uterus as late as day 45 of pregnancy, Austin and coworkers (2004) postulated 
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that one function of ISG15 is to stabilize proteins rather than target them to 
degradation as described for polyubiquitination. In the present study, the gene for 
bovine ubiquitin activating enzyme-1 like protein (UBE1L), the initiating enzyme for 
ISG15ylation (Rempel et al., 2004), was also identified as upregulated gene. 
Furthermore, the mRNAs for IFITM1 and IFITM3, encoding proteins hypothesized to 
possess E2 enzyme activity based on a conserved E2 motif in the protein sequence 
were found to be upregulated in endometrium from pregnant animals (Pru et al., 
2001). Until now, E3 enzymes specific for ISG15 have not been identified. In this 
study we found upregulated mRNA levels for DTX3L, coding for a protein with E3 
ubiquitin ligase activity (Takeyama et al., 2003). In addition, HSXIAPAF1 (XAF1) 
mRNA levels were increased in the pregnant endometrium. The product of this gene 
was described as antagonist of XIAP (Liston et al., 2001), an anti-apoptotic protein 
that possesses E3 ubiquitin ligase activity (MacFarlane et al., 2002). If XIAP plays a 
role in ISG15ylation due to its E3 ligase activity, it would be possible that 
HSXIAPAF1 as inhibitor of XIAP plays a role in regulation of the ISG15ylation 
system. The mRNA expression patterns of IFITM3, DTX3L, and HSXIAPAF1 
revealed by in situ hybridization in the bovine endometrium were very similar to that 
of UBE1L. Based on this result and the described functions in the literature, these 
genes can be seen as potential components of the ISG15 system and are probably 
involved in the regulation of the response of the endometrium to the signaling of the 
embryo. 
With the signal transducer and activator of transcription 1 (STAT1), a central member 
of the interferonτ signaling cascade was identified. In response to IFNτ STAT 
proteins become tyrosine-phosphorylated, translocate into the nucleus and form 
hetero- and homodimers. These hetero- and homodimers bind to specific response 
elements present in the regulatory region of genes stimulated by interferons (Stewart 
et al., 2001). STAT1 homodimers increase the expression of genes such as the 
interferon regulatory factor 1 (IRF1) (Pine et al., 1994), which mRNA exhibited a 3-
fold upregulation in the present study. The interferon regulatory 1 itself stimulates the 
expression of certain type I interferon stimultated genes through binding to cis-
elements in the promotor regions (Harada et al., 1990). 
Regulation of the maternal immune system in the endometrium 
The intense cross-talk of the maternal endometrium with the fetal semi-allograft is 
reflected in the upregulation of various genes with immune-related functions, such as 
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MHC class I molecules (HLA-A, HLA-C, beta-2 microglobulin), factors of the 
complement system (C1S, C1R, SERPING1), and the lipopolysacharide binding 
protein, LBP. Major histocompatibility complex (MHC) class I molecules consist of a 
MHC encoded heavy chain and a non MHC encoded light chain (beta-2 
microglobulin, β2MG), whereat the major histocompatibility complex is a region of 
high polymorphic genes. The principal function of these molecules is to bind 
fragments of foreign proteins, thereby forming complexes that can be recognized by 
T lymphocytes. Due to this ability of discriminating self and nonself, they are the 
principal determinants of graft rejection. It is well known, that both type I and type II 
interferons induce the expression of MHC class I molecules (Wan et al., 1987; 
Garofalo et al., 1996), and a few studies have been conducted so far to elucidate the 
spatial and temporal pattern of MHC class I expression in the ruminant uterus. Choi 
and coworkers (2003) studied the effects of the estrous cycle, pregnancy, and 
intrauterine administration of recombinant ovine interferon-tau on expression of MHC 
class I α chain and β2MG genes in the ovine endometrium using slot-blot 
hybridization, in situ hybridization and immunofluorescence analyses. The study 
revealed that both, MHC class I α chain and β2MG mRNA and protein, are 
expressed in the luminal epithelium, glandular epithelium and stroma of cyclic and 
early pregnant ewes on days 10 and 12. However, expression of these genes was 
undetectable in the luminal and superficial glandular epithelium after day 14 of 
pregnancy, but was increased in stroma and deep glandular epithelium. This pattern 
of expression is similar to that of other ISGs, and IRF-2, a potent transcriptional 
repressor in the IFN signaling system, is made responsible for this phenomenon (see 
chapter 2.2). Choi et al. hypothesize, that the absence of MHC class I α chain and 
β2MG genes in the luminal epithelium is advantageous because the luminal 
epithelium directly interfaces with the conceptus trophectoderm. The silencing of 
these genes may therefore be a critical mechanism to prevent immune rejection of 
the conceptus allograft. Todd and coworkers (1998) also found that IFNτ enhances 
the expression of MHC class I molecules on ovine endometrial cells. They 
hypothesize that the upregulation of MHC class I molecules may have an effect on 
endometrial natural killer (NK) cells. NK cells, present in the endometrium, increase 
in number during pregnancy, partially due to the action of IFNτ and are potentially 
harmful for the conceptus. These cells bear specific receptors for MCH class I 
molecules, also called “killer cells inhibitory receptors” because interaction with MHC 
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class I inhibits cytotoxic activity. Thus Todd et al. propose that enhancement of 
endometrial MHC class I expression helps to prevent potential damage by the NK 
cells. 
Three factors of the complement system, C1s, C1r and C4A, are upregulated. The 
complement system is a group of serum proteins which are functionally linked and 
interact with one another in a highly regulated manner. The complement system is 
not antigen specific and is activated immediately in the presence of pathogens and is 
considered to be part of innate immunity. Several complement proteins are pro-
enzymes and when activated they become proteases and activate other complement 
proteins in turn (a cascade). There are three different ways the complement cascade 
can be activated but the effector functions are the same, the formation of a 
membrane attack complex (MAC). C1S, C1R, and C4A are part of the classical 
pathway of complement activation, which is initiated by antigen-antibody complexes  
(Abbas et al., 2005) (see fig. 25). 
 
 
 Fig. 25: Classical pathway of complement activation 
 
Simultaneously, the gene expression of SERPING1 is enhanced. The protein 
encoded by this gene is a member of the serpin (serin protease inhibitor) family and 
is also called C1 inhibitor (Ratnoff et al., 1969). It inhibits the ability of C1R and C1S 
to cleave their normal substrates by presenting a “bait” sequence that mimics the 
normal substrates of C1R and C1S. When it is then cleaved by C1R or C1S, it forms 
stable ester linkages with these serine proteases. The in situ hybridization 
experiments revealed specific expression of C1S and C1R mRNA mainly in the 
luminal and glandular epithelial cells but also weakly in the stromal cells. The 
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simultaneous upregulation of SERPING1 in the luminal and glandular epithelial cells 
could be a mechanism to protect the embryo against an attack of the complement 
system. 
UTMP is another gene that may play a role in the modulation of the maternal immune 
system. For the ovine UTMP protein inhibition of NK-like activity was shown and a 
role in protecting the conceptus from maternal cytotoxic lymphocytes was suggested 
(Tekin and Hansen, 2002). As in our study of pregnant cows, UTMP mRNA was 
found to be upregulated in endometrium of pregnant sheep (Stewart et al., 2000). 
IFITM1 has been shown to be highly expressed in gastric tumor tissues and in gastric 
cell lines, where it plays a role in malignant progression by suppressing natural killer 
cells and by increasing the invasive potential of gastric cancer cells (Yang et al., 
2005). For that reason, IFITM1 might be another gene playing a role in preventing 
maternal rejection of the fetal semi-allograft. 
Remodeling of the endometrium 
The categorization of the identified genes according their function revealed the 
orchestrated interaction of various processes and mechanisms with regard to 
preparation of the maternal endometrium for embryonic implantation. Besides CTGF, 
EPSTI1 and components of the MMP system, MMP 19 and TIMP2, genes involved in 
cell growth, proliferation and differentiation as well as regulation of gene expression 
and regulation of apoptosis underline the extensive molecular and structural changes 
taking place during the pre-implantation stage. For an overview of genes involved in 
“cell growth”, “cell differentiation”, “cell proliferation” and “cell cycle” see fig. 26.  
The enhanced expression of genes involved in these biological processes is in 
accordance with several physiological events occurring in the endometrium during 
the pre-implantation period. One event is the synthesis and secretion of histotroph by 
the endometrial glandular epithelium, which supports conceptus development and 
nourishment (Spencer and Bazer, 2004). A further event is reorganization of the 
endometrial luminal epithelium to allow its intimate association with the conceptus 
trophectoderm, e.g. receptors in the luminal epithelium become exposed or induced 
during the receptive period. Wathes and Wooding (1980) describe the changes 
occurring in the uterine epithelium of the cow between days 18 and 28 of gestation 
using electron microscopy. Throughout the estrous cycle the uterine epithelium was 
irregular columnar with a height of 15 - 35 µm. None of these cells contained more 
than one nucleus. At day 18 of gestation the uterine epithelium was more regular 
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than in non-pregnant animals and generally columnar in form. The cell height 
decreased to 20 - 25 µm and it was found that about 3 % of the cells contained two 
nuclei. All these physiological events require the endometrial cells to proliferate, to 
grow and to differentiate. The growth and differentiation of the endometrium and in 
particular of the endometrial glands during the period of early pregnancy is possible 
despite the antiproliferative effects of interferons because the endometrium exhibits a 
reduced responsiveness to the antiproliferative effects of type I interferons (Davidson 
et al., 1994). The genes involved in the processes mentioned above are discussed 
regarding their function either in this section or, those marked with an asterisk, in the 
next section, which deals with genes involved in the regulation of transcription, or 
elsewhere. 
 
 
 
 
 
 
 
Fig. 26: Genes involved in cell growth, cell proliferation, and cell cycle 
The genes are discussed regarding their function either in this section or, those 
marked with an asterix, in the next section, which deals with genes involved in the 
regulation of transcription, or elsewhere. 
 
Rho guanine-nucleotide exchange factor 12 (ARHGEF12) activates Ras proteins and 
thereby regulates cell growth (Kristelly et al., 2004). Ras proteins belong to the large 
Ras superfamily of monomeric GTPases, which help to broadcast signals from the 
cell surface to other parts of the cell. They are often required, for example, when 
receptor tyrosine kinases signal to the nucleus to stimulate cell proliferation or 
differentiation by altering gene expression. Like other GTP-binding proteins, Ras 
functions as a switch, cycling between two distinct conformational states – active 
when GTP is bound and inactive when GDP is bound. ARHGEF12 promotes the 
exchange of bound nucleotide by stimulating the dissociation of GDP and the 
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subsequent uptake of GTP from the cytosol, thereby activating Ras (Alberts et al., 
2004). 
GRIM19, the cell death regulatory protein is involved in the negative regulation of cell 
growth. Its function is described in detail in the next section. 
The insulin-like growth factor binding protein 2 (IGFBP2) is also a regulator of cell 
growth. Insulin-like growth factors (IGFs) are growth-promoting peptides that show 
significant homology with insulin and their bioavailability is controlled through several 
binding proteins. IGFBP2 is an inhibitor of IGF action by binding IGFs and 
subsequent prevention of their binding to the IGF receptors. IGFBP2 therefore 
negatively influences IGF-induced cell proliferation (Rajaram et al., 1997). 
With MMP19 and TIMP2 two genes coding for components of the matrix 
metalloproteinase system, which is classically considered to be involved in tissue 
remodeling, were identified. Until now, neither MMP19 nor TIMP2 mRNA has been 
described to be upregulated in the bovine endometrium around the time of embryonic 
implantation. A study in normal breast tissue and mammary gland tumors revealed 
strong expression of MMP19 protein in all tumor cells of benign lesions, whereas the 
progression towards an invasive phenotype and neoplastic dedifferentiation led to the 
disappearance of MMP19 and a concomitant rise in the levels of MMP2 protein was 
observed (Djonov et al., 2001). These findings suggest an important role of MMP19 
and TIMP2, the inhibitor of MMP2 (Stetler-Stevenson et al., 1989), for the regulation 
of the conceptus attachment. 
Connective tissue growth factor (CTGF), which is assumed to be involved in stromal 
remodeling and uterine cell growth, has been studied at the utero-placental interface 
in pigs (Moussad et al., 2002), mice (Surveyor et al., 1998) and humans (Uzumcu et 
al., 2000). This is the first description of CTGF mRNA expression in the bovine 
endometrium at day 18 of gestation, and CTGF seems to be a universal factor 
involved in endometrial remodeling with regard to the variety of species exhibiting 
increased expression of CTGF mRNA in the maternal environment during the 
implantation period. As another gene important for endometrium remodeling EPSTI1 
was found, and mRNA expression in bovine endometrium was shown for the first 
time. The expression of EPSTI1 mRNA has been shown in tissues characterized by 
extensive epithelial-stromal interaction and there is evidence that EPSTI1 expression 
reflects an important event associated with organ development and tissue 
remodeling. Using a tissue mRNA panel the most prominent expression has been 
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detected in human placenta (Nielsen et al., 2002), underlining the potential 
importance of this gene for endometrial remodeling prior to attachment of the 
embryo. 
Genes involved in regulation of transcription 
Regulation of transcription, the synthesis of RNA from DNA, is one of the most 
important steps in control of cell growth and differentiation and the Gene Ontology 
classification has shown, that several gene products are involved in the regulation of 
gene expression or exhibit transcription regulator activity, respectively (see fig. 27). 
In the following, the different genes are discussed regarding the known or potential 
function of their products. 
BST2 is involved in the regulation of gene expression through positive regulation of 
the NF-kappaB cascade. NF-kappaB proteins are latent gene regulatory proteins that 
lie at the heart of most inflammatory responses, and, once activated, NF-kappaB 
turns on the transcription of more than 60 known genes (Alberts et al., 2004). 
 
 
 
 
 
 
 
 
 
 
 
Fig. 27: Genes exhibiting transcription regulator activity or beeing 
involved in the regulation of gene expression, respectively 
 
CTGF has been shown to enhance growth factor-induced DNA synthesis in NIH 3T3 
fibroblasts and human vascular endothelial cells (Kireeva et al., 1997). 
DTX3L has already been mentioned above in the context of ISG15ylation because it 
possesses ubiquitin-protein isopeptide ligase activity. DTX3L is a member of the DTX 
(Deltex) family, which act as Notch signaling modifiers and may also regulate 
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transcription through interactions with specific transcription factors (Takeyama et al., 
2003). 
EIF4E, the eukaryotic translation initiation factor 4E, is the mRNA cap-binding protein 
required for the translation of cellular mRNAs utilizing the 5´cap structure (Li et al., 
2004). Since EIF4E is the rate-limiting factor for mRNA recruitment to ribosomes, it is 
a major target for regulation of translation by growth factors, hormones, and other 
extracellular stimuli, e.g. IFNτ. 
The fatty acid binding protein (heart) like FABP3 is also believed to be responsible 
for modulation of cell growth and proliferation through the regulation of gene 
expression. It belongs to a multigene family and the fatty acid binding proteins are 
divided into at least three distinct types, the hepatic-, intestinal- and cardiac-type. 
They form 14 - 15 kDa proteins and also participate in the uptake, intracellular 
metabolism and/or transport of long chain fatty acids (Entrez Gene).  
The cell death regulatory protein GRIM19 is a negative regulator of transcription. 
“GRIM” is the abbreviation of Gene associated with Retinoid-IFN-induced Mortality. It 
has been shown, that GRIM-19 interacts with STAT3 (Lufei et al., 2003), which is a 
latent cytoplasmatic transcription factor that can be activated by cytokines, such as 
IFNτ. The cell death regulatory protein GRIM19 interacts specifically with STAT3 to 
repress its transcriptional activity and its target gene expression. GRIM 19 does not 
interact with STAT1 or STAT5a. Huang and coworkers (2004) showed that GRIM19 
is a functional component of the mitochondrial complex I and that it is essential for 
early embryonic development. They generated mice deficient in GRIM19 by gene 
targeting; homologous deletion of GRIM19 causes embryonic lethality at embryonic 
day 9.5. 
The protein encoded by Gtf2ird1, general transcription factor II I repeat domain-
containing 1, contains five GTF2I-like repeats and each repeat possess a potential 
helix-loop-helix (HLH) motif. The protein functions as a positive transcriptional 
regulator under the control of Retinoblastoma protein.  
IFI16, interferon gamma inducible protein 16, is a member of the family of interferon-
inducible proteins. The gene product contains a domain at the amino terminus 
capable of binding double-stranded DNA and Johnstone and coworkers (1998) 
showed that IFI16 is a transcriptional repressor with a modular structure typical of 
many known transcription regulators. 
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The gene POLR2I encodes a subunit of RNA polymerase II, the polymerase 
responsible for synthesizing messenger RNA in eukaryotes. This subunit forms, in 
combination with two other polymerase subunits, the DNA binding domain of the 
polymerase, a groove in which the DNA template is transcribed into RNA. 
SCOTIN was identified as a novel p53-inducible protein localized to the 
endoplasmatic reticulum and the nuclear membrane. This protein can induce 
apoptosis in a caspase-dependent manner (Bourdon et al., 2002). Scotin enhances 
gene expression, like BST2, through the positive regulation of the NF-kappaB 
cascade. 
SP110 belongs to the nuclear body, which is a multiprotein complex that can function 
as an activator of gene transcription and may also serve as a nuclear hormone 
receptor coactivator. The N-terminal domain of SP110 is homologous to two other 
components of the nuclear body protein complex (SP100 and SP140, which was 
identified also), the C-terminal portion is homologous to the transcription intermediary 
factor 1 (TIF1) family of proteins (Bloch et al., 2000). 
The protein encoded by STAT1 is a member of the STAT (signal transducer and 
activator of transcription) protein family. As already mentioned in chapter 2.3, STAT 
family members are phosphorylated by receptor associated kinases in response to 
cytokines and growth factors. After phosphorylation they form homo- or heterodimers 
that translocate to the nucleus where they act as transcription activators. 
The interferon regulatory factor 1 (IRF1) is an interferon responsive gene and its 
expression is enhanced in response to binding of IFNτ to its receptor (see 2.3). IRF1 
exhibits transcription factor activity through binding to cis-elements within the 
promoters of type I interferon inducible genes (Harada et al., 1990). 
Genes involved in cell communication 
A large number of the genes identified to display higher mRNA levels in the pregnant 
animals than in the control group participate in cell communication (see fig. 28), 
which indicates once more the importance of reciprocal communication between the 
embryo and the maternal environment during the pre-implantation period. Since the 
majority of these genes has already been mentioned in one of the previous sections, 
only some of them are shortly discussed regarding their contribution to cell 
communication. 
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ARHGEF12, the Rho guanine-nucleotide exchange factor 12, helps to transmit 
signals from the cell surface to other parts of the cell by activating Ras proteins, as 
already described above (see: Remodeling of the endometrium) 
BST2, as a transmembrane protein, is involved in cell-cell signaling via the exhibition 
of signal transducer activity, but the precise mechanism is not known yet (Entrez 
Gene). 
Homo sapiens membrane-spanning 4-domains, subfamily A, member 8B (MS4A8B) 
is a member of the membrane-spanning 4A (MS4A) gene family. This gene family 
was designated by Liang and Tedder (2001) and, currently, contains at least 12 
subgroups (MS4A1 through MS4A12) that encode at least 21 proteins expressed by 
hematopoetic cells and diverse cell types in non-hematopoetic tissues. MS4A family 
proteins share structural similarity, amino acid sequence homology and chromosomal 
location. They contain 4 highly conserved membrane-spanning regions, flanked by 
N- and C-terminal cytoplasmatic regions and are likely to be components of 
oligomeric cell surface complexes involved in signal transduction (Liang et al., 2001). 
This gene was also found to be upregulated in the bovine cycling endometrium at 
day 12 of the estrous cycle as compared to the day of standing heat (Bauersachs et 
al., 2005). 
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Genes previously described in the context of reproductive processes 
Several genes identified in this study, such as PENK, CTGF, MMPs, TIMPs and 
UTMP, have already been examined regarding their relevance regarding 
reproductive processes. 
Proenkephalin, PENK belongs to the mammalian opioid system which is composed 
of opioid receptors (at least three different types) and endogenous ligands of these 
receptors. The endogenous ligands include more than 20 opioid peptides derived 
from three precursors: proenkephalin (PENK), prodynorphin (PDYN) and 
proopiomelanocortin (POMC) (Brownstein, 1993). In several studies components of 
the opioid system from human placental tissue have been isolated (Sastry et al., 
1980; Liotta et al., 1982; Ahmed et al., 1986; Belisle et al., 1988), but the 
physiological role of the opioid receptors and peptides in the placenta, an organ 
lacking innervation, is not fully understood yet. It has been shown, that opioids 
regulate the release of human chorionic gonadotropin from trophoblast tissue 
(Cemerikic et al., 1991). The presence of mRNA and peptide products derived from 
POMC, PENK (Jin et al., 1988) and DYN (Douglass et al., 1987), as well as opioid 
receptor binding sites (Baraldi et al., 1985), has been reported from the rat uterus. 
The study conducted by Zhu and Pintar (1998) revealed the presence of mRNA of 
the opioid receptors and their endogenous ligand precursors POMC, PENK and 
PDYN in the mouse uterus and placenta in sequential pregnancy states, using in situ 
hybridization. The results clearly indicate that the expression of the opioid system in 
these tissues begins soon after implantation and continues until late gestation. For 
PENK, Zhu and Pintar (1998) suggested a role of the enkephalin derived peptides in 
decidualization. They further suggest that enkephalins may be involved in the 
regulation of hypertrophy of the uterine smooth muscle and in modulating myometrial 
activity during pregnancy. Taken together, PENK seems to play a role during early 
gestation in several species, even though the precise role of PENK in the context of 
embryo-maternal communication is not clearly understood, and this study is the first 
one to describe the expression of PENK mRNA in the ruminant uterus during the pre-
implantation period. 
Numerous studies have been conducted so far in several species to elucidate the 
role of the connective tissue growth factor, CTGF, in reproductive processes. CTGF 
is a heparin-binding mitogen for fibroblasts and smooth muscle cells. Moussad and 
coworkers (2002) examined the temporal and spatial expression of CTGF at the 
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utero-placental interface in the pig using in situ hybridization and 
immunohistochemistry. Up to day 10 of pregnancy, CTGF mRNA and protein were 
abundant in luminal epithelial cells and glandular epithelial cells with lesser amount in 
stromal fibroblast. On days 12-27 there was a striking decrease in the amount of 
CTGF in luminal epithelial cells which was associated with maternal matrix 
reorganization and the onset of subepithelial neovascularization. This decrease was 
transient in nature and high amounts of CTGF appeared again on days 17-21 when 
endometrial neovascularization and matrix remodeling was completed. Moussad et 
al. (2002) concluded, that CTGF plays a role in stromal remodeling and 
neovascularization. Uzumcu and coworkers (2000) investigated the production of 
CTGF by human uterine tissues using immunhistochemical and Northern blotting 
analyses. During pregnancy, the decidual, epithelial and endothelial cells were all 
immunoreactive to CTGF and the authors suggested a role for this molecule in 
regulating aspects of uterine cell growth, migration and/or matrix production during 
pregnancy. On days 1.5 - 3.5 of pregnancy CTGF was mainly localized to uterine 
epithelial cells in the mouse uterus. On day 4.5 reduced levels of CTGF were 
determined, whereas on days 5.5 and 6.5 high levels of CTGF were present in the 
decidual cells (Surveyor et al., 1998). The aim of the study conducted by Rageh and 
coworkers (2001) was to determine mechanisms regulating the production of CTGF 
and TGF-beta1 in the mouse uterus. In situ hybridization and immunhistochemistry 
were used to localize CTGF in pseudopregant or ovariectomized mice. The 
ovariectomized animals received estradiol-17beta or progesterone, either alone or in 
combination. The results indicated that maternal factors are principal cues for CTGF 
production in the uterus, because expression of CTGF during pseudopregnancy is 
comparable to that seen in pregnancy and is regulated by ovarian steroids. Even 
though CTGF is a TGF-beta1 inducible gene, TGF-beta1 dependent and 
independent mechanisms of CTGF exist in the uterus.  
As already pointed out in “Remodeling of the endometrium”, two components of the 
matrix metalloproteinase system were found to be upregulated: matrix 
metalloproteinase 19, MMP19, and tissue inhibitor of metalloproteinase 2, TIMP2. 
Proteins of the matrix metalloproteinase (MMP) family are enzymes capable of 
degrading both the collagenous and noncollagenous components of the extracellular 
matrix (ECM) (Okada et al., 1986). Common features of the MMP family include the 
presence of zinc in the active site of the catalytic domain, synthesis of the MMPs as 
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preproenzymes that are secreted in an inactive form, activation of the latent zymogen 
in the extracellular space, recognition and cleavage of the ECM by the catalytic 
domain of the enzyme, and inhibition of enzyme activity by metalloproteinase 
inhibitors (Curry, Jr. and Osteen, 2003). TIMP2 belongs to the tissue inhibitor of 
metalloproteinase (TIMP) gene family. The proteins encoded by this gene family are 
locally produced and are natural inhibitors of the matrix metalloproteinases (Curry, Jr. 
and Osteen, 2003). The ability of TIMPs to inhibit the MMP action occurs through the 
interaction of the N-terminal domain of TIMP with the active site of the catalytic 
domain and the substrate binding groove of the MMP. The MMP system is involved 
in the breakdown of extracellular matrix in normal physiological processes, such as 
embryonic development, reproduction and tissue remodeling, as well as in disease 
processes, such as arthritis and metastasis. Numerous studies have been conducted 
to elucidate the role of the MMP system in several reproductive processes, such as 
the menstrual cycle in humans and the process of implantation in different species. 
Goffin and coworkers (2003) used reverse polymerase chain reaction to evaluate the 
mRNA expression of a large array of MMPs and TIMPs in the cycling human 
endometrium. The expression of MMP9 and TIMP3 was studied in the implantation 
window phase of the human endometrium using immunhistochemical analyses (Li et 
al., 2000). Both MMP9 and TIMP3 expression was highest during the window of 
implantation. Gao and coworkers (2001) examined the expression of MMP2, TIMP1, 
and TIMP3 mRNA at the implantation site in the uterus of rhesus monkeys during 
early stages of pregnancy using in situ hybridization and Northern Blot analyses. 
Hurst and Palmay (1999) studied developing embryonic and uterine tissues during 
the implantation period in the rat to determine if MMPs and TIMPS are detectable. 
MMP2, MMP9, and TIMP2 were detectable on each day studied. A similar yet distinct 
study was done by Zhao et al. (2002). They determined the expression of MMP2 and 
MMP9 and TIMPs1-3 mRNAs in the rat uterus during early pregnancy. 
The uterine milk protein (UTMP) is a member of the serpin superfamily of serine 
protease inhibitors even though no inhibitory activity towards any serine protease has 
been demonstrated so far (Ing and Roberts, 1989). The uterine milk protein is an 
important regulator of uterine immune function since it inhibits lymphocyte 
proliferation (Skopets et al., 1992) and reduces cytotoxic activity of NK cells (Liu and 
Hansen, 1993). NK cells are an important component of the natural immune system 
involved in immune surveillance against infectious diseases and autologous and 
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allogenic tumors (Trinchieri, 1989). NK like cells are also present in the endometrium 
of humans (King and Loke, 1990), mice (Croy et al., 2003) and sheep (Liu and 
Hansen, 1993), but the precise function is not elucidated yet. As described in chapter 
2.1.4, the expression of UTMP is presumably driven by progesterone and therefore 
UTMP is assumed to mediate the immunosuppressive effects of progesterone. 
Placenta expressed transcript protein (PLET8), also called C11orf34, has been 
previously reported to be highly expressed in pig and mouse placenta (Zhao et al., 
2004). Hitherto, nothing is known about its function. 
Surprisingly, expression of IFNτ mRNA itself (bovine trophoblast protein-1, TP-1) 
was found in the endometrial tissue samples by array hybridization. On the first 
glance, this might be due to residual trophoblast tissue adhering to the endometrium, 
but on day 18 of gestation no adhesion of the conceptus to the endometrial 
epithelium has occurred yet, as shown by an electron microscopy study conducted 
by Wathes und Wooding (1980). Moreover, IFNτ mRNA was identified to be 
upregulated in intercaruncular endometrium of pregnant heifers after artificial 
insemination as shown by array hybridization and qPCR (Bauersachs, personal 
communication), implicating, that the expression of IFNτ is a specific reaction of the 
ruminant endometrium around the time of embryonic implantation. Furthermore, it 
has been shown that human ISG15 induces IFN-gamma release by cultured T cells 
and Pru and coworkers (2000) hypothesized that bovine ISG15 would also induce 
release of IFN-gamma from peripheral blood mononuclear cells (PBMCs) in a 
manner similar to that described for human ISG15. Indeed, bovine ISG15 
upregulated IFN-gamma mRNA in PBMCs. They further detected IFN-gamma mRNA 
in higher amounts in endometrium of pregnant compared to non-pregnant cows, and 
suggested that this increase could be mediated directly by ISG15. But ISG15 failed to 
induce IFN-gamma mRNA in cultured BEND cells, which might be explained by 
means of the nature of these cells: BEND cells are a highly enriched epithelial cell 
line primarily derived from uterine luminal epithelium, so ISG15 could have failed to 
induce IFN-gamma mRNA, because the IFN-gamma mRNA found in uterine 
endometrium from pregnant cows may have originated from cells other than the 
luminal epithelium, e.g. cells of the stroma or deep glandular epithelium or 
leukocytes. So it might be possible that ISG15 induces the expression of IFNτ in 
endometrial cells, but this hypothesis remains to be proven, e.g. by in situ 
hybridization. 
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Genes involved in cell adhesion 
In domestic ruminants endometrial invasion, as it takes place in humans and rodents, 
does not occur; thus definite implantation is achieved by tight adhesion of the 
mononuclear trophoblast cells to the endometrial luminal epithelium. The present 
study revealed four genes, whose products are involved in cell adhesion; CLEC4F 
CTGF, GPLD1, and MFGE8. None of them has been mentioned to play a role in 
bovine implantation yet. CLEC4F is a member of the C-type lectins, which represent 
a large family of Ca2+-dependent lectins that share primary structural homology in 
their carbohydrate-recognition domains. Members of the large family include many 
endocytic receptors, many proteoglycans, and all known collectins and selectins, 
which have diverse functions, such as cell-adhesion and cell-cell signaling amongst 
others (Alberts et al., 2004). The connective tissues growth factor (CTGF) is 
described in “Genes previously described in the context of reproductive processes”. It 
has been shown that CTGF promotes cell adhesion by directly binding to two 
integrins, namely alpha(v)beta(3) and alpha(2b)beta(3) (Babic et al., 1999; 
Jedsadayanmata et al., 1999). The analysis of the deduced amino acid sequence of 
GPLD1 revealed four regions of internal homology, which show a significant similarity 
with the metal ion binding domains of the alpha subunits of integrins. These 
sequences share an aspartate-rich core, flanked by short, conserved segments that 
occur only in the integrins (Scallon et al., 1991). The protein encoded by MFGE8 is 
an abundant peripheral protein associated with the milk fat globule membrane but is 
also found in a wide range of tissues and is present in several body fluids (Butler et 
al., 1980; Andersen et al., 1997). MFGE8 consists of two N-terminal EGF-like 
domains, followed by two repeated C domains with homology to the C1 and C2 
domains of blood clotting factor V and VIII. The second EGF motif domain contains 
an Arg-Gly-Asp (RGD) cell adhesion sequence motif recognized by integrin receptors 
(Hvarregaard et al., 1996; Couto et al., 1996). The RGD motif is located at the turn of 
the B-loop in the EGF domain and is thereby likely to be exposed to the 
surroundings. Moreover, the sequence motif is conserved in all species and MFGE8 
proved to be an integrin receptor ligand, as affinity chromatography against bovine 
MFGE8 purified the αvβ5 integrin receptor (Andersen et al., 1997). Likewise, human 
and murine orthologous proteins have been demonstrated to interact with endothelial 
cells expressing the αvβ5 integrin (Taylor et al., 1997; Hidai et al., 1998). Furthermore, 
functional analyses carried out by Andersen and colleagues (2000) demonstrated, 
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that MFGE8 is a specific ligand for the αvβ5 and α5βv integrin receptors through its N-
terminus, and that it can link to surfaces by binding to phospholipids through its C-
terminus.  
Genes, whose function remains to be elucidated in the context of early embryo-
maternal communication 
Neighbor of BRCA1 gene 2 (NBR2) was identified by its close proximity on human 
chromosome 17 to tumor suppressor gene BRCA1. The physical distance between 
the transcription start sites of the NBR2 and BRC1 genes is 218 base pairs, 
suggesting that regulation of the expression of both genes may be coordinated 
through a bi-directional prometer. The NBR2 cDNA contains an open reading frame 
of 112 amino acids and is predicted to encode a protein of approximately 12 kDa (Xu 
et al., 1997). The specific function of the gene product has not been determined yet. 
BST2, bone marrow stromal cell antigen-2, is a type-2 transmembrane protein which 
is expressed not only on certain bone marrow stromal cell lines, but also on various 
tissues. Bone marrow stromal cells regulate B-cell growth and development through 
their surface molecules and cytokines, and there are hints that BST2 facilitates pre-
B-cell growth (Ishikawa et al., 1995). On the first glance, the enhanced expression of 
this gene seems bewildering in the context of this study, but interestingly, Lysiak and 
Lala (1992) showed that certain mouse decidual stromal cells (DSC) and endometrial 
stromal cells (ESC) are actually of bone marrow origin. Decidual tissue is the 
maternal component of the maternal-fetal interface in humans and rodents and is 
composed predominantly of typical stromal-type cells as well as glandular cells and 
leukocytes. Decidual stromal cells constitute a distinctive cell class that appears in 
the endometrium during pregnancy. Initially DSC have classically been considered as 
fibroblastic cells (Riddick and Kusmik, 1977), but more recent studies demonstrated 
that DSC express antigens associated with hematopoietic cells (Imai et al., 1992; 
Montes et al., 1996; Olivares et al., 1997) and that they are, as already mentioned, of 
bone marrow orgigin (Lysiak and Lala, 1992). Furthermore, Simmons and Torok-
Storb (1991) isolated DSC with a stable antigen phenotype similar to that of bone 
marrow stromal precursors. Studies in mice have suggested that the precursor cells 
of DSC can migrate from their origin (yolk sac and/or bone marrow) to the uterus at 
any time between embryonic life and the onset of reproductive life (Lysiak and Lala, 
1992). Evaluation of the endometrium from four HLA-mismatched bone marrow 
transplant recipients demonstrated that endometrial cells can originate from donor-
Discussion 
119  
derived bone marrow cells, suggesting that nonuterine stem cells contribute to the 
regeneration of human endometrial tissue (Taylor, 2004). The results of a study 
conducted by Johnson and coworkers (2003b) indicate that the uterine stroma of 
sheep undergoes a program of differentiation similar to decidualization in invasive 
implanting species. One might hypothesize that a similar process of differentiation 
takes place in the bovine endometrium, thereby explaining the enhanced expression 
of BST2 around the time of embryonic implantation. 
CNDP dipetidase 2 (CNDP2) is a ubiquitous protein of 52.7 kDa exhibiting peptidase 
activity and belongs to the M20 metalloprotease family. CNDP2 requires Mn2+ for full 
activity, and is sensitive to inhibition by betastatin (Teufel et al., 2003). 
The protein encoded by Homo sapiens chromosome 5 open reading frame 18 
(C5orf18) is integral to membrane, but nothing about its function is known yet. The 
expression of this gene has previously been identified to be enhanced during the 
secretory phase of the estrous cycle in the bovine endometrium (Bauersachs et al., 
2005). 
The C-terminal modulator protein (CTMP) has been identified as a negative 
regulatory component of the pathway controlling protein kinase B activity (Maira et 
al., 2001). Protein kinase B (PKB) (also called Akt) is a major downstream target of 
receptor tyrosine kinases that signal via phosphatidylinositol 3-kinase and once 
activated through phosphorylation by a phospaditylinositol-dependent protein kinase 
called PDK1, protein kinase B phosphorylates a variety of cytosolic target proteins 
(Alberts et al., 2004). Epigenetic downregulation of CTMP transcription is a common 
aberration in glioblastomas (Knobbe et al., 2004). 
Homo sapiens likely ortholog of mouse D11lgp2 (LGP2) is a cytoplasmatic protein of 
678 amino acids and was identified in a study which aimed to identify genes in the 
STAT3/5 locus that may participate in normal and neoplastic development of the 
mammary gland (Cui et al., 2001). 
Only little information is available about LOC401623, Homo sapiens similar to LINE-1 
reverse transcriptase homolog. Long interspersed elements (LINE-1) are abundant 
retrotransposons in mammalian genomes that probably retrotranspose by target site-
primed reverse transcription (TPRT). During TPRT, the LINE-1 endonuclease 
cleaves genomic DNA, freeing a 3’hydroxyl that serves as primer for reverse 
transcription of LINE-1 RNA by LINE-1 reverse transcriptase. 
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Abundance levels of the cytosolic NADP-isocitrate dehydrogenase (IDH1) protein 
were shown to be dependent on the stage of the sexual cycle in human 
endometrium, with a maximum in the secretory phase (Byrjalsen et al., 1995). 
Additionally, in a holistic differential analysis of embryo-induced alterations in the 
proteome of bovine endometrium in the preattachment period, IDH1 protein showed 
a significantly higher abundance in samples derived from pregnant animals (Berendt 
et al., 2005). 
Myotubularin and related proteins, like MTMR6, constitute a large and highly 
conserved family possessing phosphoinositide 3-phosphatase activity, although not 
all members show this activity. Members of this family contain a conserved region 
called the GRAM domain that is found in a variety of proteins associated with 
membrane-coupled processes and signal transduction (Tsujita et al., 2004). As 
compared to the day of standing heat, MTMR3 is upregulated in the cycling bovine 
endometrium at day 12 of the estrous cycle (Bauersachs et al., 2005). 
Placental ribonuclease/angiogenin inhibitor (RNH1) is a member of a family of 
proteinaceous cytoplasmatic RNase inhibitors that occur in many tissues and bind to 
both intracellular and extracellular RNases. In addition to control of intracellular 
RNases, the inhibitor may have a role in the regulation of angiogenin. RNH1 may be 
essential for control of mRNA turnover, since neutral and alkaline ribonucleases play 
a critical role in the turnover of RNA in eukaryotic cells. RNH1 further displays a 
unusual combination of high affinity and relaxed stringency (Iyer et al., 2005). 
The sterile alpha motif domain present in SAMD9 is a protein interaction module that 
is present in diverse signal-transducing proteins such as the Eph family of receptor 
tyrosine kinases, diaglycerol kinases, serine-threonine kinases, Src homology 2 
domain-containing adapter proteins, and others (Thanos et al., 1999). 
SLC15A3 is a member of the solute carrier family 15 of electrogenic transporters that 
utilize the proton-motive force for uphill transport of short chain peptides and peptide-
mimetics into a variety of cells. The prototype tranporters of this family are SLC15A1 
and SLC15A2, which mediate the uptake of peptides into intestinal and renal 
epithelial cells. SLC15A3 was identified by Daniel and Kottra (2004), and shown to 
transport free histidine and certain di- and tripeptides, but it is not clear yet whether it 
is located in the plasma membrane or represents a lysosomal transporter for proton-
dependent export of histidine and dipeptides from lysosomal protein degradation into 
the cytosol. In humans, SLC15A1 is upregulated during the late secretory phase of 
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the cycling endometrium and its expression is restricted to glandular and luminal 
epithelial cells (Riesewijk et al., 2003). 
The HBxAG transactivated protein 2 (XTP2) gene is amplified and overexpressed in 
bladder cancer (Huang et al., 2002). 
Insulin-like growth factor system 
The insulin growth factor system is assumed to play a vital role in endometrial tissue 
remodeling by regulating uterine growth (Wolf et al., 2003). The changes in 
abundance of the mRNAs of IGFBP2 and CTGF, encoding a low-affinity IGF-binding 
protein, indicate the potential importance of IGFBP regulation of uterine IGFs during 
this time period. Furthermore, upregulation of MMP19 might lead to proteolysis of 
IGFBP3, which was shown to result in increased IGF-signaling in human 
keratinocytes (Sadowski et al., 2003). 
Expression levels of some genes are rather maintained at a higher level than induced 
by the embryo 
The expression of six genes, namely ATP1B2, IDH1, LY6G6C, MS4A8B, PENK, and 
TIMP2 is likely to be not specifically upregulated by the presence of a conceptus 
since they were identified as upregulated at diestrus in a study of transcriptome 
changes in bovine intercaruncular endometrium comparing late estrus and diestrus 
(Bauersachs et al., 2005). The regulation of these genes can be explained in the way 
that the presence of the embryo maintains a high level of expression by preventing 
the progression of the estrous cycle. 
Comparison to other studies respectively the literature 
Three previous studies dealing with global gene expression analysis were conducted 
in the past. Sun et al. (2004) performed suppression subtractive hybridization to find 
genes that are differentially expressed in the implantation site of the pregnant rhesus 
monkey uterus, Reese et al. (2001) compared RNAs from implantation and 
interimplantation sites to identify genes that are specifically up- or downregulated at 
the implantation site in mice, and Yoshioka et al. (2000) examined the expression of 
uterine genes before and after conceptus implantation in mice. There are very few 
genes mutually identified in one of the three studies mentioned above and in the 
current study, which deals with the identification of genes induced by the conceptus 
in the bovine endometrium during the pre-implantation period. There are two main 
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reasons for the missing concurrence regarding the set of identified genes. On the 
one hand, the process of embryonic implantation was investigated in different 
species, i.e. rhesus monkeys, mice and cows, which all exhibit fundamental 
differences concerning the mode of embryonic implantation. On the other hand, only 
Sun and coworkers virtually compared the mRNA profiles of pregnant and non-
pregnant uteri, as it was performed in the current study. The two remaining studies 
compared the mRNA profiles of implantation and interimplantation sites, both tissue 
samples derived from pregnant uteri (Reese et al., 2001) or the mRNA profiles of 
whole uterine tissues from two different days of gestation (Yoshioka et al., 2000), 
respectively, thus, the studies substantially differ from the current study concerning 
their experimental design. 
In chapter 2.1 various cytokines and growth factors are reviewed regarding their 
known or potential function in the context of embryonic implantation. Some of these 
factors, e.g. LIF, M-CSF, and HOXA10, have been demonstrated to be essential for 
embryonic implantation in species such as mice and humans. In the current study 
none of the cytokines or growth factors reviewed in chapter 2.1 was identified. This 
might be attributable to the fact that, instead of the total subtracted cDNA library, only 
a representational number of clones was analyzed by cDNA array hybridization. 
Nevertheless, several studies conducted in our laboratory have proven that the 
analysis of 1536 clones per subtracted cDNA library is sufficient to identify the most 
relevant set of differentially expressed genes (Bauersachs et al., 2003; Bauersachs 
et al., 2004). It is more likely, that some of the factors, which have been shown to be 
indispensable for embryonic implantation in the murine and human species, was 
identified in the present study because the mode of implantation differs substantially 
between these species and the cow, as already mentioned above. 
The efficiency of SSH 
During the course of this research project, the efficiency of two subtraction methods 
for generating subtracted cDNA was compared: on the one hand, subtracted cDNA 
was generated using the SSH method according to Diatchenko and coworkers 
(1996) (in the following referred to as “SSH library”), and, on the other hand, 
subtracted cDNA was purchased from the vertis Biotechnologie AG (in the following 
referred to as “vertis library”). Both subtracted cDNA populations were used to 
construct a cDNA library, which was subsequently analyzed by cDNA array 
hybridization. 
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Two major differences concerning the technique of subtraction exist between both 
approaches. The first step in the process of subtraction involves hybridization of 
cDNA from one population (tester) to excess of cDNA from another population 
(driver). The SSH method utilizes double stranded (ds) cDNA for hybridization, 
whereas the vertis Biotechnologie AG made use of single stranded (ss) cDNA. Due 
to the fact that complementary cDNA strands cannot form between tester molecules 
when using ss cDNA for hybridization, the equalization of the concentration of high- 
and low abundance sequences (a process referred to as normalization, view chapter 
2.4) only occurs when employing the SSH method. An additional difference consists 
in the second step of subtraction, which involves separation of the unhybridized 
fraction (target) from the hybridized common sequences. The SSH methods utilizes 
the so-called suppressor PCR, which selectively amplifies target cDNA fragments 
and simultaneously suppresses non-target cDNA amplification. Thereby any 
intermediate step for physical separation of ss and ds cDNAs is circumvented. The 
vertis Biotechnolgie AG, however, uses hydroxylapatite chromatography to separate 
ss and ds cDNA in a physical manner. 
From the SSH library 3072 individual cDNA clones were analyzed, whereas only 
1536 individual cDNA clones were analyzed from the vertis library, because ongoing 
sequence analysis of differentially expressed cDNAs revealed high redundancy of 
the identified genes belonging to the “vertis library”. This predominance of certain 
genes in the “vertis library” is due to the fact that, as already mentioned above, only 
when performing subtraction according the SSH method the process of normalization 
occurs. Collectively, it can be stated, that, even though the percentage of 
differentially expressed genes is almost the same in both libraries, the library 
constructed using the SSH method is more suitable for analyzing a large number of 
individual cDNA clones. Analysis of a larger number of cDNA clones from the vertis 
library is much more effort by reason of the lacking equalization of the concentration 
of high- and low abundance sequences. 
In general, cDNAs that were represented by three or more cDNA clones, either on 
the “SSH array” or “vertis array”, were present in both arrays, indicating that both 
methods are suitable for identifying the relevant subset of differentially regulated 
genes . In contrast, cDNAs that were represented by one or two cDNA clones, either 
on the “SSH array” or “vertis array”, were only present on one array in the majority of 
cases. However, some cDNAs (i.e. KIAA1404, ISG12, G1P3, and PENK) were 
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identified to be present only on one array, even though they were represented by five 
or more cDNA fragments. There is no reasonable explanation for this observation. 
Probably, for some reason, certain cDNA fragments can only be amplified and 
identified with one of the two methods. 
Final Conclusions 
In conclusion this study provides a holistic view of the quantitative changes of 
endometrial transcript levels associated with the complex embryo-maternal cross-talk 
in the bovine species. Even though the precise function is not known for each gene 
identified, the study revealed the orchestrated upregulation of genes important for 
embryonic implantation during the pre-implantation period in the bovine 
endometrium. The findings underline the importance of IFNτ as an embryo-derived 
pregnancy recognition signal. The categorization of the identified genes according 
their function revealed the orchestrated upregulation of genes essential for 
remodeling of the endometrium, and for modulation of the maternal immunsystem, 
and of several putative components of the ISG15ylation system. Moreover, many 
increased transcript levels were found for novel candidate genes which might be 
important for conditioning the endometrium for conceptus attachment. These findings 
represent interesting starting points for more detailed investigations and are a solid 
basis for building a systems biology of embryo-maternal communication and 
implantation. 
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6. Summary 
Identification of genes induced by the conceptus in the bovine endometrium 
during the pre-implantation period 
 
An intact embryo-maternal communication in the pre-implantation period is 
particularly critical for establishment of pregnancy and early embryonic losses have 
been identified as the major cause of reproductive failure in cattle. Thus, to gain 
deeper insight into this complex embryo-maternal crosstalk, a combination of 
subtracted cDNA libraries and cDNA array hybridization was applied to identify 
mRNAs differentially regulated genes in the bovine endometrium by the presence of 
a conceptus. One cDNA library was constructed according the suppression 
subtractive hybridization method (Diatchenko et al., 1996) with minor modifications; a 
second cDNA library was constructed of subtracted cDNA purchased from the vertis 
Biotechnologie AG. As biological model endometrial tissue samples of monozygotic 
twins (generated by embryo splitting) collected at day 18 of gestation were used, 
which is a unique possibility to eliminate genetic variability as a factor potentially 
affecting the results of gene expression analyses. Array hybridization was carried out 
using 33P-labeled cDNA probes obtained from five monozygotic twin pairs. Sequence 
analysis revealed 87 different genes or mRNAs, respectively, which displayed a 
difference in signal intensity of 2.0 fold or more in at least four out of five twin pairs. 
Eighty genes corresponded to genes with known or inferred function, either the 
bovine gene or the human orthologue. For 7 mRNAs a match with bovine ESTs was 
obtained only. For nine selected genes the expression in the bovine endometrium 
was quantified by the use of quantitative real-time RT-PCR to verify the results 
obtained by array hybridization and to perform more precise quantitative 
measurements for these genes. Overall, the results of array hybridization and real-
time RT-PCR correlated very well. 
Almost half of the identified genes are known to be stimulated by type I interferons 
reflecting the response to IFNτ, which is the pregnancy recognition signal in 
ruminants. Of particular interest among the interferon stimulated genes is ISG15, one 
of the most markedly upregulated genes in the present study, which is hypothesized 
to stabilize intracellular endometrial proteins through conjugation processes. For the 
ISG15ylation system mRNAs of four potential components (IFITM1, IFITM3, 
HSXIAPAF1, and DTX3L) were found in addition to ISG15 and UBE1L, and in situ 
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hybridization revealed similar mRNA expression patterns of these genes. It is 
therefore suggested, that modification of endometrial proteins through ISG15ylation 
plays a fundamental role in the IFNτ signaling. 
A classification of the identified genes according to their assignment to Gene 
Ontologies revealed the orchestrated interaction of various processes and 
mechanisms with regard to the preparation of the maternal endometrium for 
embryonic implantation. As particular interesting, genes were identified involved in 
modulation of the maternal immune system at the humoral and cellular level, cell 
adhesion, cell communication, regulation of transcription, cell differentiation, cell 
growth, and cell proliferation. These findings underline that an intense embryo-
maternal dialogue takes place during the pre-implantation period, which culminates in 
a receptive endometrium prepared for implantation of the conceptus. 
To conclude, this is the first study of its kind for cattle in the pre-implantation stage of 
embryonic development and revealed the orchestrated upregulation of genes 
important for embryonic implantation during the pre-implantation period in the bovine 
endometrium. The presented results provide new starting points for detailed 
investigations of the embryo-maternal dialogue by which the endometrium is 
prepared for conceptus attachment. 
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7. Zusammenfassung 
Identifizierung von Genen im bovinen Endometrium, welche durch den 
Konzeptus im prä-implantatorischen Zeitraum induziert werden 
 
Eine intakte embryo-maternale Kommunikation in der prä-Implantationsphase ist im 
Besonderen wichtig für die Etablierung einer Gravidität und frühe embryonale 
Verluste wurden als eine der Hauptursachen für Fruchtbarkeitsstörungen beim Rind 
identifiziert. Deshalb wurde, um einen tieferen Einblick in diesen komplexen embryo-
maternalen Dialog zu bekommen, eine Kombination aus subtraktiven cDNA Banken 
und cDNA Array Hybridisierung angewendet, mit dem Ziel, Gene zu identifizieren, die 
aufgrund der Gegenwart des Konzeptus differentiell reguliert werden. Eine 
subtraktive cDNA Bank wurde, mit kleinen Modifikationen, nach der suppression 
subtractive hybridization Methode (Diatchenko et al., 1996) hergestellt; eine zweite 
subtraktive cDNA Bank wurde aus subtraktiver cDNA hergestellt, welch von der 
vertis Biotechnologie AG erworben wurde. Als biologisches Modell dienten 
endometriale Gewebeproben von monozygoten Zwillingen (generiert durch 
Embryosplitting), welche an Tag 18 der Gravidität gewonnen wurden. Diese 
Vorgehensweise ist eine einmalige Gelegenheit um den Einfluss genetischer 
Variabilität auf die Ergebnisse von Genexpressionanalysen zu eliminieren. Die Array 
Hybridisierung wurde mit 33P-markierten Proben von fünf monozygoten 
Zwillingspaaren durchgeführt. Die Sequenzanalyse ergab 87 verschiedene Gene 
beziehungsweise mRNAs, die einen Unterschied in der Signalintensität von 2,0 oder 
mehr in mindesten vier von fünf Zwillingspaaren zeigten. Achtzig mRNAs konnten 
Genen mit bekannter oder mutmaßlicher Funktion zugeordnet werden, entweder 
dem bovinen Gen oder dem humanen Ortholog. Für 7 mRNAs konnte nur ein Treffer 
mit bovinen ESTs gefunden werden. Um die Ergebnisse der Array Hybridisierung zu 
verifizieren und um eine genauere quantitative Messung durchzuführen, wurde die 
Expression neun ausgesuchter Gene durch quantitative real-time RT-PCR 
quantifiziert. Die Ergebnisse der Array Hybridisierung und der real-time RT-PCR 
korrelierten sehr gut.  
Von fast der Hälfte aller identifizierten Gene ist bekannt, dass die Expression durch 
Typ I Interferone stimuliert, was die Antwort auf IFNτ, dem 
Trächtigkeitserkennungsignal bei Ruminanten, widerspiegelt. Unter den Interferon 
stimulierten Genen ist das ISG15, eines der am deutlichsten hochregulierten Gene in 
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der vorliegenden Studie, von besonderem Interesse, von welchem angenommen 
wird, dass es intrazelluläre endometriale Proteine durch Konjugationsprozesse 
stabilisiert. Neben ISG15 und UBE1L wurden vier potentielle Komponenten des 
ISG15 Systems gefunden (IFITM1, IFITM3, HSXIAPAF1 und DTX3L) und die in situ 
Hybridisierung zeigte ähnliche mRNA Expressionsmuster dieser Gene. Es wird 
deswegen angenommen, dass die Modifikation endometrialer Proteine durch 
ISG15ylierung eine fundamentale Rolle im IFNτ Signaltransduktionsweg spielt.  
Eine Klassifizierung der identifizierten Gene nach ihrer Zuordnung zu Gene 
Ontologies deckte die koordinierte Interaktion verschiedenster Prozesse und 
Mechanismen im Hinblick auf die Vorbereitung des maternalen Endometriums auf 
die Implantation des Embryos auf. Als besonders interessant wurden Gene erachtet, 
die eine Rolle spielen in der Regulation des maternalen Immunsystems auf zellulärer 
und humoraler Ebene, der Zelladhäsion, der Zellkommunikation, der Regulation der 
Transkription, der Zelldifferenzierung und der Zellproliferation. Diese Ergebnisse 
unterstrichen, dass ein intensiver embryo-maternaler Dialog in der prä-
implantatorischen Phase stattfindet, welcher in einem rezeptiven Endometrium, 
vorbereitet auf die Implantation des Konzeptus, gipfelt.  
Abschließend ist dies die erste Studie ihrer Art in der prä-Implantationsphase der 
embryonalen Entwicklung beim Rind, wobei die koordinierte Hochregulierung von 
Genen, die im Kontext der embryonalen Implantation eine wichtige Rolle spielen, 
gezeigt werden konnte. Die Ergebnisse liefern somit neue Ausgangspunkte für 
detailliertere Untersuchungen des embryo-maternalen Dialogs, welcher das 
Endometrium auf die Adhäsion des Konzeptus vorbereitet. 
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